Febrile illnesses at the Colombo North Teaching Hospital in Sri Lanka (The Ragama Fever Study) by Bailey, Mark S
 
 
 
Febrile Illnesses at the Colombo 
North Teaching Hospital in Sri Lanka 
 
(The Ragama Fever Study) 
 
 
 
 
 
 
 
 
 
Lt Col Mark Stephen Bailey RAMC 
BSc MB ChB FRCP FFTM DTM&H 
 
 
 
 
 
 
 
 
 
Thesis submitted in fulfilment of the requirements for 
the degree of Doctor of Medicine in Tropical Medicine 
 
 
Liverpool School of Tropical Medicine 
 
 
01 July 2012 
  
 -ii- 
  
 -iii- 
Abstract 
 
Acute undifferentiated febrile illnesses in the tropics and sub-tropics are caused by a 
wide range of infectious diseases that often have indistinguishable clinical features. 
In developing countries there may also be insufficient microbiology facilities to 
identify these infections leading to missed diagnoses, inefficient use of healthcare 
resources, over-use of empirical treatments, a lack of information on antimicrobial 
resistance and inaccurate epidemiological data for guiding prevention strategies. 
These problems occur in Sri Lanka, but a prospective, systematic, representative and 
comprehensive study of febrile illnesses has never been performed. 
 
The Ragama Fever Study was performed at a major hospital in western Sri Lanka 
that served both urban and rural areas. Its aims were to identify the causes of febrile 
illnesses in a large sample of patients admitted to the hospital over a 1-year period, 
develop clinical prediction rules that could distinguish between the most common 
infectious diseases and assist in the evaluation of rapid (point-of-care) diagnostic 
tests that were appropriate to this setting. 
 
617 (86.7%) of 711 febrile patients admitted to a quarter of the hospital medical 
wards were recruited. 56.4% had confirmed infections with organisms identified 
including dengue (22.2%), chikungunya (16.7%), leptospirosis (5.2%), various 
bacteraemias (4.2%), Q fever (2.9%), rickettsial infections (2.3%), tuberculosis 
(1.1%) and urinary tract infections (0.8%). 7.6% had confirmed infections with no 
organisms identified including cellulitis (2.4%), respiratory tract infections with 
radiographic changes (2.1%) and pulmonary tuberculosis with radiographic changes 
(1.6%). 4.1% had confirmed non-infectious diseases and 37.2% had unconfirmed 
diseases including “viral fever” (13.3%), undifferentiated fever (7.8%), respiratory 
tract infections (6.8%), urinary tract infections (3.4%), leptospirosis (2.8%) and 
gastroenteritis (1.0%). 
 
Clinical prediction rules for identifying dengue fever and chikungunya were 
developed using imputation, multiple logistic regression, scoring algorithms and 
receiver operating characteristic (ROC) curve analysis. The dengue fever rule had 
sensitivity = 49.6%, specificity = 93.9%, positive predictive value (PPV) = 70.8% 
and negative predictive value (NPV) = 86.1%. The chikungunya rule had sensitivity 
= 35.0%, specificity = 95.0%, PPV = 60.0% and NPV = 87.1%. ROC curve analysis 
could not identify any probability cut-offs that would produce clinical prediction 
rules with acceptable combinations of both sensitivity and specificity. 
 
A commercial (Panbio) rapid serology test for dengue fever showed sensitivity = 
43.4%, specificity = 88.8%, PPV = 54.6% and NPV = 83.5% on samples from 
admission and significantly better diagnostic performance on follow-up. When 
repeated in conjunction with a PanBio rapid NS1 antigen detection test, the 
diagnostic performance improved with sensitivity = 89.9%, specificity = 75.0%, PPV 
= 69.0% and NPV = 92.3% on admission. 
 
This study confirmed the wide range of infections that present as febrile illnesses in 
Sri Lanka and showed the limitations of clinical prediction rules and rapid diagnostic 
tests in identifying these on admission. I hope that it will prove a foundation for 
further work on these important topics. 
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1.1  Aims and Definitions 
 
1.1.1  Aims 
 
The Ragama Fever Study was conducted from 2006-7 at the Colombo North 
Teaching Hospital in Ragama, which is located within the Gampaha District of 
western Sri Lanka. It had three major aims : 
 
1. To identify the causes of febrile illnesses in a representative sample of patients 
admitted to the hospital over a 1-year period 
 
2. To develop clinical prediction rules that could diagnose the most common 
infectious diseases found 
 
3. To assist in the evaluation of rapid (point-of-care) diagnostic tests that were 
appropriate to this setting 
 
1.1.2  Fever 
 
In clinical practice there can be an over-simplistic view that normal body 
temperature is 37.0 °C with no variation between individuals, site of measurement or 
over time. However, normal body temperature is known to vary between individuals 
and sites with ranges of 33.2 to 38.2 °C for oral temperatures, 34.4 to 37.8 °C for 
rectal temperatures, 35.4 to 37.8 °C for tympanic temperatures and 35.5 to 37.0 °C 
for axillary temperatures [Sund-Levander et al., 2002].  Normal body temperature 
also varies within an individual by >1.0 °C due to activity, diurnal rhythm and the 
menstrual cycle [Refinetti & Menaker, 1992]. 
 
In view of this physiological variation, it is not surprising that different definitions of 
fever have been used in previous fever studies in the tropics (Table 1.1.2). Although 
definitions vary from >37.5 °C (oral) to >38.3 °C (axillary), it seems unlikely that 
such raised temperatures in symptomatic patients attending hospital would be due to 
physiological variation. However, these different definitions of fever could lead to 
variable recruitment of patients with diseases associated with “low-grade” fevers of 
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37.5‒38.0 °C (oral). Therefore standardising the definition of fever would be useful 
to ensure that different fever studies are comparable. 
 
Table 1.1.2. Definitions of fever used in previous studies in the tropics 
 
Definition of Fever Reference 
>37.5 °C (oral) Watt & Jongsakul, 2003 
>38.3 °C (oral) Leelarasamee et al., 2004 
≥38 °C (oral) Murdoch et al., 2004 
>38 °C (axillary) Wagenaar et al., 2004 
≥38 °C (unspecified) Ellis et al., 2006 
>38.0 °C (axillary) Nga et al., 2006 
unspecified Suttinont et al., 2006 
>38 °C (axillary) Blacksell et al., 2007 
unspecified Joshi et al., 2008 
≥38 °C (oral) Manock et al., 2009 
>38.3 °C (unspecified) Chrispal et al., 2010 
≥38 °C (unspecified) Kasper et al., 2010 
 
The measurement of body temperature in tropical countries often reflects the limited 
healthcare resources available. For example, there may only be a single thermometer 
per ward and patients may then be unwilling to have oral temperatures taken even if 
adequate sterilisation procedures are in place. Likewise no fever study in the tropics 
has yet been performed using tympanic temperature measurements, which are now 
the standard in developed countries. These issues need to be considered when 
defining fever for the purposes of a fever study in a developing country. 
 
1.1.3  Undifferentiated Febrile Illnesses 
 
A febrile illness is simply defined as any illness with an associated fever (eg. >38.0 
°C oral temperature). Some febrile illnesses have a specific organ focus, such as 
meningitis, pneumonia, gastroenteritis, genito-urinary infections and skin & soft 
tissue infections, which will normally lead to an early clinical diagnosis before 
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microbiological confirmation. In contrast, undifferentiated febrile illnesses (UFIs) 
are usually defined as febrile illnesses with no obvious focus of infection after initial 
clinical assessment (ie. a history & physical examination) and possibly basic imaging 
tests (eg. a chest radiograph). 
 
It is important to distinguish the definition of a UFI from that of a fever (or pyrexia) 
of unexplained (or unknown) origin (FUO or PUO) since the latter was originally 
defined as an illness of >3 weeks duration, with fever >38.3 °C on several occasions 
and no diagnosis after 1 week of study in hospital [Petersdorf & Beeson, 1961]. The 
term UFI is used in the initial stages of patient management and the term “acute UFI” 
is sometimes used to indicate that the fever has been present for <2 weeks. UFIs are 
usually caused by infections that do not have a specific organ focus, whereas FUOs 
include a higher proportion of non-infectious causes of fever, such as malignant and 
inflammatory disorders [Petersdorf & Beeson, 1961]. A UFI may persist and defy 
diagnosis long enough to become a FUO, but the terms should remain distinct. 
 
Unfortunately, the United States National Library of Medicine (NLM) Medical 
Subject Headings (MeSH) system does not include a term to cover UFIs as defined 
above. The closest term available is “Fever of Unknown Origin”, which it defines as 
“fever in which the etiology cannot be ascertained”, but despite this more general 
definition the term FUO is still most closely associated with the original Petersdorf & 
Beeson definition, which requires a fever for >3 weeks and no diagnosis after 1 week 
of hospital assessment. Some authors have used the term “acute FUO” to remove 
these time limits, but the potential for confusion remains and so the term (acute) 
undifferentiated febrile illness is preferred here even though it is less well defined. 
 
Terms such as “flu-like” illness will also be avoided since various definitions exist 
with varying degrees of sensitivity and specificity and are usually based on some or 
all of the following features: fever, headache, sore throat, cough, myalgia, nasal 
congestion, weakness and anorexia. The term “non-specific clinical features” is also 
difficult to define and inevitably rather subjective unless studies have shown that a 
disease can not be reliably identified from its clinical features alone. Such findings 
will also depend on what other diseases are present in a particular area. For example, 
hepatosplenomegaly may seem like a rather specific clinical feature, but it occurs in 
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so many different UFIs (especially in the tropics) that it may not help very much in 
making diagnoses. 
 
When performing a literature review on this topic the following terms were all used : 
 
• Undifferentiated febrile illness 
• Undifferentiated fever 
• Unexplained febrile illness 
• Unexplained fever 
• Fever of unknown/unexplained origin 
• Pyrexia of unknown/unexplained origin 
 
However, the order of the terms listed above indicates which were most useful in 
identifying relevant references for a fever study in the tropics (in descending order). 
 
1.2  Significant Causes of Undifferentiated Febrile Illness in Sri Lanka 
 
The term “significant” is somewhat subjective, but is meant to include common 
causes of UFI that are either life-threatening or likely to lead to hospital admissions. 
 
1.2.1  Historical Perspective 
 
Historically, most infectious diseases were just called “fevers” until improvements in 
clinical skills and investigations allowed them to be distinguished from each other. In 
Sri Lanka the earliest known classification of disease can be found in the masks used 
for the Sanni Yakuma exorcism ritual [Bailey & de Silva, 2006] and one of these is 
Gini Jala Sanniya – the demon of high fevers (Figure 1.2.1). In 1660 a British 
hostage (Robert Knox) of the Kandyan king in Sri Lanka, described his surroundings 
as, “extraordinarily sickly by agues and feavours whereof many died” and also wrote 
that, “my ague came to a settled course that is one in three days and so continued for 
sixteen months time”, which taken together are suggestive of falciparum malaria 
[Edirisinghe, 1988]. After taking control of Sri Lanka in 1796, British troops were 
plagued by high morbidity and mortality rates due to “jungle fever” [Marshall, 1846] 
until Major Ronald Ross IMS discovered the role of the mosquito in malaria 
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transmission in 1897 and control measures were instituted [Edirisinghe, 1988]. This 
is just one of many examples where UFIs have affected military deployments and the 
diseases responsible have been a problem for British expeditionary forces ever since 
the time of the Crusades [Bailey et al., 2011]. 
 
Figure 1.2.1. Gini Jala Sanniya – the demon of high fevers 
 
 
 
1.2.2  Malaria 
 
Malaria is a systemic infection of erythrocytes caused by Plasmodium protozoa that 
are usually transmitted by the bite of Anopheles mosquitoes. It is found throughout 
the tropics and sub-tropics wherever mosquitoes breed – except in a few areas 
(mostly islands) where eradication of the disease has been successful. Following 
transmission, there is an incubation period ranging from 10 days up to >1 year in 
certain circumstances [Kotwal et al., 2005; Boecken & Bronnert, 2005] before illness 
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develops. The clinical features (symptoms & signs) of malaria are non-specific until 
the later stages of the disease when complications occur leading to more 
characteristic patterns of disease. Therefore investigations are essential for the early 
diagnosis of malaria and traditional techniques such as microscopy of thick and thin 
blood films are now being supplemented with antigen detection kits, which are 
especially useful when expertise or laboratory facilities are limited [Abba et al., 
2011]. Early treatment of malaria is important to minimise morbidity and mortality 
and requires the use of quinine or artemisinin-based drugs with supportive therapies 
in complicated cases and also follow-up eradication therapy for hypnozoites of 
certain species [Lalloo et al., 2007; World Health Organisation, 2000]. Death from 
various complications and long-term morbidity from cerebral complications may 
occur. Preventative measures are based on bite avoidance, vector control, prompt 
diagnosis & treatment of cases and also chemoprophylaxis for travellers. 
 
In Sri Lanka, malaria seems to have been present since the end of the 13th century 
AD, but probably not before this date [Edirisinghe, 1988]. Major epidemics wee 
reported during the period of British colonial rule and the most severe of these was in 
1934-5 when ~100,000 people died [Gill, 1936]. From 1947-1963 malaria was 
almost eradicated by dichlorodiphenyltrichloroethane (DDT) spraying, but case 
numbers then increased again due to DDT resistance in mosquitoes and internal 
conflict that interrupted the eradication programme [Edirisinghe, 1988]. Despite a 
switch to malathion spraying in 1973 and improved case detection and treatment 
from 1977, morbidity levels in 1986 were as high as in 1952 [Pinikahana & Dixon, 
1993]. However, since 2000 the improving security situation in malarious areas and 
subsequent enhancement of the eradication programme has led to dramatic benefits 
[Briët et al. 2005]. Malaria control has now entered the pre-elimination stage with 
very few indigenous cases being reported [Rajakaruna et al., 2010; Fernando et al., 
2009]. Not surprisingly, studies of malaria in Sri Lanka have shown that it had a bi-
modal occurrence each year associated with rainfall [Briët et al., 2008] and that 
clinical diagnosis of cases was not reliable [van der Hoek et al., 1998]. Today 
malaria in Sri Lanka is still diagnosed by microscopy of thick and thin blood films 
because there remains widespread expertise with this technique and hence no need 
for the use of malaria antigen kits. 
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1.2.3  Enteric Fever 
 
Enteric fever is a systemic infection caused by Salmonella typhi and S. paratyphi 
bacteria that are usually transmitted faeco-orally and then infect epithelial cells and 
mononuclear phagocytes. It was previously found in temperate and tropical 
countries, but is now restricted to developing countries due to successful control 
programmes elsewhere. Following transmission and an incubation period ranging 
from 6 to 30 days, the disease normally has an insidious onset with worsening fever 
and non-specific clinical features in the first week followed by abdominal pain and 
possibly hepatosplenomegaly, lymphadenopathy or “rose spots” in the second week. 
If untreated then diarrhoea and many different organ-specific features may occur in 
the third week including cholecystitis, hepatitis, urinary tract infection (UTI), 
pneumonia, meningitis, neuropathy, cardiomyopathy, osteomyelitis, haemolysis, 
thrombo-embolism and intestinal haemorrhage or perforation. If the patient survives 
then recovery will usually begin by the fourth week. Paratyphoid infection is often 
thought to produce a less severe illness with minimal mortality compared to typhoid 
infection, but recent studies have described indistinguishable clinical syndromes for 
the two diseases [Maskey et al., 2006]. 
 
Although the clinical features of enteric fever become more characteristic as the 
disease progresses, it is important to give specific anti-microbial treatment at an early 
stage to limit its morbidity and mortality and so clinical prediction rules or early 
laboratory diagnosis are important. Clinical prediction rules to distinguish enteric 
fever from other causes of fever elsewhere in Asia have been unsuccessful and the 
same study also found that typhoid and paratyphoid were indistinguishable [Vollaard 
et al., 2005]. A study in Turkey did develop a validated clinical prediction rule for 
identifying enteric fever using culture positive cases only [Hosoglu et al., 2006], but 
this was specific to an area that lacks the most common causes of undifferentiated 
febrile illness in Sri Lanka and it also included use of the Widal serology test, which 
is unreliable when used on single samples in the early stages of the disease or in 
vaccinated individuals. An earlier study in Malaysia developed an unvalidated 
prediction system [Ross & Abraham, 1985], but this included serology-positive, 
culture-negative enteric fever cases and also relied on Widal test results. Therefore 
laboratory diagnosis remains most important and since anti-microbial resistance is a 
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major problem in enteric fever, this means that microbiology cultures of blood, 
faeces, urine or bone marrow remain the gold standard diagnostic tests [Parry et al., 
2011]. The Widal serology test is simple, quick and cheap to perform, but suffers 
from non-standardised reagents and inappropriate interpretation of results, which 
lead to a low sensitivity and specificity overall. Other serology tests based on the S. 
typhi Vi antigen produce more accurate results, but their usefulness in the acute 
situation is limited by the need for paired (acute and convalescent) samples. Several 
attempts have been made to package serology tests for enteric fever into rapid 
diagnostic (point-of-care) tests, but these remain insufficiently sensitive, specific and 
consistent to be of use in endemic countries [Parry et al., 2011]. The development of 
antigen detection and nucleic acid amplification tests to diagnose enteric fever 
remains a challenge, but these do promise to overcome many of the inherent 
limitations of serology tests. The widespread development of fluoroquinolone 
resistance in S. typhi and S. paratyphi means that anti-microbial treatment with 
intravenous (IV) ceftriaxone or oral (PO) azithromycin is required, which has 
implications for costs and the further development of resistance if their use is not 
targeted appropriately [Butler, 2011]. Prevention of enteric fever is based on good 
hygiene and sanitation measures, adequate treatment of cases and long-term carriers 
and also vaccination, which has a cumulative efficacy of only 51-55% over 3 years 
[Fraser et al., 2007] and is ineffective against most paratyphoid infections. 
 
In Sri Lanka the number of enteric fever notifications reduced gradually from 2987 
cases in 2004 to 1805 cases in 2007 and these were predominantly from the northern 
parts of the country affected by internal conflict [Epidemiology Unit, 2004-2007]. 
Most of these diagnoses would have been made without laboratory investigations and 
overall the disease is thought to be relatively uncommon in Sri Lanka compared to 
other more densely populated south Asian countries [de Silva & Premaratna, 
personal communication]. However, confirmed enteric fever does seems to occur in 
sufficient numbers in Sri Lanka to produce several case reports, including some that 
describe chloramphenicol and ciprofloxacin resistance [de Silva et al., 1993; 
Karunanayake & Atukorala, 2004] and also a case series on ileal perforation [Peiris 
et al., 1993a] and an evaluation of a new serology test using 29 culture-positive cases 
[Herath, 1993]. 
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1.2.4  Other Bacteraemias 
 
If blood cultures are performed to look for enteric fever organisms in 
undifferentiated febrile illnesses, then it is likely that other bacteraemias resulting 
from occult infections will also be discovered.  Examples include endocarditis, lower 
respiratory tract infections (LRTIs), intra-abdominal collections and urinary tract 
infections (UTIs), which sometimes lack their distinctive clinical features. Patients 
who are immunocompromised may also develop systemic infections without focal 
features due to organisms that would normally be better contained by the immune 
system. 
 
Melioidosis is a rare systemic infection caused by Burkholderia pseudomallei 
bacteria that are transmitted from soil or water through skin wounds or inhalation. 
The disease and organism responsible were first described in opium addicts in 
Rangoon by Capt Alfred Whitmore IMS [Whitmore & Krishnaswami, 1912] and it is 
now known to occur throughout south and south-east Asia with known risk factors 
including rice paddy farming and diabetes mellitus. Melioidosis usually begins after 
an incubation period of 1 to 21 days, but latent infection with recurrence many years 
later has also been described. A minority (~25%) of patients will present with an 
undifferentiated febrile illness, whilst the majority (~75%) will present with fever 
and focal clinical features due to pneumonia, septic arthritis, osteomyelitis, cellulitis, 
intra-abdominal abscesses or other localised infections. Diagnosis relies on standard 
blood cultures with careful identification of isolates and serology tests that are not 
widely available. Treatment usually begins with IV ceftazidime or an IV carbapenem 
for at least 10-14 days and is then usually followed by co-trimoxazole and 
doxycycline for 12-20 weeks to prevent recurrence [Limmathurotsakul & Peacock, 
2011]. This regimen is expensive and difficult to deliver in developing countries and 
surgical intervention may also be necessary. Prevention measures are limited to 
occupational advice at the present time. In Sri Lanka melioidosis has been 
occasionally reported for many years and the organism responsible has also been 
found in soil samples [Inglis et al., 2008]. 
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Other bacteria that cause undifferentiated febrile illnesses, but which do not grow in 
standard blood cultures include those responsible for brucellosis, tuberculosis, 
leptospirosis and Q fever. 
 
1.2.5  Brucellosis 
 
Brucellosis is a systemic infection caused by Brucella species of bacteria that are 
usually transmitted from infected animals through ingestion, inhalation or skin 
abrasions and then infect cells of the mononuclear phagocyte system. The organism 
responsible was first described in British soldiers in Malta by Capt (later Major-
General Sir) David Bruce RAMC [Bruce, 1887] and the disease is now mostly found 
in developing countries with limited veterinary resources. Following transmission 
and an incubation period ranging from 5 days to several months, the disease usually 
has an insidious onset with fever and non-specific clinical features initially. 
Thereafter more specific features may be lymphoid (hepatosplenomegaly or 
lymphadenopathy), osteoarticular (sacroiliitis, spondylitis, septic arthritis or 
osteomyelitis), genitourinary (epididymo-orchitis, spontaneous abortion, 
glomerulonephritis, abscesses), neurological (meningo-encephalitis or neuropathy) or 
in other sites. 
 
This variety of presentations makes clinical diagnosis difficult and so laboratory 
confirmation is needed by specialist extended blood cultures, which have low yields 
in chronic cases or serology tests, which include some promising rapid point-of-care 
tests [Franco et al., 2007]. Combination treatment with doxycycline (for 6 weeks), 
rifampicin (for 6 weeks) and gentamicin (for 2 weeks) seems to offer higher cure 
rates than earlier WHO regimens [Skalsky et al., 2008; World Health Organisation, 
2006]. Prevention of this zoonotic infection relies on occupational advice and 
veterinary measures including vaccination, but no human vaccine or 
chemoprophylaxis is available. 
 
In Sri Lanka human brucellosis has been occasionally reported for many years 
[Maretic et al., 1962; de Silva & Wijeratne, 1981] and seroepidemiology studies in 
animals have shown ~5% seroprevalence in cattle, mostly from the eastern and 
northern (dry zone) parts of the country [Sixl et al., 1988; Silva et al., 2000]. 
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1.2.6  Tuberculosis 
 
Tuberculosis (TB) due to Mycobacterium tuberculosis bacteria usually occurs as a 
localised respiratory infection, but ~50% of cases have extra-pulmonary features and 
the disease may present as an undifferentiated febrile illness – especially in those 
who are immunocompromised by drugs or other diseases such as HIV infection. The 
disseminated or miliary form of TB usually presents with fever and non-specific 
clinical features except for possible lymphadenopathy, hepatosplenomegaly or 
nodular shadowing on chest radiographs. In such cases a clinical diagnosis is 
necessary initially, but this may be confirmed later by specialist cultures of blood, 
lymph node biopsies or early morning urine samples. Tuberculin skin testing (TST) 
and TB interferon-gamma release assays (IGRAs) can also be useful in diagnosis, but 
may not be able to distinguish between active and latent disease. Treatment requires 
multi-drug therapy with drugs such as rifampicin, isoniazid, pyrazinamide and 
ethambutol in regimens that last for at least 6 months overall and there are currently 
major concerns regarding the development of multi-drug resistance. Preventative 
measures may include Bacille Calmette-Guérin (BCG) vaccination, but this is of 
limited efficacy and so prompt isolation, diagnosis and treatment of cases is 
essential. 
 
In Sri Lanka TB is less common than in other more densely populated south Asian 
countries with a prevalence of 79 per 100,000 population and an incidence of 27 per 
100,000 population for new smear positive cases [WHO, 2008]. Although the 
number of cases is relatively small, the socio-economic impact of having TB for 
individuals and their families is at least 3-4 times greater than for other 
communicable diseases in Sri Lanka [Morton-Bailey, 2010]. The Central Chest 
Hospital, Welisara in Gampaha District is the specialist centre for TB in Sri Lanka, 
but due to limited resources they do not usually attempt cultures from “clinically-
obvious” TB cases and this is reserved for cases where the diagnosis is less certain or 
drug resistance is suspected. Isolates from recurrent TB cases at this hospital have 
been studied and 46% had resistance to at least one drug with individual drug 
resistance rates varying from 7.6% for isoniazid to 15.3% for p-amino salicylic acid 
(PAS) [Magana-Arachchi et al., 2010].  
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1.2.7  Leptospirosis 
 
Leptospirosis is a systemic infection caused by Leptospira spirochaetes (spiral-
shaped bacteria) that are usually transmitted from infected animals through direct 
contact with their urine or indirectly when contaminated freshwater or wet soil 
comes into contact with skin or mucous membranes (including ingestion). There are 
currently 13 pathogenic species and an overlapping classification based on >260 
different serovars (serotypes) and also additional saprophytic species and serovars 
[Adler & de la Peña Moctezuma, 2010]. This makes the epidemiology of 
leptospirosis difficult to study, but it is known that nearly all mammals can become 
infected and some (eg. rodents) act as carriers due to chronic infection of the 
proximal renal tubules. Leptospirosis is usually said to be the most widespread 
zoonotic disease in the world and is more common in developing countries and 
certain high-risk activities (eg. farming, water sports). 
 
Following transmission the spirochaetes circulate to all organs and cause endothelial 
damage, but asymptomatic infection is common and only 10% of symptomatic 
infections lead to severe (icteric) disease. After an incubation period ranging from 2 
to 26 days, the disease usually has an abrupt onset with fever and non-specific 
clinical features initially. Headache, myalgia and muscle tenderness in the lower 
trunk and legs may be severe, but conjunctival suffusion is a more specific early 
finding. Thereafter other more specific features may include oliguria, acute renal 
failure, icterus, hepatitis, (haemorrhagic) pneumonitis, haemorrhage, meningitis, 
myocarditis and uveitis. A biphasic febrile illness consisting of a “leptospiraemic 
phase”, temporary recovery and then an “immune phase” is sometimes described, but 
is not a consistent finding. The diagnosis of leptospirosis can occasionally be made 
by dark-field microscopy (DFM) or specialist cultures of urine or blood, but the 
former is very insensitive and the latter take 2-4 weeks to become positive 
[Wuthiekanun et al., 2007]. Serology tests remain the main methods used, but these 
are complicated due to the large number of different serovars that can cause 
infections and are usually negative at presentation [Limmathurotsakul et al., 2012]. 
Diagnostic PCR tests have been developed, but are likely to be of limited value in 
developing countries [Thaipadungpanit et al., 2011; Bourhy et al., 2011]. Treatment 
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of leptospirosis with doxycycline for mild disease or IV benzylpenicillin for severe 
disease is recommended and should be given as early as possible. Prevention of this 
zoonotic infection relies on occupational advice, environmental health measures and 
chemoprophylaxis with doxycycline, but no vaccine is available. 
 
In Sri Lanka leptospirosis was first identified in 1953 and in 1962 past or present 
infection was found in 26 (24%) of 109 patients in a fever study and in 19 (12%) of 
163 people surveyed in high-risk areas [Maretic et al., 1962]. In 1964 a clinical study 
of 63 confirmed acute cases seen at the Colombo General Hospital showed marked 
seasonal variation coinciding with the rainy seasons in May and October and that 
more cases were from the north Colombo area than central or southern parts 
[Rajasuriya et al., 1964]. This study also described the frequency of clinical and 
laboratory findings in detail (Table 1.2.7.1), but there was selection bias towards 
more severe cases and even then the most common individual findings could nearly 
all have been due to other infections that cause undifferentiated febrile illnesses in 
Sri Lanka. Nevertheless the authors felt that the combination of fever with myalgia 
and conjunctival suffusion was sufficient to make a diagnosis in most cases. In 1974 
a similar study at the Colombo North General Hospital also targeted suspected 
leptospirosis cases only, but recruited 81 patients with a wider range of presentations 
[Ramachandran et al., 1974].  The clinical and laboratory findings were similar 
(Table 1.2.7.2) and fever, myalgia and conjunctival suffusion were present in >80% 
of cases. From 1974 to the beginning of the Ragama Fever Study the only original 
scientific publication on leptospirosis in Sri Lanka was a single case report. The 
frequencies of leptospirosis cases notified in Sri Lanka and the Gampaha District 
before and during the Ragama Fever Study are shown in Table 1.2.7.3 
[Epidemiology Unit, 2004-2007], but most of these will be clinical diagnoses only. 
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Table 1.2.7.1. Clinical and laboratory features of leptospirosis in Ceylon (1964) 
 
History % Examination % Investigations % 
Fever 100 Fever 100 ↑ ESR 100 
Myalgia 97 Conjunctival suffusion 95 Positive serology 96 
Male sex 95 Icterus/jaundice 60 Neutrophilia 94 
Headache 91 Hepatomegaly 44 ↑ Urea 73 
Sudden onset 87 Pneumonitis 35 Albuminuria 70 
Chills / rigors 81 Haemorrhage 14 ↑ Bilirubin 66 
Nightmares 64 Bradycardia 14 Positive DFM of blood 40 
Insomnia 56 Hypotension 14 Positive DFM of urine 35 
Nausea/vomiting 56 Neurological signs 13 ↑ Liver transaminases 35 
Constipation 38 Lymphadenopathy 10   
Arthralgia 27 Neck rigidity 5   
Photophobia 23 Splenomegaly 3   
Delirium 16     
Deafness/tinnitus 10     
Diarrhoea 8     
Death 3     
 
 
Table 1.2.7.2. Clinical and laboratory features of leptospirosis in Sri Lanka (1974) 
 
History % Examination % Investigations % 
Male sex 99 Fever 98 Positive serology 95 
Fever 98 Conjunctival suffusion 86 ↑ ESR 85 
Myalgia 93 Monophasic fever 83 Albuminuria 57 
Death 10 Icterus/jaundice 49 ↑ Urea 51 
  Hepatomegaly 42 Leukocytosis 50 
  Oliguria/anuria 22 ↑ Bilirubin 49 
  Hypotension 21 ↑ Liver transaminases 35 
  Meningism 8 Positive blood culture 4 
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Table 1.2.7.3. Leptospirosis Cases in Sri Lanka and Gampaha District (2004-7) 
 
Leptospirosis 
Total Cases in 
Sri Lanka 
Cases in 
 Gampaha (%) 
Gampaha vs  
Other Districts 
2004 1427 133 (9%) =4th 
2005 1537 220 (14%) 1st 
2006 1568 211 (13%) 2nd 
2007 2187 311 (14%) 1st 
 
 
1.2.8  Q Fever 
 
Q fever is a systemic infection caused by Coxiella burnetti bacteria that are usually 
transmitted from infected animals through direct contact or inhalation of an 
environmental spore-like form, which then infect cells of the mononuclear phagocyte 
system. Following an incubation period ranging from 1 to 60 days, the disease 
usually has an acute onset with an undifferentiated febrile illness, atypical 
pneumonia or anicteric hepatitis. Acute Q fever is usually self-limiting after a few 
weeks, but chronic Q fever infection may develop months to years later in 1-5% of 
cases and 68% of these are due to endocarditis with the remainder presenting as other 
chronic vascular infections, respiratory infections, undifferentiated febrile illnesses, 
hepatitis or osteomyelitis [Brouqui et al., 1993]. The clinical features of Q fever are 
non-specific and so laboratory diagnosis is essential. This is based on serology tests 
and also PCR tests that have only recently become established. Q fever serology 
measures antibody responses against C. burnetti Phase 2 antigens (which are raised 
in acute Q fever) and Phase 1 antigens (which are raised in chronic Q fever) and the 
definition of positive results varies between different laboratories [Healy et al., 
2011]. Treatment of acute Q fever with doxycycline 200 mg/day for 14 days seems 
to reduce morbidity [Dijkstra et al., 2010], but chronic Q fever usually requires 
treatment with doxycycline and hydroxychloroquine for at least 18 months [Raoult et 
al., 1999; Million et al., 2010]. Prevention of this zoonotic infection relies on 
occupational advice and veterinary measures including vaccination and prevention in 
humans can also be achieved with vaccination [Gidding et al., 2009] or 
chemoprophylaxis [Benenson & Tigertt, 1956]. 
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In Sri Lanka Q fever has been reported in a single clinical case [Schmid et al., 
1952a] and seroepidemiology studies have shown previous exposure in 4% of 
slaughter-house workers and from 0% to 8% of slaughtered animals [Schmid et al., 
1952b; Sixl et al., 1988]. 
 
1.2.9  Rickettsial Infections 
 
Rickettsial infections include the typhus fevers (louse-borne/epidemic due to 
Rickettsia prowazekii and flea-borne/endemic/murine due to R. typhi), spotted fevers 
(numerous tick-borne infections including Rocky Mountain, Mediterranean, African 
and Indian varieties due to numerous local species), scrub typhus (mite-borne due to 
Orientia tsutsugamushi) and also less common diseases such as bartonellosis, 
ehrlichiosis and anaplasmosis [Parola et al., 2005; Botelho-Nevers & Raoult, 2007]. 
These primitive bacteria infect endothelial cells and following incubation periods 
from 2 to 16 days (or longer for bartonellosis), the diseases usually have an acute 
onset with an undifferentiated febrile illness. Thereafter skin manifestations such as a 
centripetal rash or an eschar at the site of the arthropod bite may develop as well as 
multi-organ disease and death rates vary from 10-20% for epidemic typhus, ~4% for 
endemic typhus, and 1-35% for scrub typhus [Botelho-Nevers & Raoult, 2007]. 
Clinical diagnosis is limited in the early stages, especially when skin manifestations 
are minimal and laboratory diagnosis is also usually restricted to serology tests that 
are only available in specialist laboratories and suffer from cross-reactivity problems 
[La Scola & Raoult, 1997]. The use of the Weil-Felix serology test is no longer 
recommended due to poor sensitivity and specificity [Kularatne & Gawarammana, 
2009] and there are no established rapid diagnostic tests available. Treatment of 
rickettsial infections usually consists of doxycycline given for 7-10 days depending 
on the species involved. Prevention relies on bite avoidance, vector control and 
chemoprophylaxis with doxycycline can also be given. 
 
In Sri Lanka rickettsial infections were first reported in 1940 and in 1944 an outbreak 
of scrub typhus affected >750 Commonwealth troops of whom 85% had eschars and 
~2% died [Sayers & Hill, 1948]. In 2001 a one-year case series from the Central 
Province reported 8 cases of scrub typhus, 10 cases of spotted fever and 2 cases of 
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murine typhus [Kularatne et al., 2003]. In 2003 a one-year case series from the 
Western Province reported 19 cases of scrub typhus, 8 cases of spotted fever and no 
cases of murine typhus [Premaratna et al., 2008]. Nationally, the number of notified 
rickettsial infections increased from 789 cases in 2005 to ~1,200 cases in subsequent 
years and most of these were from the central, southern and northern parts of the 
country [Epidemiology Unit, 2005-7]. 
 
1.2.10  Dengue 
 
Dengue is a systemic infection caused by dengue virus (DENV), which is a flavivirus 
transmitted by the bite of Aedes mosquitoes that usually breed in urban areas. There 
are 4 serotypes of dengue virus (DENV-1, DENV-2, DENV-3 & DENV-4). Humans 
can be infected once with each of these and are the only known reservoir of 
infection. Dengue is the most common arbovirus infection worldwide and is found in 
most tropical areas with the potential to cause outbreaks and spread wherever 
appropriate Aedes mosquitoes are found. Following transmission dengue virus 
infects mononuclear phagocyte cells and may lead to a sub-clinical illness or after an 
incubation period of 3-14 days the disease presents with an acute onset of either 
classic dengue fever (DF), dengue haemorrhagic fever (DHF) or dengue shock 
syndrome (DSS). 
 
Dengue typically presents with an undifferentiated febrile illness of the “fever-
arthralgia-rash” type and may include features such as headache, retro-orbital pain, 
arthralgia, myalgia, nausea, vomiting, a maculopapular rash that can become 
confluent with “islands of sparing”, petechiae, leukopenia and thrombocytopenia. 
The illness persists for 2-7 days, sometimes with a biphasic fever and then settles 
spontaneously with an overall mortality of 1%. DHF and DSS mostly occur in 
patients who have previously been infected by another dengue virus serotype and are 
thought to be due to a process of “antibody-dependant immune enhancement” that 
leads to more serious illnesses [Halstead, 2007]. DHF is defined as a combination of 
fever (for 2-7 days), haemorrhage (positive tourniquet test, petechiae, ecchymoses, 
purpura, bleeding from mucosa, gastrointestinal tract or injection sites), 
thrombocytopenia (<100,000 cells/mm3 or <100 x 109/L) and plasma leakage 
(pleural effusion, ascites, hypoproteinaemia, haematocrit >20% above normal or 
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>20% decrease after fluid resuscitation). DSS is defined as DHF with circulatory 
failure (cool peripheries with sweating and restlessness, tachycardia with low volume 
pulse, hypotension or pulse pressure <20 mm Hg). These definitions were established 
in previous WHO guidelines [WHO, 1997] and were designed more for research than 
clinical purposes. Therefore the most recent guidelines (published after the Ragama 
Fever Study was performed) are much simpler and use the term “severe dengue” to 
include both DHF and DSS [WHO, 2009]. A summary of the latest definitions is 
shown in Figure 1.2.10 and these continue to be evaluated at present. 
 
Figure 1.2.10. WHO dengue case classification and levels of severity (2009) 
 
 
 
The haemagglutination inhibition (HAI) test and plaque reduction neutralisation 
technique (PRNT) are still officially the “gold standards” for diagnosing dengue 
[WHO, 1997]. The HAI test has good sensitivity and PRNT is specific enough to 
distinguish different serotypes, but both are impractical and no longer used for 
diagnosis [WHO, 2004]. For this they have been replaced by capture ELISAs for 
IgM and IgG antibodies and also reverse transcriptase polymerase chain reaction 
(RT-PCR) tests, which have good sensitivity and specificity respectively [Peeling et 
al., 2010]. However, the former do suffer from cross-reactivity with other 
flaviviruses (including yellow fever and Japanese encephalitis) and the latter are not 
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widely available in developing countries. Rapid diagnostic tests for dengue include 
numerous serology tests for IgM and IgG antibodies and newer “non-structural 1” 
(NS1) antigen detection tests  [Blacksell et al., 2011b]. Simultaneous testing for IgM 
and IgG antibodies and also NS1 antigen is necessary to achieve acceptable levels of 
diagnostic accuracy [Blacksell et al., 2011b], but sensitivities up to 87% and 
specificities up to 97% can be achieved in this way [Blacksell et al., 2012]. 
Treatment of all forms of dengue consists of supportive treatment including early and 
careful fluid resuscitation and the use of platelet transfusions and critical care 
facilities where available. Prevention currently relies on bite avoidance and mosquito 
control and development of a vaccine remains challenging [Konishi, 2011]. 
 
In Sri Lanka dengue was first described in the early 20th century [Mendis, 1967], but 
despite all 4 serotypes being present there were very few DHF/DSS cases reported 
until 1989, which could not be explained at the time [Messer et al., 2002]. Since then 
there have been major outbreaks in 2002 and 2004 and these were thought to be due 
to changes in the circulating DENV-1 genotype and DENV-3 clades [Kanakaratne et 
al., 2009]. An adult case series from Kandy in the Central Province in 2001-3 
[Kularatne et al., 2005] recruited 183 confirmed dengue cases using a serology test 
after one week of illness, which showed either IgM (suggestive of primary infection) 
or IgM and IgG antibodies (suggestive of secondary infection). Clinical and 
laboratory findings were similar in both confirmed cases and those that were just 
clinically-diagnosed, but only the former are shown here (Table 1.2.10.1). There was 
also a trend towards leukopenia that was most marked on the 5th day of fever. The 
authors suggested that a combination of the clinical picture, thrombocytopenia, 
leukopenia and elevated liver enzymes could be used as markers for early diagnosis 
of dengue infection. Another adult series from Colombo in 2004 [Malavige et al., 
2006] recruited 108 confirmed dengue cases using similar serology tests and criteria. 
Similar clinical and laboratory findings were reported (Table 1.2.10.2) although there 
were more DHF cases in this later series. The authors also compared clinical and 
laboratory features of dengue from studies in Sri Lanka, Singapore, Cuba, Thailand, 
Nicaragua, Bangladesh and Taiwan and found significant variation, which might 
have been due to a difference in the number of primary or secondary and DF or DHF 
cases in each series. The frequencies of dengue cases notified in Sri Lanka and the 
Gampaha District before and during the Ragama Fever Study are shown in Table 
 -24- 
1.2.10.3 [Epidemiology Unit, 2004-2007], but most of these will be clinical 
diagnoses only. 
 
Table 1.2.10.1. Clinical and laboratory features of dengue in Kandy (2001-3) 
 
History % Examination % Investigations % 
Headache 79 Fever 21 Platelets <100 x 109/L 91 
Myalgia 74 Flushing 40 Tourniquet test positive 36 
Vomiting 62 Rash 15 ↑ Liver transaminases 31 
Male Sex 59 Haemorrhage 13   
Death 1 Effusions 3   
 
Table 1.2.10.2. Clinical and laboratory features of dengue in Colombo (2004) 
 
History % Examination % Investigations % 
Myalgia 76 Hepatomegaly 45 Platelets <100 x 109/L 79 
Headache 66 Flushing 42 WCC < 4 x 109/L 31 
Vomiting 64 Haemorrhage 42 ↑ Haematocrit 22 
Male sex 59 Shock 14   
Arthralgia 57 Effusions 11   
Diarrhoea 29 Splenomegaly <1%   
Abdominal pain 17     
Death 4     
 
Table 1.2.10.3. Dengue cases in Sri Lanka and Gampaha District (2004-7) 
 
Dengue 
Total Cases in 
Sri Lanka 
Cases in 
 Gampaha (%) 
Gampaha vs  
Other Districts 
2004 15414 3015 (20%) 2nd 
2005 5882 1243 (21%) 2nd 
2006 11902 1774 (15%) 2nd 
2007 7271 980 (13%) 2nd 
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1.2.11  Japanese Encephalitis 
 
Japanese encephalitis is a cerebral infection caused by Japanese encephalitis virus 
(JEV), which is also a flavivirus transmitted by the bite of Culex mosquitoes that 
breed in rural areas. The natural reservoirs are birds and the most important 
amplifying hosts are usually domestic pigs. Japanese encephalitis is found 
throughout south-east Asia, causes outbreaks when it reaches new areas and now 
extends as far as Pakistan and Australia. Following transmission there is an 
incubation period ranging from 5 to 15 days before the disease begins with an 
undifferentiated febrile illness [Misra & Kalita, 2010]. Seroepidemiology studies 
show that only 1 in 25 to 1 in 1000 infections lead to encephalitis [Halstead & Grosz, 
1962; Huang, 1982] and the remainder have only an undifferentiated febrile illness or 
no symptoms at all. A study in Thailand showed that JEV infection was responsible 
for 22 (14%) of 156 patients hospitalised with acute undifferentiated fever and none 
had neurological features [Watt & Jongsakul, 2003]. Even when Japanese 
encephalitis does present with neurological features, these may be variable, diverse 
and non-specific compared to other CNS infections occurring in affected countries. 
Neurological features include seizures, Parkinsonian features, flaccid paralysis, upper 
motor neurone lesions, abnormal movements, cerebellar signs, cranial nerve palsies, 
abnormal behaviour and coma. Japanese encephalitis leads to death in a third of 
cases, long-term morbidity in a third and complete recovery in the remaining third 
[Gould & Solomon, 2008]. 
 
Hence laboratory investigations are required to confirm JEV infections, which 
consist of serology tests that can also be performed on CSF and RT-PCR tests that 
are not widely available in developing countries. The standard serology tests are now 
IgM and IgG capture ELISAs that use specific JEV antigens, but testing in parallel 
for dengue and careful interpretation of results is recommended due to cross-
reactivity between these two flaviviruses. Anti-JEV IgM is detectable in serum and 
CSF in 70-75% of cases after 4 days of illness and in >95% of cases after 7-10 days 
of illness [WHO, 2007]. Commercial versions of these tests have been developed 
(including some kits that test in parallel for dengue) and these have sensitivities 
varying from 17 to 96.7% and specificities varying from 89 to 99.5% if dengue 
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serology is also performed [Jacobson et al., 2007; Lewthwaite et al., 2010; 
Khalakdina et al., 2010; Robinson et al., 2010]. 
 
No specific anti-viral treatment for JEV infection is available at present and so 
supportive therapy is all that can be offered, which may involve critical care facilities 
and lifelong community care to overcome the range and severity of possible 
neurological complications that may occur. Prevention relies on bite avoidance and 
mosquito control (which are difficult in rural areas) and vaccination of both domestic 
hosts and humans. Currently available Japanese encephalitis vaccines usually require 
boosters every 2-3 years and are expensive, but improved and cheaper vaccines are 
now being developed and licensed [Halstead & Thomas, 2011]. 
 
In Sri Lanka JEV was first isolated in 1974 and occurred sporadically until 1985 
when an outbreak led to >500 cases in the northern and western parts of the country 
and a similar outbreak occurred in 1987 [Peiris et al., 1992]. A seroepidemiology 
study in 1988 showed evidence of previous JEV infection in 10 to 20% of school 
children in Ragama, which is within the Gampaha District of the Western Province 
and it also had the highest recorded annual incidence of encephalitis cases (74 per 
100 000) in 1990 and 1991 [Peiris et al., 1993b]. Since then a childhood vaccination 
programme in affected areas of Sri Lanka seems to have been effective, but 
uncertainty remains due to limited resources for laboratory diagnosis and the fact that 
only 0.1 to 4.0% of JEV infections lead to encephalitis. 
 
1.2.12  Chikungunya 
 
Chikungunya is a systemic infection caused by chikungunya virus (CHIKV), which 
is an alphavirus transmitted by the bite of Aedes mosquitoes that usually breed in 
urban areas. The name of the disease means “that which bends over” in the local 
Makonde language following its discovery in Tanganyika in 1952 [Robinson, 1955]. 
There are distinct African and Asian genotypes of the virus and in Africa non-human 
primates are thought to be important reservoirs of infection. Periodic epidemics of 
chikungunya occur including one in the 1960s, which spread through several Asian 
countries and another that spread from Kenya around the Indian Ocean to south-east 
Asia in 2004-8 [Staples et al., 2009]. Following transmission CHIKV infects 
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mononuclear phagocyte cells, endothelial cells, fibroblasts and myoblasts leading to 
a sub-clinical illness or else after an incubation period of 1-12 days the disease 
presents as an undifferentiated febrile illness of the “fever-arthralgia-rash” type.  
 
Clinical features include fever (that may be biphasic), arthralgia (which is 
polyarticular and affects mostly the small joints), rash (that is maculopapular) and 
also headache and gastrointestinal symptoms. Its most characteristic feature is 
persistent arthralgia that can continue for years in some patients and there seems to 
be a minimal risk of mortality [Burt et al., 2012]. The only reported laboratory 
feature was said to be leukopenia and diagnosis is based on serology tests including 
haemagglutination inhibition (HAI) and enzymed immunosorbent assays (EIA) for 
IgM antibodies and a RT-PCR test has recently been developed. Treatment of 
chikungunya consists of supportive treatments only and persistent arthralgia is the 
most difficult symptom to control. Prevention currently relies on bite avoidance and 
mosquito control. 
 
In Sri Lanka an outbreak of chikungunya occurred in May-July 1965 and was found 
to affect mostly urban areas [Mendis, 1967]. Serum samples taken before the 
outbreak showed existing antibodies against chikungunya in 86% of subjects aged 
>40 years, but 0% of those aged <11 years suggesting that the virus had been present 
in Sri Lanka ~40 years previously [Hermon, 1967]. A case series from Colombo in 
1965 [Munasinghe et al., 1966] recruited 42 confirmed chikungunya cases using 
serology tests. Detailed clinical and laboratory features were reported (Table 1.2.12) 
and it was noted that chikungunya was difficult to distinguish from dengue, but could 
be distinguished from leptospirosis by the absence of nightmares and having an ESR 
<50 mm/hr. No cases of chikungunya were identified in Sri Lanka in the few years 
before the Ragama Fever Study, but in 2006 an epidemic of a new CHIKV variant 
was known to be spreading from east Africa around the Indian Ocean and had 
already reached India [Yergolkar et al., 2006]. 
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Table 1.2.12. Clinical and laboratory features of chikungunya in Ceylon (1965) 
 
History % Examination % Investigations % 
Arthralgia 100 Fever 100 Platelets <100 x 109/L 74 
Headache 91 Lymphadenopathy 100 ESR <40 mm/hr 96 
Anorexia 83 Conjunctival suffusion 66 ESR <20 mm/hr 67 
Chills 81 Relative bradycardia 54 WCC < 4 x 109/L 9 
Flushed face 81 Rash 43 ↑ Liver transaminases 3 
Myalgia 69 Hypotension 30 Tourniquet test positive 2 
Backache 48 Biphasic fever 17   
Vomiting 33 Bleeding 17   
Constipation 31 Meningism 10   
Sore throat 29 Splenomegaly 7   
Rigors 26 Hepatomegaly 2   
Diarrhoea 17     
Photophobia 17     
 
 
1.2.13  Hantavirus Infection 
 
Hantaviruses from the Bunyaviridae family cause systemic infections leading to 
haemorrhagic fever with renal syndrome (HFRS) in Asia and Europe and Hantavirus 
pulmonary syndrome (HPS) in North and South America. They were probably 
responsible for >35,000 cases of “trench nephritis” in British troops on the Western 
Front during World War I [Atenstaedt, 2006] and led to >3,000 military cases of 
“epidemic haemorrhagic fever” during the Korean War [Paul & McClure, 1958] and 
also affected British troops during the last Balkans Conflict [Stuart et al., 1996]. 
More than 21 different hantaviruses are known to live in various rodents and cause 
disease in humans and the most important examples are Hantaan virus (HTNV) and 
Seoul virus (SEOV) in Asia, Puumala virus (PUUV), Dobrava-Belgrade virus 
(DOBV) and Tula virus (TULV) in Europe and Sine Nombre virus (SNV) and Andes 
virus (ANDV) in America. The total number of pathogenic human hantaviruses may 
increase further with the discovery of a distinct group related to the Thottapalayam 
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(TPMV) hantavirus, which was originally found in insectivores (shrews) in southern 
India [Carey et al., 1971; Song et al., 2007] and is now known to extend to Nepal 
and China (Kang et al., 2011; Guo et al., 2011]. Other hantaviruses have so far only 
been discovered in rodents, but may cause human infection (perhaps with less 
obvious pathogenicity) according to serology results. Thailand virus (THAIV) and 
closely-related hantaviruses [Johansson et al., 2010] are good examples of this in 
Asia [Pattamadilok et al., 2006]. 
 
Hantaviruses are transmitted from their animal hosts via (aerosolised) excreta and 
bites and their pathogenesis in humans remains poorly understood [Jonsson et al., 
2010]. Following an incubation period of 14 to 28 days, the diseases usually have an 
acute onset with an undifferentiated febrile illness for the first 3 to 7 days followed 
by the more characteristic haemorrhagic, renal or pulmonary features thereafter. 
However, even at this stage it is clinically very difficult to distinguish hantavirus 
infections from similar presentations of leptospirosis. Laboratory diagnosis is based 
on serology tests that suffer from cross-reactivity between different hantaviruses and 
PCR tests that are very rarely available in developing countries. No specific anti-viral 
treatment is available at present and so supportive therapy for organ failures is all 
that can be offered. Prevention is limited to giving advice, rodent control and trying 
to improve the living conditions of people in affected areas. 
 
In Sri Lanka hantavirus infection has been identified using serology tests in patients 
with “leptospirosis-like” infections, who remained sero-negative for leptospirosis 
itself. 14 (6%) of 248 patients tested had antibodies against both HTNV and SEOV 
hantaviruses and in 4 patients living outside Colombo there were IgM titres or high 
IgG titres suggestive of acute infection [Vitarana et al., 1988]. A parallel study 
showed that 13 (14%) of 96 rats in Colombo harbour were seropositive for SEOV 
with lower titres against HTNV and PUUV and a hantavirus with some antigenic 
similarity to SEOV was isolated from them [Vitarana et al., 1988]. These results 
suggest that novel hantaviruses may be present in Sri Lanka and that the findings in 
humans and rats may not be related. Similar results were found in subsequent years 
[Vitarana, 1994] and in southern India a more recent serotyping study showed 
reactivity to both HTNV and THAIV hantaviruses, but not SEOV or PUUV and 
TPMV testing was not performed [Chandy et al., 2009a]. All these serology results 
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are difficult to interpret due to the genetic diversity and cross-reactivity of 
hantaviruses and also the possibility of novel hantaviruses being involved. However, 
more direct evidence comes from a related study of 344 patients with acute 
undifferentiated febrile illnesses, of which 18 (5%) were diagnosed with acute 
hantavirus infection by serology and 6 of these were also PCR positive [Chandy et 
al., 2009b]. The sequences obtained showed 84-99% homology and were most 
closely related to HTNV (84-99% homology), then SEOV (69-79% homology) and 
THAIV (61-72% homology) and were quite distinct from TPMV (8-30% homology). 
 
1.2.14  Other Virus Infections 
 
Many other virus infections can present with undifferentiated febrile illnesses, 
including Epstein-Barr virus (EBV), cytomegalovirus (CMV), human 
immunodeficiency virus (HIV), some respiratory viruses (including influenza) and 
also polio, measles, mumps, rubella, varicella and hepatitis viruses in their initial 
stages. Those with the potential to cause outbreaks in developing countries have been 
studied in detail, but limited resources mean that diagnostic tests are only routinely 
performed for blood-borne viruses with serious consequences, such as HIV, hepatitis 
B virus (HBV) and hepatitis C virus (HCV). 
 
In Sri Lanka outbreaks of measles, mumps, varicella and hepatitis A have occurred in 
recent years due to conflict, lack of vaccination and relatively low seroprevalence 
rates for protective antibodies. Influenza outbreaks occur on a seasonal basis in Sri 
Lanka and were responsible for 11% of all acute respiratory tract infections seen at 
the Colombo North Teaching Hospital, Ragama in Gampaha District [Perera et al., 
2010]. There is a low incidence of chronic blood-borne virus infections in Sri Lanka 
with rates of <0.1% for HIV [UNAIDS, 2009], 2.5% for HBV [Padmasiri et al., 
1995] and 0.16% for HCV [Senevirathna et al., 2011] and the country now has 
universal HBV vaccination with >98% coverage [WHO, 2010]. 
 
1.2.15  Non-Infectious Diseases 
 
Several non-infectious diseases can present with undifferentiated febrile illnesses and 
the relative proportion of these will increase if the normal FUO/PUO definition is 
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used because this requires a fever duration of >3 weeks [Petersdorf & Beeson, 1961] 
and most infectious causes will last for a shorter time. Examples include several 
malignancies and autoimmune diseases, which are known to occur in the tropics. 
 
1.3  Previous Fever Studies in South & South-East Asia 
 
The causes of undifferentiated febrile illnesses in Sri Lanka are likely to be similar to 
those in other south Asian countries (eg. India and Nepal) and also south-east Asian 
countries (eg. Thailand, Burma and Vietnam). Therefore previous fever studies from 
both these regions were reviewed. 
 
1.3.1  Sri Lanka 
 
The only wide-ranging fever study in Sri Lanka was published >40 years ago 
[Maretic et al., 1962]. Case definitions were not provided, but the target population 
seems to have been agricultural workers mostly from Western Sri Lanka who 
presented with febrile illnesses (“PUO”) to various hospitals and had serum samples 
sent to the Medical Research Institute in Colombo. This seems to have been a 
laboratory-based study and no clinical details were recorded, but serology tests for 
brucellosis, leptospirosis, Q fever, rickettsial infections and arbovirus infections were 
performed. Its results show that in 1957 there were 225,804 cases of PUO reported in 
Sri Lanka with 3,644 deaths and the serology results are summarised in Table 1.3.1. 
 
Table 1.3.1. Causes of PUO in Ceylon (1957) 
 
Disease Number Positive Number Tested Percentage Positive 
Brucellosis 24 551 4% 
Leptospirosis 26 109 24% 
Q fever 4 27 15% 
Scrub typhus 33 Not reported - 
Murine typhus 166 Not reported - 
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There are obvious limitations to this study and one must assume that malaria had 
already been tested for at the referring hospital since it was such a common problem 
at the time. It is also likely that the “murine typhus” category includes cases of 
rickettsial spotted fevers since these could not be distinguished using the tests 
available at that time. Overall, it is difficult to draw any firm conclusions from this 
study, but it does show that the infections listed occurred in significant numbers in 
Sri Lanka in 1957. 
 
1.3.2  India 
 
The only recent published fever study from India was of “non-malarial acute 
undifferentiated fevers” [Joshi et al. 2008]. On this occasion malaria cases were 
excluded because these were relatively easy to diagnose using laboratory tests and 
there was concern that other infections causing acute undifferentiated febrile 
illnesses were being incorrectly diagnosed and treated as malaria, which is a common 
problem globally including Africa [Reyburn et al., 2004]. This was a retrospective 
study that simply recruited all in-patients >12 year old who had been investigated for 
malaria from June to November 2006 in a rural hospital in central India. 144 (12%) 
of 1197 such patients were diagnosed with malaria and the remainder were not tested 
systematically or comprehensively for other infections. However, 47 (27%) of 176 
tested had dengue, three (27%) of 11 tested had leptospirosis, two (18%) of 11 tested 
had acute hepatitis E virus infection, 12 (13%) of 90 tested had TB meningitis, four 
(10%) of 41 tested had acute or chronic HBV infection, seven (8%) of 90 tested had 
bacterial meningitis and 19 (8%) out of 240 tested had positive blood cultures, but 
these were mostly Gram positive contaminants and no Salmonella species (including 
those causing enteric fever) were grown. Overall, it is difficult to draw any firm 
conclusions from this short, retrospective, non-systematic and non-comprehensive 
study, but the range of infections identified is of interest. 
 
1.3.3  Nepal 
 
Most parts of Nepal have a different climate to Sri Lanka, but a high-quality fever 
study was performed in Kathmandu from January to March and July to August 2001 
[Murdoch et al., 2004]. All adults (≥14 years old) with fever (axillary temperature 
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≥38°C) that arrived at Patan hospital were invited to join the study within 24 hours of 
admission. After providing written informed consent, the patients were interviewed 
and examined with data recorded on standardised assessment forms. The information 
collected included demographics, symptoms, past medical history, recent 
antimicrobial therapy and clinical signs. Venous blood samples were collected for 
culture and acute serology tests and urine samples were collected for antigen tests 
and simple assays of anti-microbial activity [Liu et al., 1999]. Patients were also 
asked to return 5-7 days after presentation to provide another blood sample for 
convalescent serology tests. Using the results obtained, multivariable logistic 
regression was performed to evaluate variables associated with diagnoses. 
 
Infectious causes of fever (including some co-infections) were found in 323 (37%) of 
876 patients recruited as summarised in Table 1.3.3.1. 164 patients (19%) reported 
taking anti-microbials before attending hospital, but urinary anti-microbial activity 
was found in 307 (38%). The correlation between clinical diagnoses made by the 
physicians and laboratory diagnoses was very poor and the logistic regression 
identified only a few significant associations as shown in Table 1.3.3.2. 
 
Table 1.3.3.1. Diagnosis of febrile illnesses in Kathmandu, Nepal (2001) 
 
Disease Cases* Percentage  
Enteric fever 
S. typhi 
S. paratyphi 
117 
(60) 
(57) 
13% 
(7%) 
(6%) 
Murine typhus 97 11% 
Pneumococcal pneumonia 53 6% 
Leptospirosis 36 4% 
Scrub typhus 28 3% 
HIV infection 11 1% 
Legionellosis 2 < 1% 
Dengue 0 0% 
Malaria 0 (of 506 tested) 0% 
 
* N = 876 
 -34- 
 
Table 1.3.3.2. Independent predictors of diagnoses in Kathmandu, Nepal (2001) 
 
Diagnosis Variable OR (95% CI) P Value 
Enteric fever Hospital admission 0.1 (0.04–0.5) 0.001 
 Leukopenia 3.5 (1.6–4.7) < 0.001 
Pneumococcal pneumonia Leukocytosis 2.2 (1.1–4.3) 0.019 
 Clinical chest signs 4.4 (2.1–9.1) < 0.001 
 Radiological chest signs 3.1 (1.5–6.3) 0.002 
Scrub typhus Anaemia 17.2 (1.2–246.0) 0.04 
 
This was a prospective, systematic study that extended across the two main seasons 
in Nepal and although it was focused on blood stream infections, several other 
important causes of febrile illness were tested for as well. Only 13% of patients 
returned to give convalescent blood samples at a median time of 5 days following 
admission and this is likely to have reduced the number of cases identified by 
serology tests (eg. murine typhus, leptospirosis, scrub typhus and dengue). Despite 
the logistic regression findings, the authors stated that no clinical predictors were 
identified to reliably distinguish between the different infections and so they 
recommend that the development of cheap and accurate diagnostic tests would be 
most appropriate in this setting. 
 
A subsequent retrospective fever study that also concentrated on blood stream 
infections was performed at Dhulikhel hospital in Kathmandu from 2002-4 [Sharma 
et al., 2006]. The medical and laboratory records were reviewed for all patients (of 
all ages) who presented with an axillary temperature ≥38°C and had a blood culture 
taken. Positive blood cultures were found in 122 (7%) of 1774 patients who met the 
recruitment criteria and the most common diagnoses made were enteric fever in 52% 
(41% typhoid and 11% paratyphoid) and pneumococcal infection in 12%. Although 
clinical features were recorded, they were not correlated to the final diagnoses and 
overall this study added little to what was already known. However, a later study 
performed retrospective IgM serology tests on paired samples from 103 of these 
same cases and made diagnoses of murine typhus in 26%, scrub typhus in 22%, 
leptospirosis in 10% and dengue in 8% [Blacksell et al., 2007a]. Overall 18% had 
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evidence of co-infections and in many cases (including all of the dengue cases) the 
IgM titre did not increase between samples suggesting that the infections were not 
acute. Again no clinical correlation was provided and so the results only reinforced 
what was already known about the differential diagnosis of febrile illnesses in the 
Kathmandu area of Nepal. 
 
1.3.4  Thailand 
 
More fever studies have been produced in Thailand than any other country in this 
region. In 1991 a study of acute undifferentiated fevers was performed at Chiangrai 
hospital in north Thailand to determine what proportion were due to JEV infection 
[Watt & Jongsakul, 2003]. This prospective study was carried out during the rainy 
season of June to December since cases were known to be most common at that time. 
The patients to be recruited were defined as those “attending the adult out-patients 
department … with an oral temperature ≥37.5°C, a history of fever lasting ≤2 weeks, 
no known chronic medical problems, no known current infectious disease and no 
neurological signs”. A standardised data collection sheet was used to collect clinical 
and laboratory data on each case and IgM serology for dengue and JEV infection 
were performed on admission samples only. From 156 patients recruited there were 
35 (22%) with dengue, 22 (14%) with JEV infection and the remaining 99 (63%) 
were undiagnosed. However, positive IgM serology only indicates that acute 
infection had occurred within the last 6 weeks and testing only a single sample for 
each patient led to equivocal results in 8 (36%) of the JEV infection cases. Limited 
attempts were made to correlate clinical and laboratory features with the diagnoses 
due to the small numbers of cases identified. Overall, this was a prospective, 
standardised study that was performed at a specific time of year to identify only two 
specific infections. Although limited in its scope and by the serology testing 
performed, it remains a well-designed study and confirmed that JEV infection can 
present with an acute undifferentiated febrile illness. 
 
The same authors later conducted another study at three hospitals in north, west and 
south Thailand to investigate the use of a combined rapid diagnostic test for scrub 
and murine typhus, leptospirosis, dengue and typhoid [Watt et al., 2005]. In this 
prospective study patients were recruited if they presented with “acute febrile 
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illnesses of unclear etiology … if their duration of fever by history was <3 weeks, a 
blood smear for malaria was negative, and informed written consent was given.” 
Confirmed diagnoses were made using blood, urine and stool cultures for enteric 
bacteria and paired IgM and IgG serology tests. Only acute sera were tested with the 
rapid diagnostic test under investigation. From 310 patients recruited, there were 
only 36 (12%) with confirmed, single diagnoses covered by the rapid diagnostic test, 
of whom 18 (50%) had scrub typhus, six (17%) had murine typhus, six (17%) had 
leptospirosis, four (11%) had dengue and two (6%) had typhoid. Results for the rapid 
diagnostic test were positive for the correct infection as defined by culture or 
serology in 94% of patients, but were also positive for incorrect infections in 92% of 
these cases. Overall, this was another prospective, standardised study that was 
conducted for the specific purpose of evaluating a new diagnostic test. Although it 
was a well-designed study, the frequencies of confirmed diagnoses can not be 
considered representative of the study group nor the wider population and the rapid 
diagnostic test had insufficient specificity to be of any value in this context. 
 
A high-quality fever study was performed at a hospital near the River Kwai on the 
Thai-Burmese border from 1999-2002 [Ellis et al., 2006]. This used a precise yet 
concise definition for recruitment and conduct of the study as shown : 
 
“Adult inpatients and outpatients presenting with temperature ≥ 38°C or history of 
fever over the previous 48 hours were admitted to the study and evaluated for cause 
of fever. Patients with fever >48 hours were also eligible for enrollment, as long as 
the cause of fever was not yet known. Patients presenting for continuation of 
treatment of known cause of fever were excluded, as were those who were unable or 
unwilling to provide blood samples 2-4 weeks after enrollment. Clinical information 
and blood samples were obtained at enrollment and after approximately 3 weeks. 
Informed consent was obtained from each study subject before enrollment.” 
 
Routine haematology, biochemistry, renal function and liver function tests were 
performed for all patients at admission. Blood was also taken for malaria blood films 
at admission and for acute and convalescent serology tests at admission and 2-4 
weeks later. Blood cultures were not performed and other investigations were 
performed at the discretion of the physicians responsible for patient care. From 613 
 -37- 
patients recruited, there were 530 (86%) who returned for convalescent serology 
tests, 294 (48%) with laboratory diagnoses, 166 (27%) with clinical diagnoses and 
153 (25%) with no diagnosis made as shown in Table 1.3.4.1. There were 34 patients 
(6%) with apparent dual diagnoses of whom 22 (65%) seemed to have both malaria 
and leptospirosis.  
 
Table 1.3.4.1. Diagnosis of febrile illnesses on the Thai-Burmese border (1999-2002) 
 
Diagnosis Cases* Percentage** 
Malaria 
P. falciparum 
P. vivax 
Mixed or other 
155 
(95) 
(48) 
(12) 
25% 
(16%) 
(8%) 
(2%) 
Leptospirosis 107 18% 
Lower respiratory infection 64 10% 
Upper respiratory infection 57 9% 
Rickettsiosis 
Spotted fever group rickettsiosis 
Murine typhus 
Scrub typhus 
36 (of 46 tested) 
(20) 
(9) 
(7) 
6% 
(3%) 
(2%) 
(1%) 
Gastroenteritis 16 3% 
Urinary tract infection 13 2% 
Dengue 9 2% 
HIV/AIDS 7 1% 
Pulmonary TB 7 1% 
Typhoid 5 (of 31 tested) 1% 
Japanese encephalitis 1 < 1% 
Not diagnosed 153 25% 
Other diagnoses 7 3% 
 
* N = 613; ** Total is > 100% due to dual diagnoses 
 
Clinical and laboratory variables that were potential predictors of specific diagnoses 
were analysed using univariate statistics. Variables associated with diagnoses at a 
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significance of P < 0.1 then underwent multivariate logistic regression. Variables 
with a significance of P < 0.05 after regression were considered to be independent 
predictors of the diagnoses. Unfortunately, the only significant predictors were for 
malaria as shown in Table 1.3.4.2. 
 
Table 1.3.4.2. Independent predictors of diagnoses on the Thai-Burmese border 
(1999-2002) 
 
Diagnosis Variable OR (95% CI) P Value 
Malaria (all) Out-patient 3.2 (1.7–6.0) < 0.001 
 Temperature ≥38°C 2.3 (1.4–3.8) 0.001 
 Platelets <150 x 109/L 17.2 (10.4–28.5) < 0.001 
Malaria (falciparum) Temperature ≥38°C 2.1 (1.2–3.5) 0.006 
 Platelets <150 x 109/L 8.8 (5.1–15.5) < 0.001 
 
Malaria was expected to be the most common infection in this study, but the numbers 
of leptospirosis cases was unexpected. The fact that 28 (26%) of these 107 
leptospirosis cases were dual infections is of concern especially since this diagnosis 
was made on serology tests only. The fact that blood cultures were not performed 
and only a minority were tested by PCR tests for typhoid and by serology tests for 
rickettsioses will mean that the frequency of these infections was under-estimated. 
Overall, this was a prospective study that was run for >1 year with well-defined 
recruitment criteria and a mostly standardised approach to assessing patients. It 
tested for most of the relevant infections in this area (but did not include blood 
cultures) and included exact definitions for both laboratory and clinical diagnoses. It 
also correlated the diagnoses made with the demographic, clinical and laboratory 
data collected and identified independent predictors of diagnoses, although the 
results were disappointing in this respect. 
 
Another high-quality fever study in Thailand was performed in 5 different hospitals 
across the country from 2001-2 [Suttinont et al., 2006]. The focus of the study was 
acute undifferentiated febrile illnesses and the recruitment criteria were less precisely 
defined according to the statement that, “Most adult patients who … presented at one 
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of these hospitals with acute fever (of <15 days’ duration) without an obvious focus 
of infection were included in the study.” Thereafter a standardised approach was 
followed and all patients had routine haematology, biochemistry, renal and liver 
function tests performed as well as urinalysis and chest radiography. Blood was sent 
for leptospiral cultures (but only occasionally for bacterial cultures) and also for 
acute and convalescent serology tests using samples from the admission and 2-4 
weeks after discharge. 577 (68%) of 845 patients recruited had confirmed laboratory 
diagnoses as shown in Table 1.3.4.3, which is a simplified version showing details of 
dual infections. Although diagnoses were correlated with geographical location and 
seasonality, no correlations were made with other demographic, clinical or laboratory 
features. 
 
Table 1.3.4.3. Diagnosis of undifferentiated febrile illnesses in Thailand (2001-2) 
 
Diagnosis Cases* Percentage 
Leptospirosis 312 37% 
Scrub typhus 135 16% 
Dengue 44 5% 
Influenza 39 5% 
Murine typhus 15 2% 
Rickettsia helvetica infection 8 1% 
Q fever 7 1% 
Japanese encephalitis 3 < 1% 
Melioidosis 3 < 1% 
Other bacterial infections 7 1% 
Unknown 268 32% 
 
* N = 845 
 
Overall, this was a prospective study that was run for 1 year with poorly-defined 
recruitment criteria and a mostly standardised approach to assessing patients. It 
tested for most of the relevant infections in this area (but did not include bacterial 
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blood cultures) and it did not include clinical diagnoses. It also did not correlate the 
diagnoses made with the demographic, clinical and laboratory data collected. 
 
1.3.5  Vietnam 
 
No comprehensive fever studies have been performed in Vietnam, but the following 
detailed case definition was used in a study to evaluate some novel serology tests for 
leptospirosis [Wagenaar et al., 2004] : 
 
“To be considered a febrile patient, an individual had to present with an axillary 
temperature of >38°C and to have been febrile for <2 weeks. Patients found smear-
positive for malaria (by microscopy), those with severe disease requiring referral 
(such as meningitis or sepsis), or signs and symptoms indicating a specific localised 
disease (such as tonsillitis, pneumonia, abscesses, peritonitis, arthritis, 
pyelonephritis) or chronic underlying conditions such as renal or hepatic disease, 
diabetes mellitus, HIV infection, and those taking immunosuppressive medication 
were excluded.” 
 
Although not stated as such, this is clearly an attempt to define patients with 
undifferentiated febrile illnesses. Similarly, in a study of brucellosis seroprevalence 
in Vietnam, the following definition was used for such illnesses [Nga et al., 2006] : 
 
“Acute undifferentiated fever was defined as any febrile illness of duration less than 
14 days, confirmed by an axillary temperature ≥38.0 °C, without any indication for 
either severe systemic or organ specific disease.”  
 
Both of these studies are designed to investigate a single disease and so have little to 
add to the previous studies with regard to designing a comprehensive fever study in 
Sri Lanka. However, the attempts to define undifferentiated febrile illnesses are of 
interest since there is considerable variation in this respect amongst all of the 
previous studies. 
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1.3.6  Statistical Analysis 
 
Most fever studies will perform a simple descriptive analysis of the diagnoses made 
and comment on how representative these findings are likely to be for the population 
in that area on a seasonal basis. Ideally, a fever study should also collect 
demographic, clinical and laboratory data that can be correlated with the diagnoses 
made. In two of the studies reviewed [Murdoch et al., 2004; Ellis et al., 2006] this 
was done using univariate analysis and then multivariate logistic regression. The data 
for each diagnosis were compared to the remainder of the cohort using appropriate 
univariate tests for dichotomous, ordinal and continuous variables. Those variables 
associated with a diagnosis at a significance of P < 0.1 then underwent multivariate 
logistic regression and those with a significance of P < 0.05 after regression were 
considered to be independent predictors of that diagnosis. Unfortunately, in both of 
these studies the results of this process did not identify many clinically useful 
predictors for specific infections (Tables 1.3.3.1 & 1.3.4.2) and therefore it was not 
possible to construct clinical prediction rules to help in diagnosing these diseases. 
 
Most prediction rules that relate to infectious diseases are aimed at identifying a 
mortality risk [Lim et al., 2003] or a clinical syndrome such as community-acquired 
pneumonia [Hopstaken et al., 2003; Flanders et al., 2004; Falguera et al., 2009; 
Bilkis et al., 2010], bacteraemia [Bleeker et al., 2007; Shapiro et al., 2008] or urinary 
tract infection [Gorelick et al., 2003]. Rules that aim to identify specific infectious 
diseases are less common and mostly relate to distinguishing between different forms 
of meningitis [Patel et al., 2010; Cohn et al., 2012; Hristea et al., 2012]. 
 
So far there are published rules for only one of the infections that present with an 
acute undifferentiated febrile illness in Sri Lanka. These were for enteric fever of 
which one was from Malaysia, but was not validated [Ross & Abraham, 1985] and 
the other was from Turkey [Hosoglu et al., 2006], but the range of infections causing 
acute undifferentiated febrile illnesses was much smaller than in Sri Lanka. This 
suggests that developing a clinical prediction rule to distinguish between different 
causes of acute undifferentiated febrile illness in Sri Lanka will be difficult. 
However, it remains a worthwhile aim since it could avoid the unnecessary use of 
valuable or scarce resources – including investigations, antibiotics and hospital beds. 
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1.3.7  Lessons Learnt from Previous Studies 
 
Previous fever studies in this region are usually focussed on : 
 
 • Identifying bacteraemias (blood stream infections) using blood cultures  
 • Identifying other infections that require serology or PCR tests 
 • Correlating diagnoses to demographic, clinical and laboratory findings 
 
However, none of the studies reviewed here perform well all in three of these areas 
and none of the published papers indicate how representative the study population 
was in comparison to eligible patients who were not recruited for various reasons. 
This was often due to a lack of systematic recruitment and no data on recruitment 
rates in different groups was published in any of these studies. For example, in some 
countries a woman may feel that they can not join a study without their husband’s 
permission or may feel less able to return for follow-up. 
  
The ideal fever study in south or south-east Asia should : 
 
 • Be prospective 
 • Run continuously for ≥1 year 
 • Precisely define the patients to be recruited 
 • Obtain informed written consent from participants 
 • Keep demographic details of eligible patients who were not recruited 
 • Record demographic, clinical & laboratory data in a standardised format 
 • Include malaria tests, blood cultures & paired serology tests for relevant pathogens 
 • Use precise definitions for confirmed/laboratory & unconfirmed/clinical diagnoses 
 • Correlate the final diagnoses with the demographic, clinical & laboratory data 
 • Seek to develop clinical prediction rules to help in diagnosing the infections found 
 • Assist in the development of appropriate diagnostic tests for use in the host country 
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1.4  Situation and Objectives 
 
Some variation in the way that fever studies are performed is due to the situation in 
which they are conducted and these local factors must be considered when designing 
a study such as this. Fever studies are usually hospital-based to ensure that adequate 
numbers of patients with the most serious infections are recruited, but this does mean 
that their findings are not necessarily representative of the wider population. 
 
1.4.1  Geographical Situation 
 
Sri Lanka is an island measuring 270 by 140 miles that is located within the tropics 
and lies 22 miles from the south-east coast of India. In keeping with its tropical 
location it lacks summer and winter seasons, but has rainy seasons instead. The 
south-west part of the island is called the “wet zone” and has two rainy seasons per 
year, whereas the north-eastern part is called the “dry zone” and has only a single 
rainy season per year. The total population is ~20 million and this is distributed as 
shown in Figure 1.4.1. Sri Lanka was previously part of the British Empire and 
called Ceylon, but changed its name at independence in 1948. The country’s 
economic development has been hindered by a succession of civil conflicts 
(including the Tamil conflict from 1983-2009) and natural disasters (including the 
Indian Ocean tsunami in 2004), which mean that it remains a developing country. 
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Figure 1.4.1. Population density of Sri Lanka in 2001 (© 2012 recoverlanka.net) 
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1.4.2  Medical Situation 
 
Medical facilities in Sri Lanka include a network of hospitals of various sizes that 
extend across the country according to the population distribution. Laboratory 
facilities can be very limited in the smaller hospitals and only the six large teaching 
hospitals (Colombo, Colombo North, Colombo South, Kandy, Galle and Jaffna) had 
dedicated medical microbiologists at the time of this study. Hence these were the 
best places to conduct a fever study and Colombo North Teaching Hospital (CNTH) 
at Ragama in the Gampaha District of western Sri Lanka was especially appropriate 
since it serves a large population of ~2 million people that live in both urban and 
rural settings. Its location is shown in Figures 1.4.2.1 and 1.4.2.2. 
 
Figure 1.4.2.1. Location of CNTH at Ragama in Sri Lanka (© 2012 Google) 
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Figure 1.4.2.2. Location of Ragama in Relation to Colombo and Katunayake (© 2012 
Google) 
 
 
 
CNTH is a large general hospital and is co-located with the Faculty of Medicine of 
the University of Kelaniya. The hospital has 8 adult general medicine wards and 2 of 
these (one for males and one for females) form the Professorial Medical Unit, which 
is staffed by academic consultants and offers a good setting for clinical research 
projects. CNTH has its own pathology laboratories that do basic haematology, 
biochemistry and microbiology investigations, but the Department of Microbiology 
at the Faculty of Medicine has better facilities for research. Even so at the time this 
study began there was no routine blood culture facility available within this 
department. Private laboratories in Colombo are able to do additional investigations 
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Running a microbiology laboratory remains a laborious business requiring more 
skilled staff and a wider range of supplies in comparison to modern haematology, 
biochemistry and even molecular diagnostic laboratories. Therefore microbiology 
services in developing countries are often limited and clinicians must become 
accustomed to treating suspected infection cases with empirical antibiotics. However, 
the widespread over-use of anti-microbial drugs and inability to report local 
microbial sensitivities means that there is a significant risk of antibiotic resistance 
and treatment failures. 
 
Many of the infections that occur in Sri Lanka can not be identified using 
conventional parasitology and bacteriology techniques and the necessary specialist 
cultures, serology and PCR tests would be difficult to introduce and maintain on a 
regular basis. Therefore a fever study that was able to develop clinical prediction 
rules for these infections would be most valuable. Rules with a high sensitivity 
would enable efficient use of laboratory diagnostics to confirm infections, whereas 
rules with a high specificity would enable the efficient use of hospital beds for 
admitting patients with life-threatening infections and discharging those who did not. 
The latter is especially important during the rainy seasons when there are insufficient 
hospital beds for the increased number of febrile illness patients that present. 
 
1.4.3 Objectives 
 
In accordance with the aims of the study (Section 1.1.1) the following objectives 
were established : 
 
1. To design a fever study that was appropriate to the diseases, facilities and needs of 
a hospital serving a mixed urban and rural population in Sri Lanka. 
 
2. To submit this research proposal for approval of its scientific merit, research ethics 
and estimated costs to the University of Kelaniya, Liverpool School of Tropical 
Medicine and Defence Postgraduate Military Deanery. 
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3. To recruit and train an appropriate number of medical research assistants to help 
with the recruitment and assessment of patients (especially out of hours) thus helping 
to ensure that the study sample was as complete and representative as possible. 
 
4. To establish a safe and reliable system for transporting diagnostic samples in 
optimum conditions to a range of international reference laboratories. 
 
5. To create an electronic database to store anonymous patient data – including 
demographics, clinical features, laboratory results and final diagnoses obtained from 
the reference laboratories. 
 
6. To conduct the study over a 1-year period with minimal interruption and regular 
progress meetings to minimise problems. 
 
7. To analyse the diagnostic results and correlate these to the demographic, clinical 
and laboratory data collected and if possible, create clinical prediction rules for the 
most common infections found. 
 
8. To use an appropriate rapid diagnostic test prospectively during the study in order 
to assist in its evaluation and then provide data and samples for retrospective use in 
the evaluation of other such tests. 
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2.1  Patient Recruitment, Data Collection and Sample Collection 
 
2.1.1  Patient Recruitment 
 
This was a prospective and systematic study carried out at the Colombo North 
Teaching Hospital (CNTH) at Ragama in the Gampaha District of western Sri Lanka 
(Figure 2.1.1) over a one-year period from 06 June 2006 to 05 June 2007. This 
hospital serves a population of ~2 million people from both urban and rural areas and 
patients were recruited from the male and female wards of the Professorial Medical 
Unit (PMU), which is responsible for 25% of all adult medical admissions on an 
unselected basis.  
 
Patients with an oral temperature ≥38.0 °C on admission were eligible to join the 
study, but were excluded if they did not provide informed written consent, were aged 
<16 years, had been admitted for >24 hours or if they had already received 
antibiotics in hospital. Patients were recruited using the patient information and 
consent form shown in Appendix 1.  
 
One key objective was to ensure that the study sample was as complete and 
representative as possible and so three medically-qualified research assistants were 
employed to assist with the recruitment and assessment of patients. They received 
specific training and daily supervision for all aspects of their work and visited every 
new admission on the PMU wards to assess their eligibility for the study. Between 
them they were able to provide 24-hour cover of the wards in order to avoid 
problems with out-of-hours recruitment. Without this cover eligible patients would 
have been missed and become ineligible by exceeding the 24-hour deadline or by 
receiving antibiotics in hospital before they could be recruited. The total number of 
patients admitted to the PMU wards and the demographic details of patients not 
recruited were also collected and reviewed monthly to detect any bias in recruitment. 
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Figure 2.1.1. Location of CNTH and the Gampaha District within Sri Lanka 
 
 
 
2.1.2  Data Collection 
 
Recruited patients had demographic, epidemiological, clinical and laboratory data 
recorded by the research assistants using the data collection form shown in Appendix 
2. This form was updated 2 months into the study when a patient presented with 
imported malaria to include a question on travel overseas. Additional questions 
regarding the clinical features of enteric fever were also added once cases were 
identified. Otherwise the data collection remained the same throughout the study. 
Recruited patients were visited every day by one of the study team to update the data 
collection form with any new clinical or laboratory features. They were all requested 
to attend the out-patients clinic on a single occasion 2-4 weeks after discharge for 
clinical review and further data collection and were offered LKR 200 (~£1) to cover 
● Colombo North Teaching Hospital 
 Gampaha District 
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travelling expenses if they did attend. Those that did not attend were sent a single 
reminder card by post. 
 
In order to understand any seasonal variation in admissions, monthly rainfall data for 
the Gampaha District was obtained from the (National) Department of Meteorology, 
Sri Lanka. These measurements were made at the Katunayake Airport weather 
station, which is located 15 km north of CNTH as shown in Figure 1.4.2.2. 
 
In order to describe the distribution of cases in Gampaha District, electronic maps for 
the ArcGIS mapping software package were obtained from the Department of 
Geography, University of Kelaniya, Sri Lanka. These maps were sufficiently detailed 
to identify each Grama Niladara (GN) division, which is the smallest administrative 
division used in Sri Lanka and is similar to a UK post code. 
 
In order to identify any variation in the distribution of cases between urban and rural 
areas, population data for each GN division in Gampaha District was obtained using 
the 2001 Census from the (National) Department of Census and Statistics, Sri Lanka. 
For each GN division the area from the electronic maps and the population from the 
census records were combined in a spreadsheet to calculate the population density. 
Since there is no definition of urban or rural areas in Sri Lanka, the definitions used 
in India and certain other countries were used instead [Government of India, 2011; 
Statistics Canada, 2011]. Hence an urban area was defined as having ≥400 people / 
km2 and a rural area was defined as having <400 people / km2. 
 
In order to compare the diagnoses made in this study with other public health 
records, the weekly notifiable disease records for Gampaha and other Districts from 
2006-7 were obtained from the (National) Epidemiology Unit, Sri Lanka. However, 
it should be noted that these cases are usually diagnosed on clinical criteria only and 
the data included in these reports are not considered very reliable. 
 
All data were entered into a FileMaker Pro database by myself and 5% of all data 
entry was independently validated. All computer files were encrypted and stored 
securely with a back-up performed each week using both a password-protected 
external hard disk and a secure Internet storage system (www.mozy.com). 
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2.1.3  Sample Collection 
 
Diagnostic samples were taken by the research assistants with help from me 
whenever required. On the day of recruitment 20 ml of blood was obtained by aseptic 
technique from each patient and divided equally amongst: 
 
 • an in-house blood culture bottle for bacteria 
 • a BacT/ALERT blood culture bottle for bacteria 
 • a heparinised culture bottle for leptospires 
 • a plain tube for CRP and CPK tests 
 
These samples were kept at room temperature (25-30 °C) for up to 4 hours before 
being delivered to the laboratory. Culture bottles for bacteria were incubated at 37 
°C, whereas those for leptospires were kept at room temperature (25-30 °C) for up to 
2 weeks before being sent overseas using Aramex’s medical specimen service. Also 
on the day of recruitment a urine sample was collected for assays to measure protein 
content and detect the presence of antimicrobials. These urine samples were stored in 
a fridge at -4 °C for up to 4 hours before being delivered to the laboratory where they 
were stored at -30 °C until the time of testing. On the day following recruitment 20 
ml of blood was taken and kept at room temperature (25-30 °C) for up to 4 hours 
before being centrifuged to produce serum that was divided equally between 5 
microtubes. These serum samples were stored at -80 °C and transported with dry ice 
to laboratories overseas using DHL’s Medical Express service. Recruited patients 
were also asked to give 20 ml of blood for repeat serology tests on discharge (if they 
had been admitted for >5 days) and on follow-up 2-4 weeks later. 
 
2.2  Laboratory Investigations 
 
The microbiology investigations used in this study were all gold standard tests 
performed at research and reference laboratories in several different countries. All 
other laboratory investigations were of the highest standard available in Sri Lanka. 
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2.2.1  Malaria Investigations 
 
Malaria was diagnosed by microscopy of thick blood films stained with Giemsa at 
the Department of Parasitology, University of Kelaniya, Sri Lanka.  
 
2.2.2  Bacteraemia Investigations   
 
Bacteraemia was diagnosed using two different aerobic blood culture bottles for each 
patient at the Department of Microbiology, University of Kelaniya, Sri Lanka. Ten 
ml of blood was collected using aseptic technique and divided equally between an in-
house culture bottle and a BioMérieux BacT/ALERT FA culture bottle (Catalogue 
no. 259791, Batch no. 1014621; BioMérieux, Durham, NC). The in-house bottles 
contained a standard brain heart infusion (BHI) medium with 0.05% sodium 
polyanethol sulfonate (SPS) as recommended by the Sri Lanka College of 
Microbiologists [Thevanesam, 2001]. The BacT/ALERT bottles contained a 
commercial peptone-enriched tryptic soy broth supplemented with BHI and also 
activated charcoal that was supposed to neutralise any antimicrobials already taken 
by the patient. 
 
Both bottles were incubated at 37 °C and sub-cultured at 1, 2 and 7 days onto blood, 
chocolate and MacConkey agar plates. Sub-culturing of the in-house bottles was 
done by removing the lid and inserting a loop, whereas the BacT/ALERT bottles had 
a sub/venting needle left in place. All sub-culture plates were incubated at 37 °C for 
48 h with blood and chocolate plates in 5-10% CO2 and MacConkey plates in air. 
Identification of bacteria and their antibiotic sensitivities was done in Sri Lanka 
using standard laboratory techniques that included the use of the commercial IDS 
Rapid microbial identification panels (Span Diagnostics Ltd, India) and the Kirby-
Bauer antibiotic disk diffusion technique. These isolates were later transferred in 
concentrated BHI broth with dry ice to the Department of Medical Microbiology, 
University of Liverpool, UK where their identification and antibiotic sensitivities 
were confirmed using similar techniques and where necessary by 16S rRNA gene 
sequence analysis to confirm identities. 
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The in-house bottles were made of glass and were reused after cleaning and 
autoclaving, whereas the BacT/ALERT bottles were made of plastic and were 
disposed of after autoclaving.  
 
2.2.3  Other Bacterial Investigations 
 
Other bacterial infections were diagnosed from urine and sputum samples using 
standard microbiology techniques at the Department of Microbiology, University of 
Kelaniya, Sri Lanka. These specimens were collected as part of the patients’ routine 
management by clinicians on the Professorial Medical Unit and not in a systematic 
way relating to the study. Urine cultures were done quantitatively using a calibrated 
1 µl wire loop and cysteine lysine electrolyte-deficient (CLED) agar plates, which 
were incubated at 37 °C in room air for 48 h. Sputum cultures were performed on 
samples that passed Murray-Washington quality criteria [Murray & Washington, 
1975] using blood and chocolate agar plates, which were incubated at 37 °C in 5-
10% CO2 for 48 h. 
 
2.2.4  Tuberculosis Investigations 
 
Tuberculosis (TB) was diagnosed in conjunction with the (National) Chest Hospital 
at Welisara, which is 5 km away from Ragama and the only specialist TB hospital in 
Sri Lanka. TB cultures are not performed on all cases due to a relative lack of 
resources in comparison to the number of patients seen. Hence “clinically-typical” 
pulmonary TB cases will usually not have cultures done, but will be started on anti-
tuberculous therapy and followed up to ensure there is a good clinical response. For 
the purpose of this study a “clinically-typical” case of pulmonary TB was defined as 
having all of the following: 
 
 • suggestive clinical features eg. fever, cough, sputum, dyspnoea, weight loss 
 • a positive Mantoux test (>10 mm with 1 unit of purified protein derivative) 
 • raised inflammatory markers (ESR ≥40 mm/h or CRP ≥48 mg/L) 
 • pulmonary cavitation or pleural effusion on chest radiography 
 • no alternative respiratory diagnosis 
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(The levels chosen to define raised inflammatory markers were expected to occur in 
bacterial infections such as TB and the CRP figure reflects the serial dilutions used to 
measure this as described in Section 2.2.15) Hence in this study TB cases were 
defined as laboratory-confirmed TB (on culture or histology) or as “clinically-
confirmed” pulmonary TB (with a documented response to anti-tuberculous therapy). 
 
2.2.5    Brucellosis Investigations 
 
Brucellosis was diagnosed from serum samples using an established protocol of tests 
at the (National) Brucellosis Reference Unit, UK as described previously [Sharma et 
al., 2008]. Initially, serum samples were screened at a dilution of 1:160 with the 
commercial Brucellacapt immunocapture-agglutination assay (Vircell SL, Granada, 
Spain), which has performed well in several independent evaluations [Orduña et al., 
2000; Casao et al., 2004; Gómez et al., 2008]. 
 
The Brucellacapt assay was performed using 50 µl samples of 1:160 diluted sera, 
which were added to the wells of a U-bottom microtitre plate coated with anti-total 
human immunoglobulin. Then 50 µl of an antigen suspension (coloured Brucella 
melitensis bacteria killed by formaldehyde treatment) was added to each well and 
plates were incubated at 37 °C for 24 h. Positive reactions showed agglutination 
spread over the bottom of the well, whereas negative reactions were indicated by a 
pellet at the centre of the well. 
 
Serum samples that were Brucellacapt positive at a dilution of 1:160 were then 
further investigated using a series of validated in-house tests [Sharma et al., 2008]. 
Enzyme immunoassays (EIAs) for IgM and IgG antibodies were performed and if 
positive these were followed by a micro-agglutination (MAG) assay and a 
complement fixation test (CFT) as described previously [Sharma et al., 2008]. 
 
The EIAs were performed using whole cell Brucella abortus antigen strain S99 
obtained from the Veterinary Laboratory Agency (VLA), Weybridge, UK along with 
horseradish peroxide labelled conjugate (anti-human IgM or IgG depending on 
which assay was being performed) and enzyme substrate in a standard EIA format. 
Test sera were added using a dilution range of 1:20 to 1:10240 in a 96-well EIA 
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plate, which was incubated at 37 °C for 45 min and then read using a 
spectrophotometer at 450/620 nm within one hour of stopping the reaction. A 
negative reaction was indicated by an optical density (OD) ≤0.8 and a positive 
reaction was indicated by an OD >0.8. The end-point titre of the test serum was 
derived from the highest dilution with an OD >0.8. A negative result was defined as 
a titre of <1:20 and positive results were defined as those with titres of ≥1:20. 
 
The MAG assay was performed using safranin-stained whole cell B. abortus antigen 
strain S99 from VLA, UK. Test sera were added using a dilution range of 1:20 to 
1:2560 in a V-bottomed plate, which was incubated at 37 °C for 24 h and then read 
by naked eye. A negative reaction with no agglutination was indicated by a button of 
red-stained bacteria in the centre of the well with a surrounding pink halo. However, 
if Brucella antibodies (IgG, IgM or IgA) were present, then an antigen-antibody 
complex was formed leading to agglutination, which resulted in a mat of stained cells 
spread over the bottom of the well or a diminished button of bacterial cells in the 
centre of the well with a slightly opaque surrounding diluent. The end-point titre of 
the test serum was derived from the highest dilution that showed agglutination. A 
negative result was defined as a titre of <1:20 and positive results were defined as 
those with titres of ≥1:20. Titres of ≥1:160 were considered to be clinically 
significant, whereas titres of 1:20 to 1:160 were considered to be of indeterminate 
clinical significance. 
 
The CFT was performed using whole cell B. abortus antigen strain S99 from VLA, 
UK along with complement and sensitised sheep erythrocytes in a standard CFT 
format. Test sera were added using a dilution range of 1:4 to 1:256 in a U-bottomed 
microtitre plate, which was incubated at 37 °C for 24 h and then read by naked eye. 
A negative reaction with no complement fixation was indicated by complete lysis of 
sensitised sheep erythrocytes (lysis score four). However, if Brucella antibodies 
(IgG, IgM or IgA) were present, then an antigen-antibody complex was formed 
leading to fixation of the complement and no lysis, which resulted in a button of 
erythrocytes at the centre of the well (lysis score zero). The end-point titre of the test 
serum was derived from the highest dilution that showed 50% or more fixation (lysis 
score two). A negative result was defined as complete lysis at 1:4 dilution and 
positive results were defined as those with titres of >1:4. 
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2.2.6    Leptospirosis Investigations 
 
Leptospirosis was diagnosed by blood cultures at the Mahidol-Oxford Tropical 
Medicine Research Unit, Bangkok, Thailand and from serum samples using a 
validated in-house IgM ELISA and the micro-agglutination test (MAT) at the 
(National) Leptospira Reference Unit, UK. 
 
Blood cultures were performed using methods described previously [Wuthiekanun et 
al., 2007]. Blood was collected into 5 ml polystyrene tubes (Teklab, UK) containing 
25 U sodium heparin (Leo Pharma, UK) and kept at 25-30 °C throughout. Aliquots 
of whole blood and centrifuged plasma deposits were cultured in 0.1% semi-solid 
Ellinghausen-McCullough-Johnson-Harris (EMJH) medium with 3% normal rabbit 
serum at 25-30 °C for 13 weeks with weekly checks using dark-field microscopy. 
Isolates underwent multi-locus sequence typing (MLST) as described previously 
[Thaipadungpanit et al., 2007] and were also sent to the WHO/FAO/OIE 
Collaborating Centre for Reference & Research on Leptospirosis, Brisbane, Australia 
for serovar identification using the cross-agglutinin absorption test (CAAT) 
[Stallman, 1984]. 
 
The IgM ELISA and MAT were performed using methods described previously 
[Zochowski et al., 2001; Palmer et al., 1987; Wolff, 1954]. The former was used to 
screen samples and positives were then confirmed using the latter in accordance with 
the usual reference laboratory protocol. 
 
The ELISA was performed using heat-extracted antigen from a culture of L. 
interrogans serovar Hardjo strain Hardjo-Prajitno [Terpstra et al., 1980]. Test sera 
were added using a dilution range of 1:20 to 1:2560 in a standard ELISA plate, 
which was incubated at 37 °C for 60 min prior to the addition of peroxidise 
conjugated anti-human IgM and the necessary chromogenic substrate. Plates were 
read using a spectrophotometer at 405 nm and a positive reaction was indicated by an 
OD >0.18. The end-point titre of the test serum was derived from the highest dilution 
with an OD >0.18. Negative results were defined as those with a titre of <1:80, 
equivocal results were defined as those with titres of 1:80 to 1:160 and positive 
results were defined as those with titres of ≥1:320. 
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The MAT was performed using a battery of leptospiral antigens from reference 
strains. These were combined into the following Leptospira interrogans serogroups 
by pooling appropriate serovars (shown in brackets): Australis (australis, bratislava); 
Autumnalis (bangkinang, bim, bulgarica); Ballum (ballum); Bataviae (bataviae, 
djatzi); Canicola (broomi, canicola); Celledoni (anhoa, whitcombi); Cynopteri 
(cynopteri); Grippotyphosa (grippotyphosa, valbuzzi); Hebdomadis (hebdomadis); 
Icterohaemorrhagiae (icterohaemorrhagiae); Javanica (fluminense, javanica); Mini 
(beye, georgia, perameles); Pomona (pomona, proechimys); Pyrogenes (pyrogenes, 
robinsoni); Sejroe (hardjo; saxkoebing; sejroe) Tarassovi (rama, tarassovi) and L. 
biflexa serogroup Semaranga serovar patoc was also included. Negative results were 
defined as those with a titre of <1:80, equivocal results were defined as those with 
titres of 1:80 to 1:160 and positive results were defined as those with titres of ≥1:320 
or a fourfold rise in titre between admission and convalescent serum samples. The 
presumptive infecting serogroup was taken as that which gave the highest MAT titre 
with a convalescent serum. 
 
2.2.7  Q fever Investigations 
 
Q fever was diagnosed from serum samples by immunofluorescence assay (IFA) 
using phase I and phase II antigens from C. burnetti at the Unité des Rickettsies, 
Marseille, France as described previously [Dupont et al., 1994]. Acute Q fever was 
diagnosed if anti-phase II antibody titres were ≥200 for IgG and ≥50 for IgM or if 
seroconversion was demonstrated. Chronic Q fever was diagnosed if anti-phase I 
antibody titres for IgG were ≥800. Probable Q fever was diagnosed if anti-phase II 
antibody titres were <200 for IgG but ≥50 for IgM because these cases probably 
represent early acute infections. Evidence of past Q fever infection was diagnosed if 
anti-phase II antibody titres were ≥100 for IgG and undetectable for IgM. 
 
2.2.8  Rickettsia Investigations 
 
Rickettsial infections were diagnosed from serum samples by IFA using a panel of 
13 rickettsial antigens, which included Rickettsia prowazekii, R. typhi, spotted fever 
group (SFG) rickettsiae (R. japonica, R. helvetica, R. slovaca, R. conorii subsp. 
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indica, R. honeï, R. heilongjangensis, and R. felis), and O. tsutsugamushi (Gilliam, 
Karp, Kato and Kawasaki strains) at the Unité des Rickettsies, Marseille, France as 
described previously [La Scola et al., 1997]. Confirmed rickettsial infection was 
diagnosed if antibody titres were ≥64 for IgG and ≥32 for IgM or if seroconversion 
was demonstrated. Positive results with cross-reacting antibodies to multiple 
Rickettsia species were resolved by western blotting with cross-adsorption using the 
antigens listed. Due to some unexpected negative results for patients with obvious 
eschars the samples were later re-tested for scrub typhus at the Mahidol-Oxford 
Tropical Medicine Research Unit in Bangkok, Thailand using the same antigens as 
above. Probable rickettsial infection was diagnosed in patients with eschars and good 
responses to doxycycline, who did not meet the criteria for a confirmed infection. 
 
2.2.9  Dengue Investigations 
 
Dengue was diagnosed from serum samples by IgM and IgG capture ELISAs and 
nested RT-PCR tests at the Armed Forces Medical Research Institute for Medical 
Sciences (AFRIMS), Bangkok, Thailand and by virus isolation at the (National) 
Novel and Dangerous Pathogens (NaDP) Unit, Porton Down, UK. 
 
The ELISAs were performed and interpreted as described previously [Innis et al., 
1989; Vaughn et al., 1999; Blacksell et al., 2012]. Antigens for dengue virus types 1 
to 4 (DENV-1 to DENV-4) were produced by sucrose acetone extraction of the 
brains of suckling mice infected with the following prototype mouse adapted virus 
strains: DENV-1 Hawaii, DENV-2 New Guinea C, DENV-3 H-87 and DENV-4 H-
241. Acute dengue infection was diagnosed if the admission sample had ≥40 U of 
dengue IgM antibodies (with dengue IgM ≥ JEV IgM antibodies) or if paired 
samples had <15 U of dengue virus IgM antibodies in the admission sample 
increasing to ≥30 U in the convalescent sample (with dengue IgM ≥ JEV IgM 
antibodies). Primary and secondary infections were determined when the ratio of 
anti-dengue virus IgM to IgG was ≥1.8 or <1.8 respectively. In the absence of 
diagnostic IgM levels, a 2-fold increase in IgG to a value ≥100 U was also 
considered indicative of acute secondary dengue infection. Recent (non-acute) 
dengue infection was diagnosed if dengue IgM antibodies were below diagnostic 
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levels and IgG antibodies were >100 U in the acute sample, but failed to rise in the 
convalescent sample. 
 
The same diagnostic approach using the AFRIMS dengue (DEN) IgM antibody 
capture (MAC) ELISA, IgG antibody capture (GAC) ELISA and equivalent Japanese 
Encephalitis Virus (JEV) MAC and GAC ELISAs for serological diagnosis has been 
described in various ways. The most concise and recent version of this is shown 
below and summarised in Figure 2.2.9 [Pan-Ngum et al, 2012]. 
 
Acute primary dengue infections were defined if : 
 
1. The admission sample showed DEN MAC ELISA ≥40 U, a ratio of DEN MAC 
ELISA to JEV MAC ELISA ≥1 and a ratio of DEN MAC ELISA to DEN GAC 
ELISA ≥1.8:1. 
or 
2. The admission sample showed DEN MAC ELISA in admission sample <15 U and 
in convalescent-phase specimen ≥30 U. 
 
Acute secondary dengue infections were defined if : 
 
1. The admission sample showed DEN MAC ELISA ≥40 U, a ratio of DEN MAC 
ELISA to JEV MAC ELISA ≥1 and a ratio of DEN MAC ELISA to DEN GAC 
ELISA <1.8:1. 
or 
2. The admission sample showed DEN MAC ELISA <40 U, a ratio of DEN GAC 
ELISA in convalescent-phase specimen to admission specimen ≥2 (2-fold rise) and 
DEN GAC ELISA in convalescent-phase specimen ≥100. 
 
(Acute JEV infection was defined if the admission sample showed DEN MAC 
ELISA ≥40 U and a ratio of DEN MAC ELISA to JEV MAC ELISA <1.) 
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Figure 2.2.9. Flow chart describing the AFRIMS dengue diagnostic algorithm 
 
 
 
The RT-PCR tests were performed and interpreted as described previously [Lanciotti 
et al., 1992], but were modified by the use of avian myeloblastosis virus reverse 
transcriptase, a 12.5-pmol primer concentration and a nested RT-PCR amplification 
of 25 cycles. This RT-PCR uses nested primers to produce amplicons of different 
sizes for each dengue virus type and so a type-specific result was obtained. RT-PCR 
tests were done on all admission samples except for cases that were proven to be 
dengue serology negative on paired tests. 
 
Dengue virus isolations were performed on admission samples that were RT-PCR 
positive using Vero E6 cells (ATCC CRL1586) grown in modified Eagle’s medium 
at 37 °C using Bio-Safety Level 3 (BSL-3) facilities as described previously [Ter 
Meulen et al., 2000]. Cultures were inspected daily and any that showed a cytopathic 
effect (CPE) had supernatant analysed by RT-PCR (as above) to confirm the 
presence of dengue virus. 
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2.2.10  Japanese Encephalitis Investigations 
 
Japanese encephalitis virus (JEV) infections were diagnosed from serum samples by 
IgM and IgG capture ELISAs at AFRIMS, Bangkok, Thailand as described 
previously [Burke & Nisalak, 1982; Innis et al., 1989]. Antigens for JEV were 
produced by sucrose acetone extraction of the brains of suckling mice infected with 
the prototype mouse adapted virus strain JEV Nakayama. Acute JEV infection was 
diagnosed if the admission sample had ≥40 U of JEV IgM antibodies (with JEV IgM 
> dengue IgM antibodies) as described previously in Section 2.2.9. 
 
2.2.11  Chikungunya Investigations 
 
Chikungunya was diagnosed from serum samples by haemagglutination inhibition 
(HAI) and enzymed immunosorbent assays (EIA) for chikungunya virus IgM 
antibodies at AFRIMS, Bangkok, Thailand and by a real-time RT-PCR test and virus 
isolation at the NaDP Unit, Porton Down, UK. 
 
The HAI assays were performed and interpreted as previously described [Clarke & 
Casals, 1958]. Antigens for chikungunya virus (CHIKV) were produced by sucrose 
acetone extraction of the brains of suckling mice infected with a mouse adapted virus 
strain. The EIAs were performed using this same antigen and the same method as the 
AFRIMS dengue serology tests [Innis et al., 1989].  Acute chikungunya infection 
was diagnosed if paired samples showed a 4-fold increase in titres on the HAI assay 
or if single samples had >40 U of chikungunya IgM antibodies on the EIA. However, 
testing of single samples was not able to determine if a chikungunya infection was 
acute or recent (non-acute) and so these cases must be considered indeterminate. 
Recent (non-acute) chikungunya infection was diagnosed if paired samples failed to 
show a 4-fold increase in titres on the HAI assay. 
 
The real-time RT-PCR tests were performed as described previously [Edwards et al., 
2007] and were done on all samples including discharge and follow-up samples. 
During this study the RT-PCR appeared over-sensitive in comparison to the 
AFRIMS serology results for paired samples. This led to several inconsistent results 
in which samples were RT-PCR positive, but serology negative despite testing paired 
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samples. However, the RT-PCR results in question were all weakly positive and so a 
simple adjustment of the real-time RT-PCR crossing point was made to reduce the 
sensitivity of the test and so convert these apparent false positives into negatives. 
Doing so also removed some other cases that were weakly positive on RT-PCR and 
had provided admission serum samples only. 
 
A selection of RT-PCR positive cases were further analysed with another RT-PCR 
test to amplify part of the chikungunya virus E1 gene [Edwards et al., 2007]. These 
sequences were then used to determine the phylogenetic relationship between 
chikungunya viruses in this study and a variety of reference strains. 
 
Chikungunya virus isolations were performed on admission samples that were RT-
PCR positive using Vero E6 cells (ATCC CRL1586) grown in modified Eagle’s 
medium at 37 °C using Bio-Safety Level 3 (BSL-3) facilities as described previously 
[Ter Meulen et al., 2000]. Cultures were inspected daily and any that showed a 
cytopathic effect (CPE) had supernatant analysed by RT-PCR (as above) to confirm 
the presence of chikungunya virus. 
 
2.2.12  Hantavirus Investigations 
 
Hantavirus infections were diagnosed from paired serum samples only by 
commercial serology tests, a diagnostic RT-PCR in-house test and RT-PCR 
amplification plus sequencing of the small (S), medium (M) and large (L) segments 
of the hantavirus genome at the NaDP Unit, HPA Porton Down, UK. 
 
Initially, serum samples were screened with the commercial Hantavirus IgG 
DxSelect ELISA (Catalogue no. EL1600G; Focus Diagnostics, Cypress, CA, USA), 
which is an ISO-certified test that has performed well in previous Asian studies 
[Chandy et al., 2008]. This ELISA used a cocktail of hantavirus antigens from 
Hantaan virus (HTNV), Seoul virus (SEOV), Puumala virus (PUUV), Dobrava-
Belgrade virus (DOBV) and Sin Nombre virus (SNV), which were coated onto 
polystyrene microwells and used to detect IgG antibodies against these virus types. 
The screening ELISA is an indirect test in which the optical density (OD) is 
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proportional to the antigen-specific IgG antibodies present in the sample. The results 
were obtained by comparison of the sample OD readings with reference cut-offs. 
 
Serum samples that were hantavirus IgG positive were then further investigated 
using the commercial Hantavirus IgM DxSelect ELISA (Catalogue no. EL1600M; 
Focus Diagnostics, Cypress, CA, USA), which is the IgM version of the IgG ELISA  
used for screening samples. (This IgM ELISA produces too many false positives for 
it to be used as a screening test [J Osborne, personal communication].) All hantavirus 
IgG positive cases were also tested with commercial combined IgM/IgG IFAs for the 
HTNV, SEOV and PUUV types (Catalogue nos. PR77056, PR77060, PR77065, 
Progen, Heidelberg, Germany), which have performed well in previous studies and 
are considered the best available serology test overall [Koraka et al., 2000]. These 
IFA tests were performed according to the manufacturer’s instructions and a positive 
result was indicated by bright punctuate granular staining in the cytoplasm of the 
infected cells. The tests were repeated with serial dilutions of the sera in order to 
identify those that had a four-fold increase in titres, which was considered indicative 
of an acute infection. 
 
Any cases with serological evidence of acute hantavirus infection underwent RT-
PCR testing [Kramski et al., 2007], which was designed to detect the major 
pathogenic hantaviruses found in Asia, Europe and America (HTNV, SEOV, PUUV, 
DOBV, TULV, SNV & ANDV). However, no positives were identified and so a 
series of degenerate primers for the hantavirus S segment [Reynes et al., 2003], M 
segment [Nichol et al., 1993] and L segment [Klempa et al., 2006] were used to 
identify any possible hantavirus in these samples. Those with sequences suggestive 
of THAIV were re-tested using specific primers for that hantavirus [Pattamadilok et 
al., 2006; Hugot et al., 2006] in order to obtain more detailed sequence information. 
The sequences identified were compared with those for the hantavirus isolate 
obtained previously from rats in Sri Lanka [Vitarana et al., 1988], which is now 
stored as strain “Sri R 87-1315” at the Korea University [JW Song, personal 
communication]. 
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2.2.13  Other Virology Investigations 
 
Other virus infections such as mumps and chickenpox were diagnosed clinically and 
confirmed by the virology investigations used at the appropriate reference 
laboratories of the Health Protection Agency (HPA), UK. 
 
2.2.14  Urinary Antimicrobial Investigations 
 
Antimicrobial activity in urine samples was identified by microbiological assays 
described previously [Liu et al., 1999]. Reference isolates of Bacillus 
stearothermophilus (ATCC 7953), Escherichia coli (ATCC 25922) and 
Streptococcus pyogenes (ATCC 19615) were obtained from the American Type 
Culture Collection (Manassas, VA, USA). These were used to create confluent plates 
of colonies on Mueller-Hinton agar for B. stearothermophilus and E. coli and 
Mueller-Hinton agar containing 5% sheep blood for S. pyogenes. Then 8 mm filter 
paper disks were dipped in the admission urine samples and pressed onto the agar 
surface. Duplicate tests for each sample were performed and the plates were 
incubated overnight at 56 °C for B. stearothermophilus and 35 °C for E. coli and S. 
pyogenes. The diameters of zones of inhibition were measured and expressed as the 
mean of the duplicate tests. Zones ≥10 mm with any of the 3 assay strains were 
considered positive, but results were subject to the following interpretation. 
 
The sensitivities and specificities for the detection of antimicrobial activity from 
individual plates have been determined as 100.0% and 85.9% respectively for B. 
stearothermophilus, 94.9% and 94.9% respectively for S. pyogenes and 71.8% and 
98.7% respectively for E. coli (Liu et al., 1999). However, the combination of S. 
pyogenes and E. coli exhibited a sensitivity of 97.4% and specificity of 94.9% [Liu et 
al., 1999] and so this was used as the criteria for a positive result indicative of a 
patient having taken antimicrobial drugs within the previous 48 hours. Samples that 
produced zones on B. stearothermophilus plates only were considered equivocal.  
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2.2.15  Other Laboratory Investigations 
 
C-reactive protein (CRP), creatine phosphokinase (CPK) and urinary total protein 
were measured on admission as part of the study. CRP was measured in order to see 
if it could help distinguish between viral and bacterial infections. This test was done 
using a simple semi-quantitative latex agglutination assay (Clinotech Diagnostics, 
Richmond, BC, Canada) that uses serial dilutions to generate results of either <6, 6, 
12, 24, 48, 96 or >96 mg/L. CPK and urinary total protein were measured to see if 
they could help distinguish leptospirosis from other infections. These tests were done 
using automated analysers at the Nawaloka Hospital, Colombo, Sri Lanka, which is 
one of the leading private hospitals in the country and runs its own ISO-certified 
laboratory in conjunction with the Metropolis laboratory chain based in India. 
 
Other haematology and biochemistry parameters were measured as part of the 
patients’ routine management by clinicians on the Professorial Medical Unit and not 
in a systematic way relating to the study. These investigations were performed either 
at the Department of Pathology of the Colombo North Teaching Hospital (CNTH) or 
by a variety of private laboratories adjacent to the hospital. Most of these private 
laboratories are run by the leading private hospitals in the country and their results 
are generally considered to be accurate by clinicians at CNTH. 
 
2.3  Formulation of Clinical Prediction Rules for Use in Sri Lanka 
 
Attempts were made to formulate clinical prediction rules for all confirmed 
infections that had >50 cases diagnosed using gold standard investigations. 
 
2.3.1  Statistical Methods for the Formulation of Clinical Prediction Rules 
 
Data was exported from FileMaker Pro into SPSS 19 (SPSS Inc., Chicago, IL, USA) 
for statistical analysis. Univariate analysis of binary variables was performed using 
either Pearson’s chi-square test or Fisher’s exact test to obtain unadjusted odds ratios 
(UORs) with 95% confidence intervals (CIs). Univariate analysis of continuous 
variables was performed using Student’s independent samples t-test, which was 
 -71- 
interpreted in conjunction with Levene’s test for equality of variances and results to 
obtain UORs with 95% CIs for appropriate unit increases in each variable. 
 
Multivariate analysis using logistic regression was then performed to calculate 
adjusted odds ratios (AORs) for the variables associated with each infectious disease. 
However, if the use of complete case methodology for the logistic regression led to 
>10% of cases being excluded due to missing values, then multiple imputation 
methodology was used with 5 iterations to produce 5 (complete) imputed data sets 
for further analysis [Roth & Switzer, 1999]. Logistic regression was then performed 
by selecting candidate variables with P values > 0.1, which were then eliminated one 
by one using a backwards stepwise approach. The odds ratios for new model were 
now AORs, which had been adjusted for the effects of each other. 
 
In order to develop clinical prediction rules, scoring systems using point values were 
developed from the regression coefficient (labelled “B” in SPSS) in the logistic 
regression model and receiver operating characteristic (ROC) curves were generated 
to assess the discriminant ability of the model [McNeil & Hanley, 1984]. Sensitivity 
and specificity (with 95% CI) were determined using the prediction rule at different 
cut-off values. Positive predictive value (PPV) and negative predictive value (NPV) 
were calculated using standard methods. 
 
2.4  Evaluation of Commercial Diagnostic Tests for Use in Sri Lanka 
 
Attempts were made to evaluate commercial diagnostic tests for confirmed infections 
that had >50 cases diagnosed using gold standard investigations. This was done 
prospectively for dengue fever because an appropriate test was already available 
(Section 2.4.1) and the number of confirmed cases was expected to be significantly 
>50. The evaluation of other commercial diagnostic tests was expected to take place 
immediately after the study period, but no other suitable tests were available at this 
time. In due course other rapid diagnostic tests for dengue (Section 2.4.2) and 
chikungunya (Section 2.4.3) were evaluated retrospectively using the data and 
samples obtained in this study. 
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2.4.1 Prospective Use of a Commercial Diagnostic Test for Dengue 
 
Several commercial dengue diagnostic tests were available, which at the time of the 
study were all serology tests. Those made by Panbio (Panbio Pty Ltd, Brisbane, 
Australia) seemed to be the most widely used and highly regarded [Vaughn et al., 
1999; Groen et al., 2000; Blacksell et al., 2006a; Blacksell et al., 2006b; Blacksell et 
al., 2007; Blacksell et al., 2008]. The Panbio Dengue Duo Cassette (Catalogue no. R-
DEN03D) was a new serology test based on materials and methods evaluated 
previously. It is an immuno-chromatic test (ICT) packaged in a convenient cassette 
mechanism for point-of-care testing, which can be used with either whole blood or 
serum and is read with the naked eye. 
 
In this study the Panbio Dengue Duo Cassette was used to test samples obtained on 
admission, discharge (if the patient was admitted for >5 days) and follow-up (at 2-4 
weeks after discharge) as described in Section 2.1.3. All tests were performed 
according to the manufacturer’s instructions by myself using serum samples on the 
same day that the blood was taken. The results were determined by naked eye as 
negative, equivocal or positive for each IgM and IgG band. Samples that initially 
returned an equivocal result were re-tested to confirm the result. 
 
The presence of an IgM positive band was indicative of acute dengue infection, 
which was classed as a primary infection if there was no IgG positive band or a 
secondary infection if there was an IgG positive band. The presence of an IgG band 
alone was indicative of a previous dengue infection only. Diagnostic accuracy was 
calculated for the dengue assays relative to the final patient diagnosis (dengue 
positive or dengue negative) based on the results of the reference tests. However, due 
to the subjective nature of reading ICTs, equivocal results were first assigned as 
positive and then as negative for separate analyses to determine which grouping had 
the best diagnostic accuracy. Diagnostic performance was assessed by calculations of 
sensitivity, specificity, positive predictive value (PPV) and negative predictive value 
(NPV) with exact 95% confidence intervals (CI). 
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2.4.2 Retrospective Use of Commercial Diagnostic Tests for Dengue 
 
After the main study period in 2006-7, several new commercial diagnostic tests for 
dengue became available including some that combined IgG & IgM serology with 
NS1 antigen detection. Therefore six rapid diagnostic tests were evaluated at a later 
date using the samples and reference diagnostic results obtained for 549 patients 
from this study. 
 
The six assays were (i) the Biosynex Immunoquick Dengue Fever IgG & IgM Assay 
(Biosynex, France), (ii) the Merlin Dengue Fever IgG & IgM Combo Device 
(Merlin), (iii) the Panbio Dengue Duo IgG & IgM Cassette (Inverness, Australia), 
(iv) the Bio-Rad NS1 Antigen Strip (Bio-Rad, France), (v), the Panbio Dengue NS1 
Antigen Strip (Inverness, Australia) and (vi) the Standard Diagnostics Dengue Duo 
NS1 Antigen and IgG/IgM Combo Device (Standard Diagnostics, South Korea). All 
assays were performed according to the manufacturers’ instructions at the Mahidol-
Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand by an 
experienced operator. 
 
Diagnostic accuracy was calculated for these dengue rapid diagnostic tests by 
comparing the interpretation of the operator to the final patient diagnosis (dengue 
positive or dengue negative) from the reference serology. Equivocal results where 
the immuno-chromatographic line was faint were considered negative for the 
purpose of diagnostic accuracy evaluation. Diagnostic performance was assessed 
from calculations of sensitivity, specificity, NPV and PPV with exact 95% CIs using 
Stata/SE 10.0 (Stata Corp., College Station, TX). 
 
2.4.3 Retrospective Use of a Commercial Diagnostic Test for Chikungunya 
 
Also following the main study period, a pair of commercial serology tests for 
chikungunya became available. Therefore these were evaluated at a later date using 
the samples and reference diagnostic results obtained for 292 patients with paired 
serum samples from this study. 
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The assays were the Standard Diagnostics chikungunya IgM antibody rapid ICT and 
chikungunya IgM antibody ELISA (Standard Diagnostics, South Korea). All assays 
were performed according to the manufacturers’ instructions at MORU, Bangkok, 
Thailand by an experienced operator. The ICT was tested with acute specimens only 
(as would be the case in clinical practice) and the ELISA was tested with both acute 
and convalescent specimens. 
 
Diagnostic accuracy was calculated for these chikungunya diagnostic tests by 
comparing the interpretation of the operator to the final patient diagnosis 
(chikungunya positive or chikungunya negative) from the reference serology. 
Equivocal results where the immuno-chromatographic line was faint were considered 
negative for the purpose of diagnostic accuracy evaluation. Diagnostic performance 
was assessed from calculations of sensitivity, specificity, NPV and PPV with exact 
95% CIs using Stata/SE 10.0 (Stata Corp., College Station, TX). 
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3.1  Patient Recruitment, Data Collection and Sample Collection 
 
3.1.1  Patient Recruitment 
 
As planned, patient recruitment took place over a 1-year period from 06 June 2006 to 
05 June 2007 on the Professorial Medical Unit (PMU), which is responsible for a 
quarter of all adult medical admissions at the Colombo North Teaching Hospital. 
During this time there were 11 173 patients admitted, of whom 711 (6.4%) had fever 
≥38.0 °C and of these 617 (86.8%) were recruited. The reasons for non-recruitment 
were : 
 
 • “already received antibiotics in hospital” in 42 (44.7%) 
 • “admitted for >24 hours” in 31 (33.0%) 
 • “refused consent” in 21 (22.3%) 
 
Recruited patients were compared to both non-recruited patients and all patients 
admitted with respect to sex, age and date of admission to ensure that recruitment 
was representative. These data were reviewed on a monthly basis throughout the 
study so that immediate action could be taken to remedy any problems. A summary 
of these figures per month is shown (Table 3.1.1.) Admission and recruitment figures 
for April are artificially low because the PMU was closed to admissions for two 
weeks during the undergraduate clinical exams. 
 
Amongst all patients admitted there were 53.2% males (p < 0.01 compared to 
females admitted). However, amongst patients with fever there were 64.6% males (p 
< 0.01 compared to males admitted) and amongst patients recruited there were 65.6% 
males (p < 0.74 compared to males with fever). Hence with respect to sex ratio, the 
recruited population was representative of all patients with fever. However, there 
was a significant difference in the sex ratio of all patients admitted compared to 
patients with fever. 
 
Amongst patients with fever the mean age (SD) was 38.0 (16.7) years and was 
similar for both patients recruited (37.9 (14.0) years) and those not recruited (38.4 
(17.2) years).  However, amongst males with fever the mean age (SD) was 35.5 
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(15.5) compared to 42.5 (17.7) in females. There were similar differences between 
males and females recruited (35.5 (15.2) years vs. 42.6 (18.1) years) and males and 
females who were not recruited (35.7 (17.8) years vs. 42.2 (15.8) years). Hence with 
respect to mean age, the recruited population was representative of all patients with 
fever. However, there was a significant difference in the mean age of males with 
fever compared to females with fever. 
 
Although the total number of patients admitted each month was remarkably 
consistent (Table 3.1.1), the number of patients with fever varied significantly and 
seemed to be related to monthly rainfall (Figures 3.1.1.1 & 3.1.1.2). The greatest 
number of patients with fever was seen one month after the rainy seasons in October 
and April, whereas the least number was seen at the peak of the dry seasons in July 
and February. The diseases that made the greatest contribution to this seasonal 
variation were dengue and chikungunya and the monthly frequencies of confirmed 
cases are shown (Figures 3.1.1.3 & 3.1.1.4). The pattern of rainfall seen during the 
study period was comparable with that seen in the previous five years, except for an 
unexpected increase in August and a greater volume of rainfall during the October-
November rainy season (Figures 3.1.1.5 & 3.1.1.6). 
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Table 3.1.1. Patients admitted, patients with fever and patients recruited each month 
 
Month Jun 2006 
Jul 
2006 
Aug 
2006 
Sep 
2006 
Oct 
2006 
Nov 
2006 
Dec 
2006 
Jan 
2007 
Feb 
2007 
Mar 
2007 
Apr 
2007 
May 
2007 Totals 
All admitted 952 (100%) 
911 
(100%) 
946 
(100%) 
947 
(100%) 
938 
(100%) 
1008 
(100%) 
1030 
(100%) 
938 
(100%) 
797 
(100%) 
959 
(100%) 
783 
(100%) 
964 
(100%) 
11,173 
(100%) 
Males admitted 493 (52%) 
435 
(48%) 
503 
(53%) 
491 
(52%) 
522 
(56%) 
533 
(53%) 
564 
(55%) 
485 
(52%) 
401 
(50%) 
507 
(53%) 
424 
(54%) 
591 
(61%) 
5,949 
(53%) 1 
Females admitted 459 (48%) 
476 
(52%) 
443 
(47%) 
456 
(48%) 
416 
(44%) 
475 
(47%) 
466 
(45%) 
453 
(48%) 
396 
(50%) 
452 
(47%) 
359 
(46%) 
373 
(39%) 
5,224 
(47%) 
No. with fever (% of all admitted) 38 (4%) 
31 
(3%) 
56 
(6%) 
55 
(6%) 
64 
(7%) 
117 
(12%) 
97 
(9%) 
53 
(6%) 
42 
(5%) 
50 
(5%) 
33 
(4%) 
75 
(8%) 
711 
(6%) 
All with fever 38 (100%) 
31 
(100%) 
56 
(100%) 
55 
(100%) 
64 
(100%) 
117 
(100%) 
97 
(100%) 
53 
(100%) 
42 
(100%) 
50 
(100%) 
33 
(100%) 
75 
(100%) 
711 
(100%) 
Males with fever 24 (63%) 
26 
(84%) 
31 
(55%) 
38 
(69%) 
47 
(73%) 
77 
(66%) 
61 
(63%) 
33 
(62%) 
25 
(60%) 
32 
(64%) 
19 
(58%) 
46 
(61%) 
459 
(65%) 2 
Females with fever 14 (37%) 
5 
(16%) 
25 
(45%) 
17 
(31%) 
17 
(27%) 
40 
(34%) 
36 
(37%) 
20 
(38%) 
17 
(40%) 
18 
(36%) 
14 
(42%) 
29 
(39%) 
252 
(35%) 
No. recruited (% of all with fever) 22 (58%) 
23 
(74%) 
51 
(91%) 
42 
(76%) 
54 
(84%) 
110 
(94%) 
83 
(86%) 
45 
(85%) 
38 
(90%) 
47 
(94%) 
31 
(94%) 
71 
(95%) 
617 
(87%) 
All recruited 22 (100%) 
23 
(100%) 
51 
(100%) 
42 
(100%) 
54 
(100%) 
110 
(100%) 
83 
(100%) 
45 
(100%) 
38 
(100%) 
47 
(100%) 
31 
(100%) 
71 
(100%) 
617 
(100%) 
Males recruited 17 (77%) 
20 
(87%) 
29 
(57%) 
28 
(67%) 
44 
(81%) 
74 
(67%) 
51 
(61%) 
28 
(62%) 
24 
(63%) 
29 
(62%) 
19 
(61%) 
42 
(59%) 
405 
(66%) 3 
Females recruited 5 (23%) 
3 
(13%) 
22 
(43%) 
14 
(33%) 
10 
(19%) 
36 
(33%) 
32 
(39%) 
17 
(38%) 
14 
(37%) 
18 
(38%) 
12 
(39%) 
29 
(41%) 
212 
(34%) 
 
1 P < 0.01 compared to females admitted; 2 P < 0.01 compared to males admitted; 3 P = 0.74 compared to males with fever 
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Figure 3.1.1.1. Rainfall in Gampaha District, patients admitted and patients with 
fever during this study in 2006-7 
 
 
 
 
Figure 3.1.1.2. Rainfall in Gampaha District, patients recruited and patients with 
fever but not recruited during this study in 2006-7 
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Figure 3.1.1.3. Rainfall in Gampaha District and confirmed dengue cases during this 
study in 2006-7 
 
 
 
 
Figure 3.1.1.4. Rainfall in Gampaha District and confirmed chikungunya cases 
during this study in 2006-7 
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Figure 3.1.1.5. Rainfall in Gampaha District from 2001-7 and mean from 2001-7 
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Figure 3.1.1.6. Rainfall in Gampaha District from 2006-7 and mean from 2001-6 
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3.1.2  Data Collection 
 
All 617 patients recruited had data collection forms completed and the quality of this 
work seemed to be very good due to the specific training and daily supervision of the 
research assistants. Data entry and storage in a FileMaker Pro database proved 
extremely convenient and the electronic back-up strategy avoided any loss of data 
occurring. 
 
The large amount of epidemiological, clinical and laboratory data collected will be 
analysed in relation to each disease identified. However, a few epidemiological 
details for the whole group of recruited patients are worthy of description here. 
 
As reported earlier, 65.6% of patients recruited were male and on average these were 
significantly younger than the female patients recruited (Section 3.1.1). However, 
these findings were representative of all patients admitted with fever and hence seem 
to be genuine. The increased number of fever cases presenting towards the end of the 
rainy seasons and decreased number presenting at the peak of the dry seasons have 
also been described earlier (Section 3.1.1) and seem to be a genuine seasonal effect. 
 
Amongst recruited patients the average time spent in education showed a mean (SD) 
of 10 (3) years or a median (range) of 10 (0-22) years. The average income showed a 
mean (SD) of LKR 16 000 (13 000) or a median of LKR 12 000 (0 – 100 000) and 
LKR 100 ≈ US$ 1. The occupations reported were as shown in Table 3.1.2.1. 
 
The districts where people lived are shown in Table 3.1.2.2 and Figure 3.1.2.1. From 
548 patients living in the Gampaha District, there were 541 for whom an exact 
Grama Niladari (GN) division could be identified and these are shown in Figure 
3.1.2.2 along with a map of the overall population distribution within Gampaha 
District in Figure 3.1.2.3. These maps suggest that recruitment was fairly 
representative of the whole Gampaha District if the background population 
distribution is taken into account. 
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Amongst 541 patients with known GN divisions from Gampaha District, there were 
221 (41.4%) from urban areas (population density >400 people / km2) and 320 
(59.1%) from rural areas (population density <400 people / km2). 
 
The range of water sources used for drinking, washing and bathing are shown in 
Table 3.1.2.3. These findings are consistent with the mixture of urban and rural areas 
covered in the study and for patients from Gampaha District there was a strongly 
significant association between the type of area where a patient lived and their source 
of drinking water as shown in Table 3.1.2.4. Hence the source of a person’s drinking 
water could be used as a practical indicator of whether they lived in an urban or rural 
area without the need to identify their GN division and calculate its population 
density. 
 
Notifiable disease reports for 2006, the study period and 2007 are summarised in 
Table 3.1.2.5. Gampaha District was consistently in the top three districts for cases of 
dengue, encephalitis and leptospirosis during these periods. 
 
Table 3.1.2.1. Occupations of 617 patients admitted with fever 
 
Occupation Number (%) 
House work 81 (13%) 
Education 77 (12%) 
Construction 70 (11%) 
Office work 64 (10%) 
Factory work 57 (9%) 
Shop work 56 (9%) 
Retired 45 (7%) 
Transport/Postal work 38 (6%) 
Unemployed 37 (6%) 
Stone mason 18 (3%) 
Hotel work 14 (2%) 
Farming 13 (2%) 
Military work 12 (2%) 
Police/Security work 12 (2%) 
Healthcare work 7 (1%) 
Religious work 7 (1%) 
Fishing 5 (1%) 
Unknown 4 (1%) 
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Table 3.1.2.2. District of origin for 617 patients with fever 
 
District Number (%) 
Gampaha 548 (89%) 
Puttalam 24 (4%) 
Kurunegala 14 (2%) 
Colombo 10 (2%) 
Kegalle 7 (1%) 
Other 4 (1%) 
Unknown 10 (2%) 
 
 
Table 3.1.2.3. Sources of water for 612 patients admitted with fever 
 
 Boiled / Bottled Tap Well “Tank” / Stream 
Drinking 63 (10%) 232 (38%) 316 (52%) 1 (0%) 
Washing 0 (0%) 255 (42%) 352 (57%) 5 (1%) 
Bathing 0 (0%) 250 (41%) 356 (58%) 6 (1%) 
 
 
Table 3.1.2.4. Association between area of residence and source of drinking water 
 
 Tap (%) Well (%) Total (%) 
Urban area 
(≥400 people / km2) 
118 (24%) 80 (17%) 198 (41%) 
Rural area 
(<400 people / km2) 
92 (19%) 195 (40%) 287 (59%) 
Total 210 (43%) 275 (57%) 485 (100%) 
Chi-squared = 35.084 P <0.0001 
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Figure 3.1.2.1. District of origin for 617 patients with fever 
 
 
 
 
● Colombo North Teaching Hospital 
548 548 Cases from Gampaha District 
24  24 Cases from Puttalam District 
14  14 Cases from Kurunegala District 
10  10 Cases from Colombo District 
7   7 Cases from Kegalle District 
7 548 
10 
14 
24 
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Figure 3.1.2.2. Hospital location and patients recruited from each GN division in 
Gampaha District 
 
 
 
 
 
 
  ● Colombo North Teaching Hospital 
  0 Cases from this GN division 
 1-2 Cases from this GN division 
 3-10 Cases from this GN division 
 11-20 Cases from this GN division 
 21-40 Cases from this GN division 
Total cases = 617 
Cases plotted = 541 
Cases elsewhere = 76 
 
● 
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Figure 3.1.2.3. Hospital location and population of each GN division in Gampaha 
District from the (National) Census in 2001 
 
 
 
 
 
 
● Colombo North Teaching Hospital 
  0 People in this GN division 
 1-2500 People in this GN division 
 2501-5000 People in this GN division 
 5001-7500 People in this GN division 
 7501-10000 People in this GN division 
 
Total population = 2 060 579 
 
● 
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Table 3.1.2.5.  *Notifiable diseases reported in Sri Lanka during 2006, this study period and 2007 
 
District 
Dengue Dysentery Encephalitis Enteric Fever Food Poisoning Leptospirosis Typhus Fever Viral hepatitis 
2006 Study 2007 2006 Study 2007 2006 Study 2007 2006 Study 2007 2006 Study 2007 2006 Study 2007 2006 Study 2007 2006 Study 2007 
Colombo 3419 2800 1865 356 371 361 7 6 11 82 83 124 45 78 96 143 140 163 4 2 5 69 65 155 
Gampaha 1774 1247 980 331 343 324 10 17 30 59 64 88 147 112 64 211 230 311 12 15 19 153 145 212 
Kalutara 977 741 425 506 539 488 8 6 6 84 76 65 72 56 43 136 154 221 6 1 3 47 66 64 
Kandy 1509 1414 415 452 361 316 9 10 6 115 85 66 35 22 16 101 94 150 107 98 87 139 978 1975 
Matale 389 353 121 344 271 252 7 7 6 19 22 40 21 15 13 31 36 172 2 3 5 30 99 141 
Nuwara Eliya 42 60 41 353 304 237 0 0 2 193 153 122 19 377 369 12 15 14 45 50 38 289 418 561 
Galle 260 180 100 196 204 173 3 7 13 13 14 26 12 7 44 72 83 169 21 36 27 4 14 24 
Hambantota 217 149 102 100 96 200 9 11 6 35 30 24 32 31 20 51 48 57 92 76 74 59 50 29 
Matara 537 387 236 199 273 298 11 12 10 81 71 54 36 23 25 176 209 289 253 271 220 15 24 35 
Jaffna 53 30 239 141 154 175 4 3 2 176 325 439 27 17 15 3 0 0 141 94 134 78 36 30 
Kilinochchi 2 2 1 23 3 1 0 0 0 6 4 7 24 24 0 0 0 0 0 2 2 9 6 4 
Mannar 3 9 7 57 55 32 0 0 0 139 63 116 3 3 0 1 0 2 0 0 0 10 8 26 
Vavuniya 20 28 41 153 126 86 5 5 4 96 69 21 84 62 65 2 2 3 0 0 0 8 8 14 
Mullaitivu 2 3 0 24 19 40 1 5 8 36 18 21 9 1 2 0 0 0 0 0 0 10 2 17 
Batticaloa 63 58 79 242 509 477 3 8 12 40 25 24 16 23 10 6 3 0 0 0 22 215 325 1176 
Ampara 33 20 5 263 267 204 0 0 0 12 5 6 4 4 2 15 7 8 4 1 3 19 20 37 
Trincomalee 42 61 63 218 267 335 1 1 4 45 30 30 42 58 25 3 6 12 4 3 23 175 128 121 
Kurunegala 681 637 791 553 658 532 5 3 9 87 87 73 44 43 37 74 64 87 34 44 46 64 51 109 
Puttalam 398 397 372 329 295 217 3 11 17 115 75 106 7 5 9 21 31 31 2 0 9 154 90 84 
Anuradhapura 131 94 276 446 440 203 8 15 10 44 44 22 28 14 17 47 26 41 27 24 20 64 46 48 
Polonnaruwa 84 80 70 155 175 170 1 2 3 10 11 14 124 124 64 22 22 22 5 4 0 23 34 52 
Badulla 154 124 83 786 734 651 4 3 7 119 89 99 45 23 13 39 48 49 168 165 169 184 138 400 
Monaragala 43 34 57 367 379 363 7 8 2 76 62 60 23 24 40 31 38 56 98 76 93 72 39 47 
Ratnapura 542 323 449 758 693 602 19 19 20 110 79 79 39 24 24 79 65 82 38 20 32 189 141 105 
Kegalle 481 404 444 279 294 312 3 7 11 59 60 69 16 16 10 289 220 246 62 42 46 396 148 270 
Kalmunai 46 9 9 252 280 243 1 2 4 75 31 10 17 15 14 3 2 2 1 2 2 264 144 133 
TOTAL 11902 9644 7271 7883 8110 7292 129 168 203 1926 1675 1805 971 1201 1037 1568 1543 2187 1126 1029 1079 2739 3223 5869 
 
*Most diagnoses are based on clinical criteria only. 
Red font indicates the three highest incidences per district for each disease during the period indicated. 
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3.1.3  Sample Collection 
 
From 617 patients recruited, the numbers of diagnostic samples collected and tested 
were as shown in Table 3.1.3. Serum samples and bacterial isolates were successfully 
transported to the research and reference laboratories described previously (Section 
2.1.3. and 2.2). 
 
Table 3.1.3. Samples collected from 617 patients admitted with fever 
 
Sample Number Percentage 
In-house blood culture for bacteria 595 96% 
BacT/ALERT blood culture for bacteria 604 98% 
Any blood culture for bacteria 606 98% 
Blood culture for leptospires 604 98% 
Blood sample for CRP tests 559 91% 
Blood sample for CPK tests 542 88% 
Urine sample on admission 472 76% 
Serum sample on admission 550 89% 
Serum sample on discharge 73 12% 
Serum sample on follow-up 300 49% 
Any serum sample 573 93% 
Single serum sample only 278 45% 
Paired serum samples 295 48% 
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3.2  Laboratory Results 
 
A summary of the diagnoses made from the 617 patients in this study is shown in 
Table 3.2. These are arranged in groups as follows: 
 
Group 1 diagnoses were confirmed infections in which the exact organism was 
identified using gold standard laboratory tests. 
 
Group 2 diagnoses were confirmed infections in which the exact organism could not 
be identified using a gold standard test. Cellulitis and orchitis were diagnosed if 
clinically obvious. LRTI, sinusitis and PID were diagnosed if there were supportive 
imaging results. Pulmonary TB was diagnosed according to the “clinically-typical” 
criteria defined previously (Section 2.2.5). CNS infections were diagnosed if there 
were raised leukocyte and protein counts in cerebrospinal fluid. Abscesses and septic 
arthritis were diagnosed by imaging and aspiration. 
 
Group 3 diagnoses were confirmed non-infectious diseases in which the cause was 
confirmed by gold standard laboratory tests. 
 
Group 4 diagnoses were unconfirmed by any of the above methods and represent the 
clinical diagnosis made by a senior clinician at the time the patient was discharged 
from hospital. 
 
There were 230 cases (37.2%) with unconfirmed diagnoses, which were evenly 
distributed throughout the 12-month study period with the exception of a month 
following the Sinhalese / Tamil New Year on 14 April 2007. During this period 44 
(75.9%) of 58 cases had unconfirmed diagnoses and 23 (52.3%) of these were acute 
respiratory infections. There were 14 cases (2.3%) who died, of whom five (35.7%) 
had confirmed non-infectious diseases (two myocardial infarctions, one 
cerebrovascular accident, one liver failure & one leukaemia), five (35.7%) had 
leptospirosis (three confirmed & two unconfirmed), three (21.4%) had LRTIs (all 
unconfirmed) and one (7.1%) had cellulitis (with liver failure). 
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Table 3.2. Final diagnoses in 617 patients admitted with fever 
 
Group Definition Disease Cases* % Total 
1 
C
on
fir
m
ed
 in
fe
ct
io
ns
 +
 
or
ga
ni
sm
 id
en
tif
ie
d 
Dengue 137 22.2% 
348 
(56.4%) 
Chikungunya 103 16.7% 
Leptospirosis 32 5.2% 
Bacteraemia (see Section 3.2.2) 26 4.2% 
Q fever 18 2.9% 
Rickettsial infections 14 2.3% 
Tuberculosis 7 1.1% 
UTI (no bacteraemia) 5 0.8% 
Mumps 2 0.3% 
Chickenpox 1 0.2% 
Hantavirus 1 0.2% 
Hepatitis A 1 0.2% 
Malaria 1 0.2% 
2 
C
on
fir
m
ed
 in
fe
ct
io
ns
 +
 
no
 o
rg
an
is
m
 id
en
tif
ie
d 
Cellulitis (clinically obvious) 15 2.4% 
47 
(7.6%) 
LRTI (with CXR changes) 13 2.1% 
Pulmonary tuberculosis (see Section 2.2.4) 10 1.6% 
CNS infection (with CSF changes) 2 0.3% 
Liver abscess (on imaging & aspiration) 2 0.3% 
Lung abscess (on imaging & aspiration) 1 0.2% 
Septic arthritis (on imaging & aspiration) 1 0.2% 
Sinusitis (with SXR changes) 1 0.2% 
Orchitis (clinically obvious) 1 0.2% 
PID (with USS changes) 1 0.2% 
3 
C
on
fir
m
ed
 
no
n-
in
fe
ct
io
us
 
di
se
as
es
 
Malignancy 8 1.3% 
22 
(3.6%) 
CVA 4 0.6% 
IBD 2 0.3% 
MI 2 0.3% 
Polyarthropathy 2 0.3% 
SLE 2 0.3% 
Appendicitis 1 0.2% 
Pancreatitis 1 0.2% 
4 
U
nc
on
fir
m
ed
 d
is
ea
se
s 
Viral fever 82 13.3% 
230 
(37.2%) 
Undifferentiated fever 48 7.8% 
LRTI 33 5.3% 
UTI 21 3.4% 
Leptospirosis 17 2.8% 
URTI 9 1.5% 
Gastroenteritis 6 1.0% 
Liver disease 6 1.0% 
Enteric fever 4 0.6% 
Acute abdomen 1 0.2% 
Connective tissue disease 1 0.2% 
Endocarditis 1 0.2% 
Malaria 1 0.2% 
 
*The total number of diagnoses exceeds 617 due to the presence of co-infections. 
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3.2.1  Malaria Results 
 
From 419 patients who had at least one thick blood film inspected, there was one 
(0.2%) positive for malaria and also one in whom the diagnosis was made clinically 
despite negative blood films. The single confirmed case of malaria was diagnosed as 
having a mixed Plasmodium falciparum and P. vivax infection and had recently 
returned from travelling in India, which was thought to be the origin of his infection. 
Neither of these cases had any other co-infections diagnosed. 
 
3.2.2  Bacteraemia Results 
 
From 606 patients who had at least one blood culture for bacteria done, there were 26 
(4.3%) with bacteraemia (Table 3.2.2), of whom one had co-infection with dengue 
diagnosed. 
 
Bacteraemia was detected in 18/595 (3.0%) in-house blood culture bottles compared 
to 21/604 (3.5%) in the BacT/ALERT bottles (P = 0.63). This difference was not 
significant and also did not suggest that the BacT/ALERT bottles were better at 
identifying bacteria in patients that had antimicrobials in their urine from pre-
admission use. 
 
Contamination with non-pathogenic bacteria was found in 63/595 (10.6%) in-house 
bottles compared to 19/604 (3.1%) in the BacT/ALERT bottles (P < 0.01). This is 
probably because the in-house bottles had to be opened for sub-culturing as their 
rubber caps became permanently damaged if a sub-venting needle was left in place 
and this would prevent them being reused after sterilisation. In comparison the 
BacT/ALERT bottles remained sealed throughout with a sub/venting needle inserted 
through their rubber caps and were disposed of after use. 
 
Bacterial identification and antibiotic profile results from the University of Kelaniya, 
Sri Lanka correlated well with those from the University of Liverpool, UK. Bacterial 
identifications were the same for 24 (92.3%) of 26 isolates and both exceptions 
differed at the species level only. Isolate R051 was initially identified as E. 
aerogenes and later confirmed as E. cloacae, but these are known to be closely-
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related species with only minor differences in their biochemical profiles [Farmer et 
al., 1985]. Also isolate R222 was initially identified as B. cepacia and later 
confirmed as B. pseudomallei, but it is well-known that biochemical profiles can be 
misleading when trying to distinguish these species [Inglis et al., 2005]. Antibiotic 
profiles also correlated well between the different laboratories and were identical in 
24 (92.3%) of 26 cases. 
 
Acquired antibiotic resistance was identified in six (23.1%) of the 26 isolates 
obtained from blood cultures. One S. typhi isolate was resistant to ampicillin, 
chloramphenicol, ciprofloxacin and co-trimoxazole. From the E. coli isolates, four 
were resistant to ampicillin, of which two were also resistant to co-amoxiclav and 
one of these was also resistant to cephalosporins, ciprofloxacin and gentamicin. The 
K. pneumoniae isolate showed extended spectrum beta-lactamase (ESBL) resistance 
and was confirmed to have the CTX-M-15 enzyme on genetic testing. 
 
Two cases of bacteraemia shown in Table 3.2.2 were of particular interest and could 
merit publication as case reports. Patient R130 was a 25-year-old woman with 
Haemoglobin E (HbE) β-thalassemia and a splenectomy, who presented with a 
severe gastroenteritis and had Campylobacter jejuni isolated from her blood cultures. 
Patient R222 was a 35-year-old paddy farmer with type 1 diabetes mellitus, who 
presented with a severe LRTI followed by septic arthritis and death, who had 
Burkholderia pseudomallei isolated from his blood cultures. The isolate was initially 
identified as B. cepacia using microbial identification panels in Sri Lanka, but was 
later identified as B. pseudomallei using 16S rRNA gene sequence analysis in the 
UK. Soil samples from the patient’s paddy fields were sent to the Mahidol-Oxford 
Tropical Medicine Research Unit in Bangkok, Thailand for culture and these grew B. 
thailandensis only. This is usually thought to be an environmental species with 
minimal pathogenicity, but human infections have been reported previously [Glass et 
al., 2006]. 
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Table 3.2.2. Cases of bacteraemia diagnosed by blood cultures 
 
Infection Cases UI Organism IHB BAB AMs 
UTI 9 
R059 Escherichia coli – + ND 
R061 Escherichia coli + + – 
R249 Escherichia coli – + – 
R350 Escherichia coli – + +/– 
R390 Escherichia coli + – ND 
R459 Escherichia coli – + +/– 
R507 Escherichia coli – + – 
R608 Citrobacter kosseri – + + 
R051 Enterobacter cloacae + – – 
LRTI 6 
R021 Streptococcus pneumoniae + + – 
R481 Streptococcus pneumoniae + – + 
R526 Streptococcus pneumoniae + + ND 
R222 Burkholderia pseudomallei + + + 
R609 Enterobacter cloacae + + + 
R419 Klebsiella pneumoniae – + – 
Enteric Fever 5 
R353 Salmonella typhi + – + 
R427 Salmonella typhi + + +/– 
R431 Salmonella typhi + + – 
R518 Salmonella typhi + + ND 
R519 Salmonella typhi + + + 
Abscess 2 
R472 Acinetobacter calcoaceticus – + + 
R181 Staphylococcus aureus + + – 
Endocarditis 2 
R471 Streptococcus bovis + + + 
R479 Streptococcus viridans + + + 
Gastroenteritis 1 R130 Campylobacter jejuni + + ND 
URTI 1 R502 Streptococcus pyogenes + – ND 
Totals 26   18 21  
 
UTI, urinary tract infection; LRTI, lower respiratory tract infection; URTI, upper 
respiratory tract infection; UI, unique identifier; IHB, in-house bottle; BAB, 
BacT/ALERT bottle; AMs, antimicrobials detected in urine; ND, not done; +/–, 
equivocal. 
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3.2.3  Other Bacterial Results 
 
Other bacterial infections in urine and sputum samples were diagnosed as part of the 
patients’ normal management, but very few samples were sent to the Department of 
Microbiology, University of Kelaniya. (It seems likely that more were sent to the 
Department of Pathology of the Colombo North Teaching Hospital instead, but very 
few of these could be traced.) From 617 patients in the study, there were five (0.8%) 
who had urinary tract infections (UTIs) diagnosed from urine samples alone and 
none who had lower respiratory tract infections (LRTIs) diagnosed from sputum 
samples alone. None of these five UTI cases had any co-infections diagnosed. All 
other cases of UTI or LRTI were diagnosed by blood cultures due to the associated 
bacteraemias (Section 3.2.2). 
 
3.2.4  Tuberculosis Results 
 
From 617 patients in the study, there were 17 (2.8%) diagnosed as tuberculosis (TB). 
There were seven with laboratory-confirmed TB (three on culture and four on 
histology) of whom five had pulmonary TB and two had extra-pulmonary TB. There 
were also 10 with “clinically-typical” pulmonary TB as defined previously (Section 
2.2.4) of whom five had good responses to anti-tuberculous therapy and five had 
undocumented responses due to their care being transferred away from the (National) 
Chest Hospital at Welisara. All patients diagnosed with TB had raised inflammatory 
markers with ESR ≥65 mm/h or CRP ≥96 mg/L, which exceeded the necessary 
levels defined in Section 2.2.4. None of these 17 TB cases had any co-infections 
diagnosed. 
 
3.2.5  Brucellosis Results 
 
From 573 patients who provided serum samples (295 paired samples and 278 single 
samples), there were five (0.8%) positive at a dilution of 1:160 on the Brucellacapt 
screening assay. The complete brucellosis serology results for these patients are 
shown in Table 3.2.5. 
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Although EIA IgM titres >20 are considered positive, MAG titres of 20 to 160 are of 
indeterminate clinical significance and none of these five patients had significant 
EIA IgG or CFT titres. Hence none of them have evidence of acute or chronic 
brucellosis, nor is it possible to speculate regarding previous exposure to Brucella in 
these patients.  
 
Table 3.2.5. Complete brucellosis serology results for patients with a positive 
screening result 
 
Sample Brucellacapt EIA IgM EIA IgG MAG CFT 
R056A Positive 40 <20 80 <4 
R469A Positive <20 <20 ND ND 
R476F Positive <20 <20 ND ND 
R503F Positive <20 <20 ND ND 
R529F Positive 20 <20 40 <4 
 
 
3.2.6  Leptospirosis Results 
 
From 604 patients who had a blood culture for leptospires done, there were 19 
(3.1%) that had Leptospira isolated. From 573 patients who provided serum samples 
(295 paired samples and 278 single samples), there were 35 (6.1%) positive on the 
IgM ELISA, but only 23 (4.0%) positive on the MAT. Combining the culture and 
ELISA results would identify 41 cases of leptospirosis, whereas combining the 
culture and MAT results would identify only 32 cases.  These results are summarised 
in Table 3.2.6.1. Of the nine cases not proven on gold standard investigations 
(culture or MAT), seven had equivocal MAT results and seven had either a 4-fold 
rise in their IgM ELISA titre or else the maximum possible titre (1:2,560) on 
admission and only one (R590) had neither of these results. So the number of 
leptospirosis cases confirmed by gold standard tests remains 32, but there is evidence 
to suggest that the true number of confirmed cases should be 40 or 41. In addition 
there were 8 unconfirmed cases, who were clinically diagnosed with leptospirosis but 
not fully investigated with cultures and paired serology tests and in three this was 
due to early death or urgent transfer for haemodialysis. Of the 32 confirmed 
leptospirosis cases, three had co-infections diagnosed of whom one had dengue, one 
had Q fever and one had scrub typhus.  
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CAAT and MLST analysis was performed on 14 (73.7%) and 17 (89.5%) of the 19 
isolates because the remainder could not be recovered from frozen storage. These 
results have been entered in the Leptospira MLST website database 
(http://leptospira.mlst.net) as shown in Table 3.2.6.2 and have also been submitted to 
GenBank [Boonsilp et al., 2013]. The CAAT analysis identified nine of 14 isolates 
as Pyrogenes at serogroup and serovar level and the remaining five isolates had 
uncertain identities. The MLST analysis was more specific and identified sequence 
types (STs) for all 17 isolates and revealed eight different sequence types (STs). 
However, four of these (STs 49, 74, 75 and 76) were closely related within a single 
clonal complex (CC 12 in this case) and these accounted for 13 (76.5%) of the 17 
isolates identified. Overall, these results are suggestive of endemic disease and not an 
outbreak situation in which a dominant clone predominates, as was reported in 
Thailand [Thaipadungpanit et al., 2007]. 
 
Some of the clinical and laboratory features on admission for confirmed leptospirosis 
cases from this study are shown in Table 3.2.6.3. The characteristic appearance of 
conjunctival suffusion with icterus in a leptospirosis patient (R561) is shown in 
Figure 3.2.6.1, but this is a very rare occurrence in Sri Lanka since most cases an 
anicteric. With only 32 confirmed cases it was thought that performing multiple 
logistic regression and developing a clinical prediction rule would not be feasible. 
However, samples to evaluate leptospirosis diagnostic tests are available from 32 
confirmed cases, of whom 23 have paired serum samples (Table 3.2.6.1) and 17 have 
had isolates identified by CAAT or MLST (Table 3.2.6.2). 
 
Of all the infections tested for, leptospirosis was the most likely to have a focal 
distribution due to its mode of transmission and so the distribution of the 41 cases 
identified by culture or ELISA were plotted as shown in Figure 3.2.6.2.  One GN 
division (Ihala Karagahamuna North with a population of 3634 on the Census in 
2001) had three cases (R025, R028 & R503), but cultures were negative for all of 
these and so a comparison of isolates was not possible. The remaining cases had a 
similar distribution to the other patients recruited (Figure 3.1.2.2) and the overall 
population of Gampaha District (Figure 3.1.2.3). 
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Table 3.2.6.1. Cases of leptospirosis diagnosed by blood culture and serology tests 
 
UI Culture Serum ELISA MAT AMs 
R010 + Paired + + – 
R025 – Paired + +/– + 
R026 – Paired + +/– + 
R028 – Single + +/– + 
R065 – Paired + + + 
R116 + Paired + + – 
R122 + Single +/– + – 
R136 – Paired + + + 
R144 – Paired + +/– + 
R150 + Paired + +/– + 
R160 ND Paired + + ND 
R163 + Paired + + – 
R166 + Single – – ND 
R168 + Single – – ND 
R186 + Paired + – – 
R194 – Paired + + + 
R205 + Paired + + – 
R235 + Paired + + – 
R238 + Paired + + ND 
R248 – Paired + – – 
R312 – Single + +/– ND 
R358 + Single – – +/– 
R407 – Single + + + 
R437 + Paired + + + 
R444 + Single – – +/– 
R450 – Paired + + ND 
R457 + Paired + + +/– 
R461 – Single + +/– + 
R474 – Paired + + + 
R480 + Paired + – ND 
R489 – Paired + + + 
R493 + Single + + ND 
R499 + Paired + + + 
R503 – Paired + + + 
R554 – Paired + + + 
R561 – Paired + +/– +/– 
R567 – Paired + + + 
R590 – Paired + – +/– 
R597 – Single + + + 
R601 + Single – – – 
R612 – Paired + + – 
 
UI, unique identifier; ELISA, enzyme-linked immuno-sorbent assay; MAT, micro-
agglutination test; AMs, antimicrobials detected in urine; ND, not done; +/–, 
equivocal. Shading indicates cases that were not proven by gold standard 
investigations (culture or MAT). 
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Table 3.2.6.2. CAAT and MLST analysis of isolates from the Ragama Fever Study in the Leptospira MLST Database (http://leptospira.mlst.net) 
 
 
Case Host Gender Age Country Region Latitude Longitude Year Species Serogroup Serovar ST glmU pntA sucA tpiA pfkB mreA caiB Source 
R010 Human Male 49 Sri Lanka Gampaha 7.089895 79.999413 2006 L. borgpetersenii Possibly Celledoni Undesignated 144 24 27 30 34 67 27 28 Mark Bailey 
R116 Human Female 45 Sri Lanka Kurunegala 7.4833333 80.3666667 2006 L. borgpetersenii Undesignated Undesignated 157 28 27 29 28 40 26 14 Mark Bailey 
R122 Human Male 17 Sri Lanka Gampaha 7.089895 79.999413 2006 L. interrogans Pyrogenes Pyrogenes 49 5 1 1 1 3 2 7 Mark Bailey 
R150 Human Male 20 Sri Lanka Kegalle 7.1204053 80.3213106 2006 L. interrogans Pyrogenes Pyrogenes 49 5 1 1 1 3 2 7 Mark Bailey 
R163 Human Male 44 Sri Lanka Gampaha 7.089895 79.999413 2006 L. interrogans Pyrogenes Pyrogenes 74 1 1 1 2 3 2 7 Mark Bailey 
R166 Human Male 30 Sri Lanka Gampaha 7.089895 79.999413 2006 L. interrogans Possibly Canicola Undesignated* 49 5 1 1 1 3 2 7 Mark Bailey 
R168 Human Male 38 Sri Lanka Gampaha 7.089895 79.999413 2006 L. interrogans Pyrogenes Pyrogenes 49 5 1 1 1 3 2 7 Mark Bailey 
R205 Human Male 29 Sri Lanka Puttalam 8.0341667 79.8352778 2006 L. interrogans Pyrogenes Pyrogenes 75 5 1 1 5 3 2 7 Mark Bailey 
R235 Human Male 24 Sri Lanka Gampaha 7.089895 79.999413 2006 L. interrogans Possibly Grippotyphosa Undesignated 140 3 3 3 3 4 5 16 Mark Bailey 
R358 Human Male 53 Sri Lanka Gampaha 7.089895 79.999413 2006 L. interrogans Pyrogenes Pyrogenes 49 5 1 1 1 3 2 7 Mark Bailey 
R437 Human Male 24 Sri Lanka Gampaha 7.089895 79.999413 2007 L. interrogans Died Died* 76 5 1 1 2 3 2 7 Mark Bailey 
R444 Human Male 24 Sri Lanka Gampaha 7.089895 79.999413 2007 L. interrogans Died Died* 75 5 1 1 5 3 2 7 Mark Bailey 
R457 Human Male 51 Sri Lanka Gampaha 7.089895 79.999413 2007 L. interrogans Died Died* 76 5 1 1 2 3 2 7 Mark Bailey 
R480 Human Male 24 Sri Lanka Gampaha 7.089895 79.999413 2007 L. interrogans Pyrogenes Pyrogenes 49 5 1 1 1 3 2 7 Mark Bailey 
R493 Human Male 42 Sri Lanka Gampaha 7.089895 79.999413 2007 L. interrogans Pyrogenes Pyrogenes 75 5 1 1 5 3 2 7 Mark Bailey 
R499 Human Male 60 Sri Lanka Gampaha 7.089895 79.999413 2007 L. interrogans Possibly Hebdomadis Undesignated 80 3 1 17 3 4 5 16 Mark Bailey 
R601 Human Male 54 Sri Lanka Gampaha 7.089895 79.999413 2007 L. interrogans Pyrogenes Pyrogenes 75 5 1 1 5 3 2 7 Mark Bailey 
 
* Probably Pyrogenes based on ST; Isolates shown in shaded boxes are all from CC 12; Isolates shown in colour are unique to Sri Lanka 
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Table 3.2.6.3. Clinical and laboratory features on admission for confirmed 
leptospirosis cases from this study 
 
History % Examination % Investigations % 
Male sex 95 Conjunctival suffusion 41 Creatinine > 1.50 mg/dL 85 
Chills 93 Hepatomegaly 22 Urea > 25 mg/dL 83 
Myalgia 88 Photophobia 20 Platelets < 150 x 109/L 62 
Headache 85 Hypotension 17 SGOT (AST) > 40 IU/L 46 
Arthralgia 83 Oliguria 15 Platelets < 100 x 109/L 41 
Rigors 66 Flushing 12 Proteinuria > 100 mg/dL 39 
Vomiting 49 ITU admission 12 Neutrophils > 8.0 x 109/L 35 
Anorexia 39 Icterus/jaundice 10 SGPT (ALT) > 60 IU/L 29 
Dysgeusia 34 Bleeding 7 Lymphocytes < 1.0 x 109/L 27 
Sore throat 32 Lymphadenopathy 7 WCC > 4.0 x 109/L 22 
Cough 29 Splenomegaly 2 Bilirubin > 20 md/dL 6 
Abdominal pain 27 Conjunctival haemorrhage 0 Haematocrit > 0.45 6 
Nausea 22 Rash 0   
Diarrhoea 20 Tourniquet test positive 0   
Death 12     
 
Figure 3.2.6.1. Characteristic (but rare) appearance of conjunctival suffusion with 
icterus in a leptospirosis patient (R561) 
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Figure 3.2.6.2. Distribution of leptospirosis cases in Gampaha District  
 
 
 
 
 
 
 
● Colombo North Teaching Hospital 
  0 Cases from this GN division 
 1 Case from this GN division 
 2 Cases from this GN division 
 3 Cases from this GN division 
Total cases = 41 
Cases plotted = 34 
Cases elsewhere = 7  
 
● 
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3.2.7  Q fever Results 
 
From 573 patients who provided serum samples (295 paired samples and 278 single 
samples), there were 18 (3.1%) with Q fever, of whom 13 had acute Q fever, four 
had probable Q fever and one had chronic Q fever. There were also 23 patients with 
evidence of past Q fever infection. Of the 18 Q fever cases, nine had co-infections 
diagnosed of whom five had dengue, one had chikungunya, one had leptospirosis, 
one had spotted fever and one had probable rickettsial infection. 
 
3.2.8  Rickettsia Results 
 
From 573 patients who provided serum samples (295 paired samples and 278 single 
samples), there were 14 (2.4%) with rickettsial infections, of whom six had scrub 
typhus, six had probable rickettsial infection and two had spotted fever, of which one 
(R527) was identified as Rickettsia conorii subspecies indica infection by western 
blotting with cross-adsorption (Figure 3.2.8.1). Of the 14 rickettsial infection cases, 
five had co-infections diagnosed of whom two had Q fever, two had chikungunya 
and one had leptospirosis. Amongst the six scrub typhus cases identified in 
Marseilles, only one had an eschar, only one had a rash and only two were also 
positive on scrub typhus serology in Bangkok. A total of six patients had eschars, of 
whom only one was diagnosed as scrub typhus in Marseilles compared to five in 
Bangkok, but combining these positive results would have diagnosed all six. 
 
Figure 3.2.8.1. Western blotting with cross-adsorption to distinguish R. conorii 
subspecies indica from R. typhi in a patient (R527) 
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The characteristic eschar of scrub typhus (case R349) and a typical rash of rickettsial 
spotted fever (case R527) are shown below in Figures 3.2.8.2 & 3.2.8.3. 
 
Figure 3.2.8.2. Characteristic appearance of an eschar on the left inner thigh of a 
scrub typhus patient (R349) 
 
 
 
Figure 3.2.8.3. Typical appearance of a rash on the lower limbs of a rickettsial 
spotted fever patient (R527) 
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3.2.9  Dengue Results 
 
From 573 patients who provided serum samples (295 paired samples and 278 single 
samples), there were 109 positive on dengue serology, of whom 20 (18.3%) were 
acute primary infections, 81 (74.3%) were acute secondary infections, five (4.6%) 
were recent infections and three (2.8%) were of indeterminate duration. Dengue RT-
PCR was performed on admission samples only for dengue seropositive cases and 
dengue seronegative cases that provided admission serum only. From these samples 
there were 93 positive on dengue RT-PCR, of whom two (2.2%) were DENV-1, 26 
(28.0%) were DENV-2, 62 (66.7%) were DENV-3 and three (3.2%) were DENV-4 
on genotyping. The combination of 101 acute dengue serology cases and 93 dengue 
RT-PCR positive cases resulted in 137 cases of acute dengue infection being 
identified (Table 3.2.9.1). Therefore from 573 patients tested, there were 137 
(23.9%) with acute dengue infection. Of these cases, 18 (13.1%) had co-infections 
diagnosed of whom 10 had chikungunya infection, three had Q fever, two had 
probable Q fever, two had leptospirosis and one had bacteraemia due to a urinary 
tract infection with E. coli. 
 
The monthly frequency of dengue cases was shown previously (Figure 3.1.1.3). 
Some of the clinical and laboratory features on admission for confirmed cases from 
this study are shown in Table 3.2.9.3. The characteristic (but rare) appearance of a 
confluent rash with “islands of sparing” in a dengue patient who had DHF (R006) is 
shown in Figure 3.2.9.1. Data recorded on admission was later used to develop 
clinical prediction rules for the diagnosis of dengue (Section 3.3.1). From these 137 
cases of acute dengue infection, there were 75 with paired serum samples and 49 of 
these had the serotype identified on RT-PCR testing (Table 3.2.9.2). These samples 
will be the most useful for evaluating dengue diagnostic tests in the future (Section 
3.4). 
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Table 3.2.9.1. Dengue cases from serology and RT-PCR results 
 
Dengue Serology Tests Positive 109 (19%) 60/109 = RT-PCR +ve on admission 
 Negative 464 (81%) 33/464 = RT-PCR +ve on admission 1 
 Not Done 44 no serum provided 
 Total 617  
    
Dengue Serology 
Positives 
Acute Primary 20 (18%) 15/20 = RT-PCR +ve on admission 
 Acute 
Secondary 
81 (74%) 42/81 = RT-PCR +ve on admission 
 Recent 5 (5%) 1/5 = RT-PCR +ve on admission 
∴considered acute  Indeterminate 3 (3%) 2/3 = RT-PCR +v  on admission 
∴considered acute  Total 109  
    
Dengue RT-PCR Tests 2 Positive 93 (28%) 60/93 = serology +ve 
 Negative 242 (72%) 47/242 = serology +ve 
 Not Done 282 2/282 = serology +ve 3 
 Total 617  
    
Dengue RT-PCR 
Positives 
DENV-1 2 (2%)  
 DENV-2 26 (28%)  
 DENV-3 62 (67%)  
 DENV-4 3 (3%)  
 Total 93  
    
Serology Positive and/or RT-PCR Positive 142  
 -4 Serology = “Recent” and RT-PCR –ve 
 -1 Serology = “Indeterminate” and RT-PCR 
–ve  137  
  137/573 = 24% of patients tested had acute dengue 
fever  
1. Serology negative due to lack of follow-up serum samples. 
 
2. Dengue RT-PCR tests at AFRIMS were performed for dengue seropositive cases 
and dengue seronegative cases that provided admission serum only. Therefore 
dengue seronegative cases with paired serum samples (and cases with no serum 
provided) did not have dengue RT-PCR tests. 
 
3. RT-PCR not done due to lack of admission serum samples. 
 
 
Table 3.2.9.2. Paired samples available for evaluating dengue diagnostic tests 
 
Serotype Acute primary Acute Secondary Totals 
DENV-1 0 1 1 
DENV-2 1 11 12 
DENV-3 10 26 36 
DENV-4 0 0 0 
Sub-Totals 11 38 49 
Unknown 3 23 26 
Totals 14 61 75 
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Table 3.2.9.3. Clinical and laboratory features on admission for confirmed dengue 
cases from this study 
 
History % Examination % Investigations % 
Chills 94 Flushing 41 SGOT (AST) > 40 IU/L 58 
Headache 81 Hypotension 17 Platelets < 150 x 109/L 51 
Myalgia 70 Bleeding 15 SGPT (ALT) > 60 IU/L 47 
Male sex 69 Hepatomegaly 15 WCC < 4.0 x 109/L 46 
Arthralgia 68 Lymphadenopathy 15 Neutrophils < 2.0 x 109/L 36 
Rigors 64 Conjunctival suffusion 8 Urea > 25 mg/dL 31 
Vomiting 62 Photophobia 7 Lymphocytes < 1.0 x 109/L 26 
Dysgeusia 55 Rash 5 Platelets < 100 x 109/L 26 
Nausea 34 Splenomegaly 4 Bilirubin > 20 mg/dL 21 
Cough 31 Tourniquet test positive 3 Haematocrit > 0.45 19 
Diarrhoea 30 Conjunctival haemorrhage 1 Proteinuria > 100 mg/dL 13 
Anorexia 28 Icterus/jaundice 1 Creatinine > 1.50 mg/dL 0 
Abdominal pain 16 Oliguria 1   
Sore throat 14 ITU admission 1   
Death 0     
 
Figure 3.2.9. Characteristic (but rare) appearance of a confluent rash with “islands of 
sparing” in a dengue patient with DHF (R006) 
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3.2.10  Japanese Encephalitis Results 
 
From 573 patients who provided serum samples (295 paired samples and 278 single 
samples), for serological testing at AFRIMS, there were no cases of Japanese 
encephalitis (JE) diagnosed. This is an important result for the Gampaha District of 
Sri Lanka because it has the highest recorded annual incidence of “encephalitis” 
(Table 3.1.2.5), high rates of JE exposure have previously been described in humans 
and animals [Peiris et al., 1993] and the area is well-known for its marshes where 
mosquito vectors breed and its pig-farming that provides reservoir / amplifying hosts 
for Japanese encephalitis virus (JEV). For these reasons Gampaha District has had a 
childhood JE vaccination programme in place since 1988 and although the patients in 
this study were nearly all too old to have been vaccinated, there may well have been 
some “herd immunity” conferred to reduce the incidence of JE in the adult 
population. 
 
3.2.11  Chikungunya Results 
 
From 573 patients who provided serum samples (295 paired samples and 278 single 
samples), there were 91 positive on chikungunya serology, of whom 52 (57.1%) 
were acute infections, 12 (13.2%) were recent infections and 27 (29.7%) were of 
indeterminate duration. Chikungunya RT-PCR was performed on all samples and 
from the admission samples tested there were 97 positive on chikungunya RT-PCR. 
The combination of 52 acute chikungunya serology cases and 97 chikungunya RT-
PCR positive cases resulted in 103 cases of acute chikungunya infection being 
identified (Table 3.2.11). Therefore from 573 patients tested, there were 103 (18.0%) 
with acute chikungunya infection. Of these cases, 13 (12.6%) had co-infections 
diagnosed, of whom 10 had dengue, two had scrub typhus and one had Q fever. 
 
The testing of all serum samples by chikungunya RT-PCR produced some interesting 
results. From 73 discharge samples, eight (11.0%) were positive and from 299 
follow-up samples, 24 (8.0%) were positive. Of the eight positive cases on discharge, 
all had other confirmed diagnoses (two had dengue, two had leptospirosis, one had 
scrub typhus, one had tick typhus/spotted fever, one had cellulitis and one had 
lymphoma) and had been in hospital for ≥1 week. These features suggest that the 
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chikungunya infections may have occurred during their hospital stay. From the 24 
positive cases on follow-up, five were also positive on admission, were diagnosed as 
acute chikungunya on serology and had no co-infections. Looking at the dates of 
their samples shows that these five cases had RT-PCR detectable chikungunya 
viraemia lasting from 13 to 27 days. 
 
Analysis of the RT-PCR sequence for the chikungunya E1 gene of selected cases and 
reference isolates was used to generate a phylogenetic tree (Figure 3.2.11). This 
shows that the chikungunya viruses identified in this study were all closely related to 
each other and to the epidemic strain circulating in the Indian Ocean area from 2006 
onwards [Pialoux et al., 2007]. This strain is related to a central/east African strain 
and is quite distinct from previous Asian strains. 
 
The monthly frequency of chikungunya cases was shown previously (Figure 3.1.1.4). 
Some of the clinical and laboratory features on admission for confirmed cases from 
this study are shown in Table 3.2.11.2. The typical appearance of conjunctival 
suffusion in a chikungunya patient (R483 - who did not have leptospirosis) is shown 
in Figure 3.2.11.2. Persistent arthralgia for >2 weeks was found in 27 (52.9%) of 51 
cases who attended for follow-up and this is known to be a characteristic feature of 
the disease. Data recorded on admission was later used to develop clinical prediction 
rules for the diagnosis of chikungunya (Section 3.3.2). From these 103 cases of acute 
chikungunya infection, there were 52 with paired serum samples, which will be the 
most useful for evaluating chikungunya diagnostic tests in the future (Section 3.4). 
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Table 3.2.11.1. Chikungunya results from serology and RT-PCR results 
 
Chikungunya Serology Tests Positive 91 (16%) 57/91 = RT-PCR +ve on admission 
 Negative 483 (84%) 40/483 = RT-PCR +ve on admission 1 
 Not Done 44 no serum provided 
 Total 617  
    
Chikungunya Serology Positives Acute 52 (57%) 46/50 = RT-PCR +ve on admission 
 Recent 12 (13%) 0/12 = RT-PCR +ve on admission 
 Indeterminate 27 (30%) 11/27 = RT-PCR +ve on admission ∴considered 
acute  Total 91  
    
Chikungunya RT-PCR on Admission 2 Positive 97 (18%) 57/97 = sero +ve 
 Negative 453 (82%) 29/453 = sero +ve 
 Not Done 67 5/67 = sero +ve 3 
 Total 617  
    
Chikungunya RT-PCR on Discharge Positive 8 (11%)  
 Negative 65 (89%)  
 Not Done 544  
 Total 617  
    
Chikungunya RT-PCR on Follow-Up Positive 24 (8%)  
 Negative 275 (92%)  
 Not Done 318  
 Total 617  
    
Serology +ve and/or RT-PCR +ve on Admission 131  
 -12 Serology = “Recent” and RT-PCR –ve 
 -16 Serology = “Indeterminate” and RT-PCR –ve 4 
 103  
 103/573 = 18% of patients tested had acute chikungunya fever 
 
1. Serology negative due to lack of follow-up serum samples. 
 
2. Chikunguya RT-PCR tests were performed for every serum sample and not just for 
chikungunya seropositive cases and chikungunya seronegative cases that provided 
admission serum samples only. This strategy raises the possibility that cases with 
paired serum samples could be seronegative but RT-PCR positive on admission, 
which would represent conflicting results and be difficult to explain. This did occur 
in 20 cases despite repeat testing and these were considered to be false positives. 
Hence the threshold for RT-PCR positivity was adjusted using these cases as false 
positives and cases with paired serum samples that were seropositive and also RT-
PCR positive as true positives. This adjustment classified the conflicting results as 
RT-PCR negative and also reclassified another 21 positive RT-PCR results as 
negative. 
 
3. RT-PCR not done due to lack of admission serum samples. 
 
4. There is a high proportion of chikungunya seropositive cases, which can not be 
classified as “acute” or “recent” because only a single serum sample was provided 
and chikungunya RT-PCR was negative. From these 16 cases there are 12 that seem 
to be typical acute chikungunya cases based on their epidemiological, clinical and 
laboratory data and also very high chikungunya IgM levels. 
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Figure 3.2.11.1. Phylogenetic tree comparing the partial E1 gene sequences of 
chikungunya viruses from Sri Lanka (R139 & R233) and reference isolates 
 
 
 
Phylogenetic analysis of CHIKV sequences based on partial E1 gene sequences 
(position 10344 to 10957 of the prototype CHIKV S27 genomic sequence). Sequences 
obtained in this study are boxed. The analysis was performed using MEGA 4 
software [Tamura et al., 2007], using the neighbour-joining (maximum composite 
likelihood) method. The length of the tree branches indicates the percentage of 
divergence; the percentage of successful bootstrap replicates is specified at the 
nodes (1000 replicates). ONNV (O’nyong-nyong virus) prototype sequence was 
included to root the tree; all other sequences are CHIKV. 
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Table 3.2.11.2. Clinical and laboratory features on admission for confirmed 
chikungunya cases from this study 
 
History % Examination % Investigations % 
Chills 94 Flushing 31 Urea > 25 mg/dL 51 
Headache 86 Conjunctival suffusion 20 SGOT (AST) > 40 IU/L 42 
Arthralgia 83 Hepatomegaly 14 Platelets < 150 x 109/L 33 
Myalgia 79 Photophobia 8 Lymphocytes < 1.0 x 109/L 29 
Male sex 72 Lymphadenopathy 7 SGPT (ALT) > 60 IU/L 23 
Rigors 72 Bleeding 5 WCC < 4.0 x 109/L 18 
Vomiting 47 Hypotension 5 Haematocrit > 0.45 12 
Anorexia 37 Rash 4 Neutrophils < 2.0 x 109/L 11 
Cough 26 Icterus/jaundice 2 Platelets < 100 x 109/L 4 
Nausea 21 Oliguria 1 Proteinuria > 100 mg/dL 4 
Dysgeusia 18 Splenomegaly 1 Bilirubin > 20 mg/dL 0 
Diarrhoea 12 Conjunctival haemorrhage 0 Creatinine > 1.50 mg/dL 0 
Abdominal pain 7 ITU admission 0   
Sore throat 7 Tourniquet test positive 0   
Death 0     
 
Figure 3.2.11.2. Typical appearance of conjunctival suffusion in a chikungunya 
patient (R483 - who did not have leptospirosis) 
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3.2.12  Hantavirus Results 
 
From 295 patients who provided paired serum samples for serological and RT-PCR 
tests at NaDP, there were 25 (8.5%) with positive or equivocal results on the 
Hantavirus IgG DxSelect screening ELISA, of whom most were already positive on 
admission (Table 3.2.12). From these 25 cases, there were 18 cases positive on the 
serology gold standard IgM/IgG IFA for SEOV and weaker results (consistent with 
cross-reactions) were obtained with the equivalent IgM/IgG IFAs for HTNV and 
PUUV. Six cases (R158, R446, R489, R504, R511 and R590) were also positive on 
the Hantavirus IgM DxSelect ELISA suggesting acute infection, but only one case 
(R504) had a greater than four-fold rise in the IFA titre between the admission and 
follow-up samples to confirm this. 
 
The diagnostic RT-PCR in-house test results were all negative, but this was 
considered to be unreliable due to a known detection limit of 10,000 viral copies.  
RT-PCR amplification of the hantavirus S, M and L genome segments with 
degenerate primers for hantaviruses and specific primers for THAIV hantavirus was 
performed on the acute serum of case R504. This produced short sequences from the 
M and L segments only (due to limited amounts of viral RNA being present in the 
sample). 
 
The M segment sequence was 399 nucleotide bases long and showed 83% similarity 
to THAIV hantavirus : 
 
TTGTATAATTGGGACTGTATCTAAGTTTATCCAGGGTGATACATTACTTTT
TCTAGGCCCATTAGAAGGTGGTGGTCTAATATTTAAACACTGGTGCACAT
CTACATGTCAGTTTGGTGACCCAGGTGACATCATGAGTCCAAAAAACAA
ACCTTTGCTATGCCCAGATTTCCCGGGTCAGTTTAGGAAAAAATGTAATT
TTGCAACAACCCCTATTTGTGAGTATGATGGTAACAGGATTTCTGGTTAT
AGAAAGATGATGGCTACAATTGATTCTTTCCAATCTTTCAACACAAGTGA
TATTCATTTCACTGATGAACGGATAGAGTGGAAAGACCCTGATGGGATGC
TCCGTGACCATATAAATGTATTGGTTACAAAAGATATTGATTTTGAAAA  
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The L segment sequence was much shorter at 129 bases : 
 
AAGAATGTTTATAAAACAGACTTTTTCATGTCACGAAAACTGCGTTCCTA
TATTGATTCTATGGAAGGTCTCGAACAGAATGTAAAGGAATTTCTTGAAT
TTTTTCCTGACGGTCATCATGGTGAAGTT 
 
The tree in Figure 3.2.12 shows that the hantavirus from case R504 is most closely 
related to THAIV, followed by SEOV and then HTNV, but was far-removed from 
PUUV and TPMV. These M and L sequences were quite distinct from those obtained 
for the hantavirus previously isolated from rats in Sri Lanka (Sri R 87-1315), which 
was confirmed to be more closely related to SEOV [JW Song, personal 
communication]. 
 
It is interesting to note that case R504 was a 38-year old mechanic with reported 
close rodent exposure and a previous splenectomy, who presented with a 3-day 
history of non-productive cough, bilateral lung crepitations, low CRP and had no 
other confirmed diagnosis made from blood cultures (including those for Leptospira) 
or paired serology tests for all the infections identified in this study. Hence a genuine 
hantavirus infection seems likely. 
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Table 3.2.12. Hantavirus results for patients with paired sera that had positive or 
equivocal results on an IgG screening ELISA 
 
UI Sample HANV IgG ELISA 1 
HANV 
IgG ELISA 2 
HANV 
IgM ELISA 
SEOV 
IgM/IgG IFA 
HTNV 
IgM/IgG IFA 
PUUV 
IgM/IgG IFA 
R017 
A EQV POS POS NEG ND ND 
D POS POS POS ND ND ND 
F POS POS POS NEG NEG NEG 
R019 
A POS POS NEG POS ND ND 
D POS POS NEG ND ND ND 
F POS POS NEG POS (+) NEG NEG 
R094 A POS POS NEG POS ND ND F POS POS NEG POS (++) POS (++) NEG 
R111 A POS POS NEG POS ND ND F POS POS NEG POS (+) NEG NEG 
R150 A POS POS NEG POS ND ND F POS POS NEG POS (+) NEG NEG 
R158 
A NEG NEG POS POS ND ND 
D NEG NEG NEG ND ND ND 
F EQV EQV POS POS (+) NEG NEG 
R189 A EQV EQV NEG NEG ND ND F POS POS NEG NEG NEG NEG 
R198 A POS POS NEG POS ND ND F POS POS NEG POS (++) POS (++) POS (+) 
R205 A EQV EQV NEG POS ND ND F EQV EQV NEG POS (+) NEG NEG 
R236 A EQV NEG NEG POS ND ND F POS EQV NEG POS (+) NEG NEG 
R241 A POS POS NEG POS ND ND F POS POS NEG POS (++) POS (++) NEG 
R353 A EQV POS NEG POS ND ND F EQV POS NEG POS (+) NEG NEG 
R374 A POS POS NEG NEG ND ND F POS POS NEG NEG NEG NEG 
R390 A POS POS NEG POS ND ND F POS POS EQV POS (+) NEG NEG 
R425 A NEG POS NEG POS ND ND F POS POS NEG POS (+) NEG NEG 
R446 A POS POS POS POS ND ND F POS POS POS POS (+) NEG NEG 
R457 
A NEG NEG NEG NEG ND ND 
D EQV EQV NEG ND ND ND 
F POS EQV NEG NEG NEG NEG 
R458 A POS POS NEG POS ND ND F POS POS NEG POS (+) NEG NEG 
R479 A POS POS NEG NEG ND ND D POS POS EQV NEG NEG NEG 
R489 A POS POS POS POS ND ND F POS POS POS POS (++) POS (+) NEG 
R504* A POS POS POS POS ND ND F POS POS POS POS (++) POS (++) POS (+) 
R511 
A POS EQV POS POS ND ND 
D EQV NEG POS ND ND ND 
F POS POS POS POS (+) NEG NEG 
R530 A POS EQV NEG NEG ND ND F POS POS NEG NEG NEG NEG 
R588 A NEG POS NEG NEG ND ND D EQV POS POS NEG NEG NEG 
R590 A POS POS POS POS ND ND F POS POS NEG POS (+) NEG NEG 
 
UI, unique identifier; A, admission; D, discharge; F, follow-up; +, weak positive; 
++, strong positive; *, greater than four-fold increase in SEOV IFA titre between 
admission and follow-up samples. 
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Figure 3.2.12  Phylogenetic tree comparing the M segment sequences of a hantavirus 
from Sri Lanka (R504) and reference isolates 
 
 
 
Phylogenetic analysis of hantavirus sequences based on partial M segment 
sequences. The sequence obtained in this study is boxed. The analysis was performed 
using MEGA 4 software [Tamura et al., 2007], using the neighbour-joining (p-
distance) method. The length of the tree branches indicates the percentage of 
divergence; the percentage of successful bootstrap replicates is specified at the 
nodes (1000 replicates). Thottapalayam virus sequence was included to root the tree; 
all sequences are hantaviruses. 
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3.2.13  Other Virology Results 
 
For two patients with suspected mumps and one patient with suspected varicella, the 
diagnosis was confirmed on serology tests at HPA reference labs in the UK. 
 
3.2.14  Urinary Antimicrobial Results 
 
From 472 patients that provided admission urine samples, there were 249 (52.8%) 
with antimicrobial activity against B. stearothermophilus, 159 (33.7%) against S. 
pyogenes and 121 (25.6%) against E. coli. Combining the results for S. pyogenes and 
E. coli (to maximise the sensitivity and specificity of the test) showed anti-microbial 
activity in 203 (43.0%) of cases. This left an additional 91 (19.3%) cases with anti-
microbial activity against B. stearothermophilus only, which were classified as 
equivocal. However, it indicates that anti-microbial activity may have been present 
in as many as 294 (62.3%) cases. 
 
3.2.15  Other Laboratory Results 
 
From 559 patients that provided samples for C-reactive protein (CRP) tests, the 
results were as shown (Table 3.2.15.1). 
 
From 88 patients with confirmed bacterial infections and no co-infections that 
provided samples for CRP tests (36 had leptospirosis, 22 had bacteraemia, nine had 
Q fever, nine had rickettsial infections, seven had tuberculosis and five had urinary 
tract infections), the CRP results were as shown (Table 3.2.15.1). 
 
From 199 patients with confirmed viral infections and no co-infections that provided 
samples for CRP tests (111 had dengue, 84 had chikungunya, two had mumps, one 
had chickenpox and one had hepatitis A), the CRP results were as shown (Table 
3.2.15.1). 
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Table 3.2.15.1. CRP results on admission for all cases, confirmed bacterial cases and 
confirmed viral cases 
 
CRP (mg/L) All Cases (%) Bacterial Cases (%) Viral Cases (%) 
<6 140 (25%) 11 (13%) 77 (39%) 
6 50 (9%) 1 (1%) 27 (14%) 
12 89 (16%) 2 (2%) 50 (25%) 
24 90 (16%) 8 (9%) 26 (13%) 
48 83 (15%) 15 (17%) 18 (9%) 
96 105 (19%) 49 (56%) 1 (1%) 
>96 2 (0%) 2 (2%) 0 (0%) 
Totals 559 (100%) 88 (100%) 199 (100%) 
 
After excluding co-infections, scatter plots suggested that on admission CRP ≤ 12 
mg/L was predictive of viral infection and CRP ≥ 48 mg/L was predictive of 
bacterial infection and so these cut-offs were used for further analysis. CRP was ≤ 12 
mg/L in 154 (77.4%) of 199 viral infections compared to 14 (15.9%) of 88 bacterial 
infections (OR [95% CI] = 18.089 [8.945 - 37.133], P < 0.001) as shown in Table 
3.2.15.2. CRP was ≥ 48 mg/L in 66 (75.0%) bacterial infections compared to 19 
(9.5%) viral infections (OR [95% CI] = 28.421 [13.769 - 59.491], P < 0.001) as 
shown in Table 3.2.15.3. 
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Table 3.2.15.2. Association between CRP ≤ 12 mg/L on admission and viral or 
bacterial infections 
 
 Viral Infection Bacterial Infection Total 
CRP ≤ 12 mg/L 154 14 168 
CRP > 12 mg/L 45 74 119 
Total 199 88 287 
 
Diagnostic indices (95% CI) : OR = 18.089 (8.945 - 37.133), P < 0.001; Sensitivity 
= 0.774 (0.738 - 0.801); Specificity = 0.841 (0.760 - 0.902); PPV = 0.917 (0.874 - 
0.949); NPV = 0.622 (0.562 - 0.667); LR+ = 4.864 (3.080 – 8.191); LR- = 0.269 
(0.221 - 0.344). 
 
Table 3.2.15.3. Association between CRP ≥ 48 mg/L on admission and bacterial or 
viral infections 
 
 Bacterial Infection Viral Infection Total 
CRP ≥ 48 mg/L 66 19 85 
CRP < 48 mg/L 22 180 202 
Total 88 199 287 
 
Diagnostic indices (95% CI) : OR = 28.421 (13.769 - 59.491), P < 0.001; Sensitivity 
= 0.750 (0.672 - 0.812); Specificity = 0.905 (0.870 - 0.932); PPV = 0.776 (0.696 - 
0.841); NPV = 0.891 (0.857 - 0.918); LR+ = 7.885 (5.182 - 11.971); LR- = 0.276 
(0.201 - 0.376). 
 
There were 377 patients that provided samples on admission for creatinine 
phosphokinase (CPK) tests and 472 that provided samples on admission for urinary 
total protein measurements, which were of interest with regard to the diagnosis of 
leptospirosis. There was no significant association between raised CPK on admission 
and leptospirosis (Table 3.2.15.4), but there was a marked association between 
proteinuria (>100 mg/dL) on admission and leptospirosis (Table 3.2.15.5). 
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Table 3.2.15.4. Association between CPK on admission and leptospirosis 
 
 Leptospirosis Not Leptospirosis Total 
CPK >200 U/L 13 102 115 
CPK ≤200 U/L 26 236 262 
Total 39 338 377 ! 2  = 0.05 P = 0.83 OR (95%CI) = 1.16 (0.54 – 2.46) 
 
 
Table 3.2.15.5. Association between proteinuria on admission and leptospirosis 
 
 Leptospirosis Not Leptospirosis Total 
Proteinuria 13 59 72 
No Proteinuria 19 381 400 
Total 32 440 472 ! 2  = 15.05 P < 0.01 OR (95%CI) = 4.42 (1.94 – 10.00) !
 
3.3  Formulation of Clinical Prediction Rules for Use in Sri Lanka 
 
Dengue and chikungunya were each responsible for >50 confirmed cases and so 
attempts were made to formulate clinical prediction rules for these infections. The 
number of confirmed leptospirosis cases fell short of this target, which was probably 
due to diagnostic tests that were impeded by pre-admission antibiotic use or else 
required convalescent blood samples that were often not available. 
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3.3.1  Clinical Prediction Rule for the Diagnosis of Dengue 
 
Variables recorded on admission that were potential predictors for a confirmed 
diagnosis of dengue were first subjected to univariate analysis. This included the use 
of Pearson’s chi square test, Fisher’s exact test and odds ratios for categorical 
variables and Student’s independent samples t-test (with 2-tailed significance and 
Levene’s test) for continuous variables. Using these tests the following variables 
were found to have unadjusted associations (p < 0.05) with dengue : 
 
 • Decreasing age   • Increasing education 
 • Increasing income   • Early presentation to hospital 
 • Flushing    • Haemorrhage 
 • Dysgeusia    • Headache 
 • Hypotension    • Lack of cough 
 • Lack of haemoptysis  • Nausea 
 • Vomiting    • Diarrhoea 
 • Arthralgia    • Lack of anaemia 
 • Leukopenia    • Neutropenia 
 • Thrombocytopenia   • Decreasing ESR 
 • Decreasing CRP   • Increasing SGPT 
 • Increasing SGOT   • Increasing CPK 
 
However, there was apparent overlap between these variables and so multivariate 
analysis using logistic regression was performed. Unfortunately, the use of complete 
case methodology led to 48.0% of all cases being excluded due to missing values and 
hence concerns regarding the representativeness of this analysis. Even when 
variables with >10% missing values were excluded, there were still >20% of all 
cases excluded from this type of analysis. Although these analyses of complete cases 
may have identified adjusted associations that were correct, there are also ethical 
issues regarding the omission of such a large amount of patient data. 
 
Therefore a multiple imputation method was used with 5 iterations, which allowed 
the logistic regression to be repeated on the imputed data set (which then included 
100% of cases). This identified some variables (occurrence of an eschar, 
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haemoptysis, or neurological signs) with no occurrences in the dengue cohort and so 
cases with these features were excluded from the remainder of this analysis (leaving 
594 cases to be analysed) and so too were these variables themselves. These clinical 
features could be used to exclude dengue in this cohort of patients, but only occurred 
rarely (eschar in six cases, haemoptysis in 16 and neurological signs in one) and both 
haemoptysis and neurological signs have been described previously in complicated 
forms of dengue. Some of these features may have occurred with a larger sample size 
(and more complicated forms of dengue) and would then have been included in the 
logistic regression. 
 
The results of the final logistic regression on the imputed data sets are shown in 
Tables 3.3.1.1 and 3.3.1.2. In Table 3.3.1.1 the first row (labelled “Original data”) 
shows that only 310 (52%) of the remaining 594 cases from the original data set 
would have been included in this analysis, compared to 100% of cases in the imputed 
datasets. In Table 3.3.1.2 the third column (labelled “S.E”) shows that no variables in 
the pooled imputation analysis had very high standard errors in this analysis, which 
indicated that the model was stable. 
 
Table 3.3.1.1. Classification table for logistic regression of all dengue predictors 
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Table 3.3.1.2. Logistic regression for full adjusted model for dengue 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As shown in Table 3.3.1.1 this full adjusted model has a sensitivity of 78.5% and a 
specificity of 95.2% for identifying dengue cases with the original data set, but 
sensitivities of 60.6 – 63.5% and specificities of 95.2 – 96.1% with the imputed data 
sets. However, these figures are based on a probability estimate for dengue of 0.5 
(50%), which may not be optimal for maximising both sensitivity & specificity. 
Comparing these figures for the original and imputed data sets indicates that there 
was bias towards improved sensitivity in the original data set.  
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Although sensitivity and specificity figures are important, they are not as useful 
clinically as positive predictive value (PPV) and negative predictive value (NPV). 
For the original data set the PPV was 62 / (62 + 11) = 84.9% and the NPV was 220 / 
(220 + 17) = 92.8%. For the first imputed data set the PPV was 87 / (87 + 18) = 
82.9% and the NPV was 439 / (439 + 50) = 89.8%. The results for the other four 
imputed data sets were virtually identical and so are not reported. 
 
The following nine variables (measured on admission) were identified from Table 
3.3.1.2 as independent predictors of dengue with AORs that had a significance of p < 
0.1 : 
 
 • Antibiotics Pre Admission (0 = no, 1 = yes) → positive association 
 • Rigors (0 = no, 1 = yes) → positive association 
 • Flushing (0 = no, 1 = yes) → positive association  
 • Conjunctival Suffusion (0 = no, 1 = yes) → negative association 
 • Sore Throat (0 = no, 1 = yes) → negative association 
 • Dysgeusia (0 = no, 1 = yes) → positive association 
 • Hypotension (0 = no, 1 = yes) → positive association 
 • Platelets (x109/L) → negative association 
 • CRP (mg/L) → negative association 
 
These variables were then used together in a repeat logistic regression to produce a 
parsimonious adjusted model for dengue as shown in Tables 3.3.1.3 and 3.3.1.4.  
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Table 3.3.1.3. Classification table for logistic regression of selected dengue 
predictors 
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Table 3.3.1.4. Logistic regression for parsimonious adjusted model for dengue 
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As shown in Table 3.3.1.3 this parsimonious adjusted model has a sensitivity of 
57.3% and a specificity of 93.5% for identifying dengue cases with the original data 
set, but sensitivities of 44.5 – 49.6% and specificities of 94.1 – 94.7% with the 
imputed data sets. The pooled results in Table 3.3.1.4 show that one of the variables 
used (Rigors) no longer has an AOR with P < 0.05 in this model, but this was 
retained in the model as the intention at this stage was to identify all factors 
independently associated with dengue (and so a more relaxed P value of < 0.1 was 
adopted for this part of the analysis). 
 
Continuous variables are more difficult to use in clinical prediction rules and so 
those for platelets and CRP on admission were considered for conversion into 
dichotomised variables by producing frequency and scatter plots and also by 
considering clinically relevant break-points. The resulting charts did not suggest any 
obvious break-point for dichotomisation of these variables and it would not be valid 
or useful to simply choose a mean or median value. However, from a clinical 
perspective the obvious break-point for platelets (which were often low in dengue) is 
the lower value in the normal range (150 x109/L). The break-point for CRP is less 
obvious, but as shown in Section 3.2.15 a value of ≤12 mg/L would be expected in 
viral infections such as dengue. Therefore the following continuous variables were 
converted into dichotomised variables using the rules shown : 
 
• Platelets <150 x109/L = Thrombocytopenia (0 = no, 1 = yes) → positive association 
• CRP ≤12 mg/L = Low CRP (0 = no, 1 = yes) → positive association 
 
The logistic regression was then repeated with these replacement variables to 
produce a parsimonious adjusted model using categorical variables only for dengue 
as shown in Tables 3.3.1.5 and 3.3.1.6. 
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Table 3.3.1.5. Classification table for logistic regression of selected dengue 
predictors (updated) 
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Table 3.3.1.6. Logistic regression for parsimonious adjusted model for dengue 
(updated) 
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As shown in Table 3.3.1.5 this updated parsimonious adjusted model has a 
sensitivity of 52.4% and a specificity of 93.3% for identifying dengue cases with the 
original data set, but sensitivities of 46.0 – 49.6% and specificities of 93.9 – 95.4% 
with the imputed data sets. For the original data set the PPV was 65 / (65 + 24) = 
73.0% and the NPV was 332 / (332 + 59) = 84.9%. For the first imputed data set the 
PPV was 68 / (68 + 28) = 70.8% and the NPV was 429 / (429 + 69) = 86.1%. The 
results for the other four imputed data sets were virtually identical and so are not 
reported. A summary of the diagnostic performance of the dengue prediction rule 
during its evolution is shown in Table 3.3.1.7. 
 
Table 3.3.1.7. Diagnostic performance of the dengue prediction rule 
 
 
Full Model 
using 
Original Data 
Full Model 
using 
Imputed Data 
Final Model 
using 
Original Data 
Final Model 
using 
Imputed Data 
Sensitivity 
(95% CI) 
78.5% 
(68.2–86.1%) 
63.5% 
(55.2%–71.1%) 
52.4% 
(43.7–61.0%) 
49.6% 
(41.4–57.9%) 
Specificity 
(95% CI) 
95.2% 
(91.7–97.3%) 
96.1% 
(93.9–97.5%) 
93.3% 
(90.2–95.4%) 
93.9% 
(91.3–95.7%) 
PPV 
(95% CI) 
84.9% 
(75.0–91.4%) 
82.9% 
(74.5–88.9%) 
73.0% 
(63.0–81.2%) 
70.8% 
(61.1–79.0%) 
NPV 
(95% CI) 
92.8% 
(88.8–95.5%) 
89.8% 
(86.8–92.2%) 
84.9% 
(81.0–88.1%) 
86.1% 
(82.8–88.9%) 
LR+ 
(95% CI) 
16.481 
(9.153–29.677) 
16.123 
(10.074–25.803) 
7.776 
(5.103–11.848) 
8.101 
(5.449–12.044) 
LR– 
(95% CI) 
0.226 
(0.148–0.345) 
0.380 
(0.304–0.474) 
0.510 
(0.423–0.615) 
0.537 
(0.454–0.635) 
 
Using this parsimonious model with the original data set would enable more 
complete cases to be included (480 / 617 = 78% compared to 310 / 617 = 50% for 
the full model shown in Table 3.3.1.1). However, this would still leave 22% of cases 
with missing data and so the imputation approach remains appropriate. Two of the 
variables used (Antibiotics Pre Admission and Rigors) no longer have AORs with P 
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< 0.05 in this model, but these were retained in the model as the intention at this 
stage was to identify all factors independently associated with dengue (and so a more 
relaxed P value of < 0.1 was adopted for this part of the analysis). 
 
Overall this updated model will be easier to use (since all of the continuous variables 
have been converted to dichotomous variables) and has equivalent accuracy 
compared to the original parsimonious model (in which Platelets and CRP were kept 
as a continuous variable). Therefore the updated model was chosen for construction 
of a scoring algorithm and further analysis using ROC curves. 
 
The scoring algorithm was constructed as described previously (Section 2.3.1) using 
the LR coefficients (labelled “B”) for the pooled imputation data set shown in Table 
3.3.1.6. The scores for theoretical cases with the highest and lowest probabilities for 
having dengue are shown in Tables 3.3.1.8 and 3.3.1.9. The scores for the first 
confirmed dengue case (R006) and a confirmed non-dengue case (R269 who had 
chikungunya) are shown in Tables 3.3.1.10 and 3.3.1.11. 
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Table 3.3.1.8. Scoring algorithm for dengue showing highest probability 
 
Predictor 
Weighting 
(LR Coefficient = B) 
Score 
(0 = no, 1 = yes) 
Antibiotics pre-admission 0.533 1 
Rigors 0.394 1 
Flushing 1.255 1 
Conjunctival suffusion - 0.923 0 
Sore throat - 0.893 0 
Dysgeusia 1.067 1 
Hypotension 1.899 1 
Thrombocytopenia 1.064 1 
Low CRP 1.710 1 
Constant - 3.576 
Score 4.166 
Probability 0.985 
 
Table 3.3.1.9. Scoring algorithm for dengue showing lowest probability 
 
Predictor 
Weighting 
(LR Coefficient = B) 
Score 
(0 = no, 1 = yes) 
Antibiotics pre-admission 0.533 0 
Rigors 0.394 0 
Flushing 1.255 0 
Conjunctival suffusion - 0.923 1 
Sore throat - 0.893 1 
Dysgeusia 1.067 0 
Hypotension 1.899 0 
Thrombocytopenia 1.064 0 
Low CRP 1.710 0 
Constant - 3.576 
Score - 5.572 
Probability 0.004 
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Table 3.3.1.10. Scoring algorithm for a confirmed dengue case (R006) 
 
Predictor 
Weighting 
(LR Coefficient = B) 
Score 
(0 = no, 1 = yes) 
Antibiotics pre-admission 0.533 0 
Rigors 0.394 0 
Flushing 1.255 1 
Conjunctival suffusion - 0.923 0 
Sore throat - 0.893 1 
Dysgeusia 1.067 1 
Hypotension 1.899 1 
Thrombocytopenia 1.064 1 
Low CRP 1.710 1 
Constant - 3.576 
Score 2.346 
Probability 0.913 
 
Table 3.3.1.11. Scoring algorithm for a confirmed non-dengue case (R269) 
 
Predictor 
Weighting 
(LR Coefficient = B) 
Score 
(0 = no, 1 = yes) 
Antibiotics pre-admission 0.533 0 
Rigors 0.394 1 
Flushing 1.255 0 
Conjunctival suffusion - 0.923 0 
Sore throat - 0.893 0 
Dysgeusia 1.067 0 
Hypotension 1.899 0 
Thrombocytopenia 1.064 0 
Low CRP 1.710 1 
Constant - 3.576 
Score -1.652 
Probability 0.161 
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Although the maximum and minimum probabilities generated appear impressive, a 
cut-off for the probability needs to be identified that will give acceptable levels of 
both sensitivity and specificity for a clinical prediction rule. This is unlikely to be the 
intuitive level of 0.5 and so an appropriate cut-off was sought using ROC curve 
analysis. Using the LR coefficients produced (labelled as “B” values in the tables 
shown), probabilities were calculated and used to construct ROC curves for the 
original data and each of the 5 imputations. All ROC curves for the imputed datasets 
were similar and so one was chosen at random (Imputation 1) for further analysis. 
The ROC curves for the original data and this imputed data set are shown in Figures 
3.3.1.1 and 3.3.1.2. 
 
Figure 3.3.1.1. ROC curve for diagnosing dengue from nine selected variables using 
the original data set 
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Figure 3.3.1.2. ROC curve for diagnosing dengue from nine selected variables using 
an imputed data set 
 
 
  
Examination of the pivot table co-ordinates for these ROC curves shows that the 
following cut-offs will produce the following sensitivities and specificities : 
 
Original Data : 
 
Cut-Off = 0.0826511 : Sensitivity = 0.952 : Specificity = 1 – 0.587 = 0.413 
Cut-Off = 0.5365252 : Sensitivity = 0.492 : Specificity = 1 – 0.048 = 0.952 
 
Imputation 1 Data : 
 
Cut-Off = 0.0679869 : Sensitivity = 0.956 : Specificity = 1 – 0.593 = 0.407 
Cut-Off = 0.1169457 : Sensitivity = 0.905 : Specificity = 1 – 0.475 = 0.525 
Cut-Off = 0.1831002 : Sensitivity = 0.803 : Specificity = 1 – 0.295 = 0.705 
 -138- 
Cut-Off = 0.2786798 : Sensitivity = 0.715 : Specificity = 1 – 0.206 = 0.794 
Cut-Off = 0.3643906 : Sensitivity = 0.628 : Specificity = 1 – 0.127 = 0.873 
Cut-Off = 0.5064733 : Sensitivity = 0.482 : Specificity = 1 – 0.050 = 0.950 
 
None of these probability cut-offs have both the sensitivity and specificity required 
for use in diagnosing dengue. However, the sensitivity and specificity values shown 
above indicate that the probability score for an individual patient based on this 
scoring system could offer some diagnostic information if taken in conjunction with 
other information available for that patient (but is not sufficiently accurate to form 
the basis of a diagnosis on its own).  
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3.3.2 Clinical Prediction Rule for the Diagnosis of Chikungunya 
 
Variables recorded on admission that were potential predictors for a confirmed 
diagnosis of chikungunya were first subjected to univariate analysis. This included 
the use of Pearson’s chi square test, Fisher’s exact test and odds ratios for categorical 
variables and Student’s independent samples t-test (with 2-tailed significance and 
Levene’s test) for continuous variables. Using these tests the following variables 
were found to have unadjusted associations (p < 0.05) with chikungunya : 
 
 • Increasing population density • Decreasing education 
 • Drinking water from a tap  • No antibiotics before admission 
 • Early presentation to hospital • Temperature 
 • Continuous fever pattern  • Rigors 
 • Flushing    • Conjunctival suffusion 
 • Lack of sore throat   • Lack of dysgeusia 
• Headache    • Lack of dyspnoea 
 • Lack of cough   • Lack of abdominal pain 
 • Myalgia    • Arthralgia 
 • Lack of anaemia   • Decreasing ESR 
 • Decreasing CRP 
 
However, there was apparent overlap between these variables and so multivariate 
analysis using logistic regression was performed. Unfortunately, the use of complete 
case methodology led to 48.0% of all cases being excluded due to missing values and 
hence concerns regarding the representativeness of this analysis. Even when 
variables with >10% missing values were excluded, there were still >20% of all 
cases excluded from this type of analysis. Although these analyses of complete cases 
may have identified adjusted associations that were correct, there are also ethical 
issues regarding the omission of such a large amount of patient data. 
 
Therefore a multiple imputation method was used with 5 iterations, which allowed 
the logistic regression to be repeated on the imputed data set (which then included 
100% of cases). This identified some variables (occurrence of an eschar, conjunctival 
haemorrhage, myocarditis, haemoptysis, neurological signs or admission to ITU) 
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with no occurrences in the chikungunya cohort and so cases with these features were 
excluded from the remainder of this analysis (leaving 580 cases to be analysed) and 
so too were these variables themselves. These clinical features could be used to 
exclude chikungunya in this cohort of patients, but only occurred rarely (eschar in six 
cases, conjunctival haemorrhage in 4, myocarditis in four, haemoptysis in 16, 
neurological signs in one and admission to ITU in 11). Some of these features may 
have occurred with a larger sample size and would then have been included in the 
logistic regression. 
 
The results of the final logistic regression on the imputed data sets are shown in 
Tables 3.3.2.1 and 3.3.2.2. In Table 3.3.2.1 the first row (labelled “Original data”) 
shows that only 304 (52%) of the remaining 580 cases from the original data set 
would have been included in this analysis, compared to 100% of cases in the imputed 
datasets. In Table 3.3.2.2 the third column (labelled “S.E”) shows that very few 
variables in the pooled imputation analysis had very high standard errors in this 
analysis, which indicated that the model was stable. 
 
Table 3.3.2.1. Classification table for logistic regression of all chikungunya 
predictors 
 
 
 -141- 
 
Table 3.3.2.2. Logistic regression for full adjusted model for chikungunya 
 
 
 
 
 
As shown in Table 3.3.2.1 this full adjusted model has a sensitivity of 76.4% and a 
specificity of 97.6% for identifying chikungunya cases with the original data set, but 
sensitivities of 46.1 – 56.9% and specificities of 95.8 – 96.4% with the imputed data 
sets. However, these figures are based on a probability estimate for chikungunya of 
0.5 (50%), which may not be optimal for maximising both sensitivity & specificity. 
Comparing these figures for the original and imputed data sets indicates that there 
was bias towards improved sensitivity in the original data set. 
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Although sensitivity and specificity figures are important, they are not as useful 
clinically as positive predictive value (PPV) and negative predictive value (NPV). 
For the original data set the PPV was 42 / (42 + 6) = 87.5% and the NPV was 243 / 
(243 + 13) = 94.9%. For the first imputed data set the PPV was 56 / (56 + 20) = 
73.7% and the NPV was 457 / (457 + 47) = 90.7%. The results for the other four 
imputed data sets were virtually identical and so are not reported. 
 
The following nine variables (measured on admission) were identified from Table 
3.3.2.2 as independent predictors of chikungunya with AORs that had a significance 
of P < 0.1 : 
 
    • Age (years) → positive association 
    • Male (0 = no, 1 = yes) → positive association 
    • Piped Drinking Water (0 = no, 1 = yes) → positive association 
    • Delayed Presentation (days from onset to admission) → negative association 
    • Temperature (°C) → positive association 
    • Dysgeusia (0 = no, 1 = yes) → negative association 
    • Headache (0 = no, 1 = yes) → positive association 
    • Arthralgia (0 = no, 1 = yes) → positive association 
    • CRP (mg/L) → negative association 
 
These variables were then used together in a repeat logistic regression that produced 
the results shown in Table 3.2.2.3 and 3.2.2.4.  
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Table 3.3.2.3. Classification table for logistic regression of selected chikungunya 
predictors 
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Table 3.3.2.4. Logistic regression for parsimonious adjusted model for chikungunya 
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As shown in Table 3.3.2.3 this parsimonious adjusted model has a sensitivity of 
41.1% and a specificity of 95.0% for identifying chikungunya cases with the original 
data set, but sensitivities of 34.3 – 42.2% and specificities of 94.8 – 95.4% with the 
imputed data sets. The pooled results in Table 3.3.2.4 show that one of the variables 
used (Male) no longer has an AOR with P < 0.05 in this model, but this was retained 
in the model as the intention at this stage was to identify all factors independently 
associated with dengue (and so a more relaxed P value of < 0.1 was adopted for this 
part of the analysis). 
 
Continuous variables are more difficult to use in clinical prediction rules and so 
those for age, delayed presentation, temperature and CRP on admission were 
considered for conversion into dichotomised variables by producing frequency and 
scatter plots and also by considering clinically relevant break-points. The resulting 
charts did not suggest any obvious break-point for dichotomisation of these variables 
and it would not be valid or useful to simply choose a mean or median value. Also 
from a clinical perspective there are no obvious break-points for age, delayed 
presentation and temperature. A break-point for CRP is more valid because (as 
shown in Section 3.2.15) a value of ≤12 mg/L would be expected in viral infections 
such as dengue. Therefore this was the only continuous variable to be converted into 
a dichotomised variables using the rule shown : 
 
    • CRP ≤12 mg/L = Low CRP (0 = no, 1 = yes) → positive association 
 
The logistic regression was then repeated with this replacement variable to produce a 
parsimonious adjusted model using mostly categorical variables and the other three 
continuous variables for chikungunya as shown in Tables 3.3.2.5 and 3.3.2.6.  
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Table 3.3.2.5. Classification table for logistic regression of selected chikungunya 
predictors (updated) 
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Table 3.3.2.6. Logistic regression for parsimonious adjusted model for chikungunya 
(updated) 
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As shown in Table 3.3.2.5 this updated parsimonious adjusted model has a 
sensitivity of 35.6% and a specificity of 95.3% for identifying chikungunya cases 
with the original data set, but sensitivities of 29.4 – 35.0% and specificities of 94.4 – 
95.4% with the imputed data sets. For the original data set the PPV was 32 / (32 + 
20) = 61.5% and the NPV was 402 / (402 + 58) = 87.4%. For the first imputed data 
set the PPV was 36 / (36 + 24) = 60.0% and the NPV was 453 / (453 + 67) = 87.1%. 
The results for the other four imputed data sets were virtually identical and so are not 
reported. A summary of the diagnostic performance of the chikungunya prediction 
rule during its evolution is shown in Table 3.3.2.7. 
 
Table 3.3.2.7. Diagnostic performance of the chikungunya prediction rule 
 
 
Full Model 
using 
Original Data 
Full Model 
using 
Imputed Data 
Final Model 
using 
Original Data 
Final Model 
using 
Imputed Data 
Sensitivity 
(95% CI) 
76.4% 
(63.7–85.6%) 
54.4% 
(44.8–63.7%) 
35.6% 
(26.4–45.8%) 
35.0% 
(26.4–44.5%) 
Specificity 
(95% CI) 
97.6% 
(94.8–98.9%) 
95.8% 
(93.6–97.3%) 
95.3% 
(92.8–96.9%) 
95.0% 
(92.6–96.6%) 
PPV 
(95% CI) 
87.5% 
(75.3–94.1%) 
73.7% 
(62.8–82.3%) 
61.5% 
(48.0–73.5%) 
60.0% 
(47.4–71.4%) 
NPV 
(95% CI) 
94.9% 
(91.5–97.0%) 
90.7% 
(87.8–92.9%) 
87.4% 
(84.0–90.1%) 
87.1% 
(84.0–89.7%) 
LR+ 
(95% CI) 
31.691 
(14.183–70.813) 
12.967 
(8.153–20.624) 
7.502 
(4.504–12.496) 
6.947 
(4.339–11.121) 
LR– 
(95% CI) 
0.242 
(0.151–0.390) 
0.476 
(0.385–0.589) 
0.677 
(0.579–0.790) 
0.685 
(0.594–0.790) 
 
Using this parsimonious model with the original data set would enable more 
complete cases to be included (512 / 617 = 83% compared to 304 / 617 = 49% for 
the full model shown in Table 3.3.2.1). However, this would still leave 17% of cases 
with missing data and so the imputation approach remains appropriate. Two of the 
variables used (Age and Male) no longer have AORs with P < 0.05 in this model, but 
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these were retained in the model as the intention at this stage was to identify all 
factors independently associated with dengue (and so a more relaxed P value of < 0.1 
was adopted for this part of the analysis). 
 
Overall this updated model will be easier to use (since one of the continuous 
variables has been converted to a dichotomous variable), but has decreased accuracy 
compared to the original parsimonious model (in which CRP was kept as a 
continuous variable). Therefore the updated model was chosen for construction of a 
scoring algorithm and further analysis using ROC curves. 
 
The scoring algorithm was constructed as described previously (Section 2.3.1) using 
the LR coefficients (labelled “B”) for the pooled imputation data set shown in Table 
3.3.2.6. The scores for theoretical cases with the highest and lowest probabilities for 
having dengue are shown in Tables 3.3.2.8 and 3.3.2.9. The scores for the first 
confirmed chikungunya case (R269) and a confirmed non-chikungunya case (R006 
who had dengue) are shown in Tables 3.3.2.10 and 3.3.2.11. 
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Table 3.3.2.8. Scoring algorithm for chikungunya showing highest probability 
 
Predictor 
Weighting 
(LR Coefficient = B) 
Score 
(0 = no, 1 = yes) 
Age (years) 0.017 90 
Male 0.478 1 
Piped drinking water 0.778 1 
Delayed presentation (days) - 0.272 0 
Temperature (°C) 0.418 41.0 
Dysgeusia - 1.726 0 
Headache 1.119 1 
Arthralgia 1.803 1 
Low CRP 0.994 1 
Constant - 20.489 
Score 3.351 
Probability 0.966 
 
Table 3.3.2.9. Scoring algorithm for chikungunya showing lowest probability 
 
Predictor 
Weighting 
(LR Coefficient = B) 
Score 
(0 = no, 1 = yes) 
Age (years) 0.017 16 
Male 0.478 0 
Piped drinking water 0.778 0 
Delayed presentation (days) - 0.272 21 
Temperature (°C) 0.418 38.0 
Dysgeusia - 1.726 1 
Headache 1.119 0 
Arthralgia 1.803 0 
Low CRP 0.994 0 
Constant - 20.489 
Score - 11.771 
Probability 0.000 
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Table 3.3.2.10. Scoring algorithm for a confirmed chikungunya case (R269) 
 
Predictor 
Weighting 
(LR Coefficient = B) 
Score 
(0 = no, 1 = yes) 
Age (years) 0.017 34 
Male 0.478 0 
Piped drinking water 0.778 1 
Delayed presentation (days) - 0.272 2 
Temperature (°C) 0.418 38.9 
Dysgeusia - 1.726 0 
Headache 1.119 1 
Arthralgia 1.803 1 
Low CRP 0.994 1 
Constant - 20.489 
Score 0.4992 
Probability 0.622 
 
Table 3.3.2.11. Scoring algorithm for a confirmed non-chikungunya case (R006) 
 
Predictor 
Weighting 
(LR Coefficient = B) 
Score 
(0 = no, 1 = yes) 
Age (years) 0.017 37 
Male 0.478 0 
Piped drinking water 0.778 0 
Delayed presentation (days) - 0.272 5 
Temperature (°C) 0.418 38.3 
Dysgeusia - 1.726 1 
Headache 1.119 1 
Arthralgia 1.803 1 
Low CRP 0.994 1 
Constant - 20.489 
Score - 3.0206 
Probability 0.047 
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Although the maximum and minimum probabilities generated appear impressive, a 
cut-off for the probability needs to be identified that will give acceptable levels of 
both sensitivity and specificity for a clinical prediction rule. This is unlikely to be the 
intuitive level of 0.5 and so an appropriate cut-off was sought using ROC curve 
analysis. Using the LR coefficients produced (labelled as “B” values in the tables 
shown), probabilities were calculated and used to construct ROC curves for the 
original data and each of the 5 imputations. All ROC curves for the imputed datasets 
were similar and so one was chosen at random (Imputation 1) for further analysis. 
The ROC curves for the original data and this imputed data set are shown in Figures 
3.3.2.1 and 3.3.2.2. 
 
Figure 3.3.2.1. ROC curve for diagnosing chikungunya from nine selected variables 
using the original data set 
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Figure 3.3.2.2. ROC curve for diagnosing chikungunya from nine selected variables 
using an imputed data set 
 
 
 
 
Examination of the pivot table co-ordinates for these ROC curves shows that the 
following cut-offs will produce the following sensitivities and specificities : 
 
Original Data : 
 
Cut-Off = 0.0698457 : Sensitivity = 0.956 : Specificity = 1 – 0.457 = 0.543 
Cut-Off = 0.5058091 : Sensitivity = 0.411 : Specificity = 1 – 0.047 = 0.953 
 
Imputation 1 Data : 
 
Cut-Off = 0.0808780 : Sensitivity = 0.951 : Specificity = 1 – 0.451 = 0.549 
Cut-Off = 0.0987251 : Sensitivity = 0.903 : Specificity = 1 – 0.392 = 0.608 
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Cut-Off = 0.1557211 : Sensitivity = 0.806 : Specificity = 1 – 0.277 = 0.723 
Cut-Off = 0.2476693 : Sensitivity = 0.709 : Specificity = 1 – 0.168 = 0.832 
Cut-Off = 0.3197581 : Sensitivity = 0.602 : Specificity = 1 – 0.126 = 0.874 
Cut-Off = 0.4210010 : Sensitivity = 0.505 : Specificity = 1 – 0.088 = 0.912 
Cut-Off = 0.4929564 : Sensitivity = 0.417 : Specificity = 1 – 0.050 = 0.950 
 
None of these probability cut-offs have both the sensitivity and specificity required 
for use in diagnosing chikungunya. However, the sensitivity and specificity values 
shown above indicate that the probability score for an individual patient based on 
this scoring system could offer some diagnostic information if taken in conjunction 
with other information available for that patient (but is not sufficiently accurate to 
form the basis of a diagnosis on its own). 
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3.4  Evaluation of Commercial Diagnostics Tests for Use in Sri Lanka 
 
Dengue and chikungunya were each responsible for >50 confirmed cases and so 
attempts were made to evaluate commercial diagnostic tests for these infections. This 
was done prospectively for dengue using a single rapid diagnostic serology test 
(Section 3.4.1) and then retrospectively with a larger number of serology and antigen 
detection tests (Section 3.4.2). Evaluation of a commercial diagnostic test for 
chikungunya was also done retrospectively (Section 3.4.3) because a suitably large 
number of cases had not been expected and there were no commercial diagnostic 
tests available until 2010. 
 
3.4.1  Prospective Use of a Commercial Diagnostic Test for Dengue 
 
The Panbio Dengue Duo Cassette proved simple to use, but equivocal results (where 
the bands were very faintly visible in bright light) were common despite repeat 
testing of samples when such results occurred (Figure 3.4.1). Using the IgM band as 
an indicator of acute infection produced the results shown for admission samples in 
Table 3.4.1.1 and follow-up samples in Table 3.4.1.2. The diagnostic indices are 
shown in Table 3.4.1.3 and these improved overall (especially the sensitivity) when 
equivocal results were considered as positives. 
 
Figure 3.4.1. Positive (+), weak/equivocal (w) and negative (-) bands on the Panbio 
Dengue Duo Cassette serology test used in this study 
 -156- 
Table 3.4.1.1. Results of the Panbio Dengue Duo Cassette on admission 
 
 Dengue Not Dengue Total 
Test Positive 39 29 68 
Test Equivocal 20 20 40 
Test Negative 77 390 467 
Test Not Done 1 41 42 
Total 137 480 617 
 
Table 3.4.1.2. Results of the Panbio Dengue Duo Cassette on follow-up 
 
 Dengue Not Dengue Total 
Test Positive 26 13 39 
Test Equivocal 11 8 19 
Test Negative 37 203 240 
Test Not Done 63 256 319 
Total 137 480 617 
 
Table 3.4.1.3. Diagnostic performance of the Panbio Dengue Duo Cassette 
 
 
POS v NEG 
(Admission) 
POS v NEG 
(Follow-Up) 
POS+EQ v NEG 
(Admission) 
POS+EQ v NEG 
(Follow-Up) 
Sensitivity 
(95% CI) 
33.6% 
(27.0–39.9%) 
41.3% 
(31.9%–49.1%) 
43.4% 
(36.7%–49.8%) 
50.0% 
(40.8%–58.1%) 
Specificity 
(95% CI) 
93.1% 
(91.2–94.8%) 
94.0% 
(91.2–96.3%) 
88.8% 
(86.8–90.8%) 
90.6% 
(87.6–93.3%) 
PPV 
(95% CI) 
57.4% 
(46.0–68.0%) 
66.7% 
(51.5–79.4%) 
54.6% 
(46.2–62.7%) 
63.8% 
(52.1–74.1%) 
NPV 
(95% CI) 
83.5% 
(81.9–85.1%) 
84.6% 
(82.1–86.7%) 
83.5% 
(81.6–85.4%) 
84.6% 
(81.8–87.1%) 
LR+ 
(95% CI) 
4.858 
(3.076–7.678) 
6.857 
(3.641–13.211) 
3.887 
(2.769–5.429) 
5.333 
(3.290–8.678) 
LR– 
(95% CI) 
0.713 
(0.634–0.801) 
0.625 
(0.528–0.747) 
0.637 
(0.553–0.730) 
0.552 
(0.449–0.676) 
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Combining positive and equivocal results for the admission results correctly 
classified seven (77.8%) of nine primary infections and 28 (66.7%) of 42 secondary 
infections. Using the same approach for follow-up results led to correct 
classifications in three (30.0%) of 10 primary infections and 24 (92.3%) of 26 
secondary infections. 
 
In confirmed dengue cases a down-grading of the IgM result on the Panbio Dengue 
Duo Cassette was noted between admission and follow-up samples. From 24 cases 
who were IgM positive on admission and also provided follow-up samples, there 
were 10 (41.7%) who became IgM negative and four (16.7%) who became IgM 
equivocal. Similarly, from 13 cases who were IgM equivocal on admission, there 
were eight (61.5%) who became IgM negative. 
 
3.4.2  Retrospective Use of Commercial Diagnostic Tests for Dengue 
 
From the 259 cases used in this evaluation, there were 99 (38.2%) with a confirmed 
diagnosis of acute dengue infection based on reference serology tests. The diagnostic 
performance of the commercial assays compared to the reference AFRIMS serology 
assays are shown in Table 3.4.2. 
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Table 3.4.2. Diagnostic performance of commercial dengue assays 
 
Assay 
Type 
Assay 
Brand 
Sensitivity 
 (95% CI) 
Specificity 
 (95% CI) 
PPV 
 (95% CI) 
NPV 
(95% CI) 
IgM 
Antibody 
Detection 
 
Biosynex 
79.8% 
(71-87%) 
46.3% 
(38-54%) 
49.9% 
(40-56%) 
78.7% 
(69-87%) 
 
Merlin 
72.7% 
 (63-81%) 
73.8% 
(66-80%) 
63.2% 
(54-72%) 
81.4% 
(74-87%) 
 
Panbio 
70.7% 
(61-79%) 
80.0% 
(73-86%) 
68.6% 
(59-78%) 
81.5% 
(75-87%) 
Standard 
Diagnostics 
79.2% 
(71-87%) 
89.4% 
(84-94%) 
82.3% 
(73-89%) 
87.7% 
(82-92%) 
NS1 
Antigen 
Detection 
 
Bio-Rad 
58.6% 
(48-68%) 
98.8% 
(96-100%) 
96.7% 
(86-100%) 
79.4% 
(73-85%) 
 
Panbio 
58.6% 
(48-68%) 
92.5% 
(87-96%) 
82.9 
(72-91%) 
78.3% 
(72-84%) 
Standard 
Diagnostics 
48.5% 
(39-59%) 
99.4% 
(97-100%) 
98.0% 
(89-100%) 
75.7% 
(69-81%) 
Combined 
IgM & NS1 
Detection 
 
Panbio 
89.9% 
(82-95%) 
75.0% 
(68-82%) 
69.0% 
(60-77%) 
92.3% 
(86-96%) 
Standard 
Diagnostics 
92.9% 
(84-97%) 
88.8% 
(83-93%) 
83.6% 
(75-90%) 
95.4% 
(91-98%) 
 
Further analysis showed that IgM detection in dengue cases increased from 0% on 
the first day of illness to 90% on the 10th day, whereas NS1 detection decreased 
from 100% on the first day of illness to 20% on the 10th day (Blacksell et al., 
2011b). This explains why the diagnostic performance of the combined IgM & NS1 
detection tests was superior to that of each separate test. 
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3.4.3  Retrospective Use of a Commercial Diagnostic Test for Chikungunya 
 
From the 292 paired samples used in this evaluation, there were 52 (17.8%) with a 
confirmed diagnosis of acute chikungunya infection based on reference serology & 
RT-PCR tests. The diagnostic performance of the commercial Standard Diagnostics 
(SD) assays and the reference AFRIMS serology and RT-PCR assays are shown in 
Table 3.4.3. 
 
Table 3.4.3. Diagnostic performance of commercial chikungunya assays 
 
 
Assay 
 
Sample 
(n=292) 
Sensitivity 
(Cases/Total) 
(95% CI) 
Specificity 
(Cases/Total) 
(95% CI) 
PPV 
(Cases/Total) 
(95% CI) 
NPV 
(Cases/Total) 
(95% CI) 
 
SD 
IgM ICT 
 
Acute 
 
3.9% 
(2/52) 
(0-13%) 
95.0% 
(228/240) 
(91-97%) 
14.3% 
(2/14) 
(2-43%) 
82.0% 
(228/278) 
(77-86%) 
 
SD 
IgM ELISA 
 
Acute 
 
3.9% 
(2/52) 
(0-13%) 
92.5% 
(222/240) 
(88-96%) 
10.0% 
(2/10) 
(1-32%) 
81.6% 
(222/272) 
(77-86%) 
 
SD 
IgM ELISA 
 
Convalescent 
 
84.1% 
(44/52) 
(72-93%) 
91.3% 
(219/240) 
(87-95%) 
67/7 
(44/65) 
(55-79%) 
96.5 
(219/227) 
(93-99%) 
 
AFRIMS 
HAI 
 
Acute 
 
21.2% 
(11/52) 
(11-35%) 
95.0% 
(228/240) 
(92-98%) 
47.8% 
(11/23) 
(27-69%) 
84.8% 
(228/269) 
(80-89%) 
 
AFRIMS 
IgM EIA 
 
Acute 
 
21.2% 
(11/52) 
(11-35%) 
95.4% 
(229/240) 
(92-98%) 
50.0% 
(11/22) 
(28-72%) 
84.8% 
(229/270) 
(80-89%) 
 
AFRIMS 
RT-PCR 
 
Acute 
 
88.5% 
(46/52) 
(77-96%) 
100% 
(0/240) 
(99-100%) 
100% 
(46/46) 
(92-100%) 
97.5% 
(238/244) 
(95-99%) 
 
 -160- 
Further analysis confirmed that IgM detection in chikungunya cases by the 
commercial tests was very poor within the first week of illness even when compared 
to the AFRIMS serology tests (Blacksell et al. 2011a). The high sensitivity of the 
AFRIMS RT-PCR for acute samples suggests that more direct diagnostic methods 
(such as antigen detection) could also be useful in diagnosing acute chikungunya 
infection. 
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4.  Discussion 
 
This study was partly successful in achieving its three aims (Section 1.1.1) : 
 
1. The causes of febrile illness were identified in 62.8% of a representative sample of 
patients admitted to hospital over a 1-year period and this was despite the large 
number of different diseases identified, a follow-up rate of 48.6% that compromised 
paired serology tests and non-optimised tests for leptospirosis and rickettsial 
infections. 
 
2. Clinical prediction rules were developed that could diagnose the most common 
infections found (dengue and chikungunya), but these had low sensitivity (or low 
specificity if the probability cut-off was adjusted to improve sensitivity). 
 
3. A rapid (point-of-care) diagnostic test for dengue fever was evaluated and found to 
have low sensitivity in acute samples, but this improved when the test was later 
repeated in conjunction with a new dengue antigen detection test. A chikungunya 
diagnostic test was also evaluated later and a collection of serum samples with 
confirmed diagnoses and extensive clinical data is available for future use. 
 
4.1  Patient Recruitment, Data Collection & Sample Collection 
 
Considerable efforts were made to ensure that this study was as representative as 
possible and patient recruitment ran smoothly over the 1-year period. The only 
exception to this was a 2-week period in April when monthly recruitment was 
reduced by ~28 cases (47.5%) compared to adjacent months (Table 3.1.1). Overall 
86.8% of all eligible patients were recruited with no sex or age bias, from both urban 
and rural areas and the distribution of cases within Gampaha District (Figure 3.1.2.2) 
was similar to that of the population as a whole (Figure 3.1.2.3). However, febrile 
patients were significantly younger and more likely to be male (Section 3.1.1) and 
this sex bias has been reported in most previous fever studies from Asia [Murdoch et 
al., 2004; Wagenaar et al., 2004; Suttinont et al., 2006; Joshi et al., 2008; Chrispal et 
al. 2010]. It may be that younger males have less immunity and greater exposure to 
the most common infections (dengue, chikungunya and leptospirosis) found in this 
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part of Sri Lanka. However, it is also possible that older females are less likely to 
present to hospital with febrile illness and a community-based study would be 
necessary to assess this. 
 
Although only 6.4% of all medical admissions had febrile illnesses, this number 
varied from 31 to 117 on a monthly basis, which accounts for most of the monthly 
variation in medical admissions. Not surprisingly, there were more admissions 
during and immediately after the rainy seasons (Figure 3.1.1.2) probably due to an 
increased risk of dengue, chikungunya and leptospirosis transmission. At such times 
the hospital resources became dangerously over-stretched and improving the 
effectiveness and efficiency of the management of febrile illnesses would help 
matters considerably.  
 
Data collection proceeded smoothly and the Ragama Fever Study database of 
demographic, clinical, laboratory and diagnostic data may prove to be the greatest 
legacy of this study. Complex searches are easily performed and the results can then 
be exported to various statistical software packages for analysis. With 403 fields and 
617 patient records there is great potential for further exploration of various 
epidemiological, clinical and diagnostic issues. The discovery that 48.0% of cases 
would have to be excluded from multiple logistic regression analyses (Sections 3.3.1 
& 3.3.2) due to missing values was a great surprise considering how complete the 
data collection and entry appeared to be. This is partly explained by the large number 
of variables involved and the inclusion of laboratory results that were not performed 
on all patients as part of the study. (For example, it was expected that all febrile 
patients would have a full blood count, urea & electrolytes and liver function tests 
performed as part of their routine care, but this was not the case.) Using a smaller 
number of variables focussed on a smaller number of diseases would help to avoid 
missing values, but this study was always intended to be wide-ranging so that future 
studies could be more focussed. 
 
Sample collection, processing and transportation also proceeded smoothly despite 
numerous logistical challenges. Admission blood samples were collected in 88.3–
98.2% of cases, but collecting admission urine samples was only possible in 76.5% 
of cases since this required greater patient compliance (Table 3.1.3). Despite 
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maximal efforts the follow-up rate for patients was only 48.6% and ultimately paired 
samples for serology were available in 47.8% of cases. These figures are similar or 
superior to those described in previous studies of this type in Asia, for example 32-
51% in Vietnam [Wagenaar et al., 2004] and 13% in Nepal [Murdoch et al., 2004]. 
Having such a low rate of follow-up and paired serum samples could lead to bias 
against diagnoses that resolve rapidly and completely and which require paired 
serology tests for diagnosis. Four sets of identical samples were produced for 
distribution to various international reference laboratories and one set was reserved 
for future studies in Sri Lanka. 
 
4.2  Diagnoses 
 
This study was successful in showing the wide range of infectious diseases that 
present with febrile illnesses in western Sri Lanka. Most cases (62.8%) had 
confirmed diagnoses, which is a reasonable result since the most common infections 
(dengue, chikungunya and leptospirosis) were mostly diagnosed from paired 
serology samples, which were only available in 47.8% of patients recruited. This 
confirmation rate is similar or superior to those described in previous studies of this 
type in Asia, for example 68% in Thailand [Suttinont et al., 2006], 48% on the Thai-
Burmese border [Ellis et al., 2006] and 37% in Nepal [Murdoch et al., 2004]. 
 
In retrospect it would have been useful to test for influenza and other viral and 
atypical respiratory infections because there was a marked increase in undiagnosed 
febrile illnesses (mostly acute respiratory infections) for a month following the 
Sinhalese / Tamil New Year on 14 April 2007. At this time of year people travel 
widely in Sri Lanka to be with their extended families and April to July is recognised 
as the time when most cases of influenza and other acute respiratory infections occur 
[Perera et al., 2010], which also corresponds to one of the rainy seasons in the south-
western “wet” zone of Sri Lanka (Figure 3.1.1.3). 
 
Other viruses were not universally tested for because they were not expected to occur 
in adults presenting to hospital (eg. measles, mumps, rubella, EBV, CMV and HAV) 
or because their prevalence was known to be low in Sri Lanka at the time of the 
study (eg. HBV, HCV and HIV infection) as described in Section 1.2.14. Only a 
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single patient with previously-diagnosed HIV was recruited and subsequently 
diagnosed as having pancreatitis with no infectious cause identified in the study. One 
other patient with known HIV was admitted to the medical wards used during the 
study period, but was not febrile. Both patients had previously worked and been 
sexually active in the Middle East. Two of the study patients were tested for HIV 
infection by the local consultant physicians as part of their routine care and both 
were found to be negative. 
 
Universal testing for filariasis was not included in this study for several reasons. 
Acute filariasis usually presents with obvious lymphatic or genital involvement 
rather than just an undifferentiated febrile illness. In Sri Lanka, brugian filariasis was 
previously found in certain parts of the North-Western, Eastern and Southern 
Provinces, whereas bancroftian filariasis was found in a narrow strip along the south-
western coastline [Sasa, 1976]. However, vector control and mass drug 
administration with diethylcarbamazine (DEC) have now led to complete elimination 
of Brugia malayi [Gautamadasa, 1986] and a marked reduction in the prevalence of 
Wuchereria bancrofti [Wijegunawardana, 2012]. Universal laboratory testing of 
patients in this study with microfilarial blood films or DEC provocation tests would 
have been laborious in such a large number of patients and serology tests are not able 
to distinguish between acute and previous infections. There is a filarial antigen test 
available in an immuno-chromatic test (ICT) format, but patients are known to 
remain antigen positive for years after apparently successful treatment [Schuetz et 
al., 2000] and so a positive result is not necessarily indicative of an acute infection. 
Therefore filariasis was not routinely tested for and no suspected cases were admitted 
during the study period. 
 
No confirmed, indigenous malaria cases were identified in this study and there were 
also no confirmed (or suspected) cases of brucellosis or JEV infection. As described 
earlier, these have been significant causes of undifferentiated febrile illness in Sri 
Lanka in the past. However, they do not appear to have been a significant problem in 
Gampaha District during this study and so will not be discussed further. 
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4.2.1  Bacteraemias 
 
Bacteraemia was found in only 4.2% of patients despite using two blood culture 
systems in parallel. There was no significant difference in culture positivity between 
the in-house bottles (IHBs) and BacT/ALERT bottles (BABs) despite the presence of 
antibiotic inhibitors in the latter. However, the contamination rate was significantly 
higher in the IHBs because the re-usable rubbers caps became damaged by repeated 
use. This has now led to a compromise solution in which non-reusable commercial 
bottles from a local supplier are used in the Department of Microbiology. These 
should produce similar positive culture rates, with fewer contaminants and at 
minimal additional cost compared to the previous IHB system. 
 
There was excellent correlation between the work done at the University of Kelaniya 
and the University of Liverpool in identifying bacterial isolates and antibiotic 
sensitivities. The B. pseudomallei isolate was not identified locally due to known 
limitations with the microbial identification panels used [Inglis et al., 2005; Brent et 
al., 2007]. Cases of melioidosis continue to occur in Sri Lanka, but these are mostly 
reported in travellers who have the diagnosis made when they return to their 
countries of origin [Peetermans et al., 1999; Jayasekara et al., 2006; Hesstvedt et al., 
2011]. Although, there is a risk that cases of melioidosis will be undiagnosed or 
misidentified in Sri Lanka, other prospective studies have also found very few cases 
[Inglis et al., 2008]. 
 
Acquired antibiotic resistance was found in 23.1% of bacterial isolates and these 
included quinolone resistance in S. typhi (quinolone resistance), co-amoxiclav and 
ESBL resistance in E. coli and ESBL resistance in K. pneumoniae. These resistance 
profiles could easily spread in Sri Lanka due to a lack of microbiology services, 
over-use of empirical antibiotics in hospitals and misuse of antibiotics in the 
community. For example, azithromycin was being heavily marketed for a wide range 
of infections (including upper respiratory tract infections) during the study period 
and was easily purchased over-the-counter from local pharmacies. The problem of 
antimicrobial resistance in Asia has reached prominence recently with the spread of 
New Delhi metallo-β-lactamase-1 (NDM-1) carbapenemase [Khan & Nordmann, 
2012] and ESBLs such CTX-M-15 [Wickramasinghe et al., 2012] in E. coli and K. 
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pneumoniae. Awareness of the problem and the means of preventing it seem to be 
increasing in Asia [WHO, 2011], but the role of microbiology services in guiding the 
use of antibiotics and infection control is worthy of further emphasis. 
 
4.2.2  Tuberculosis 
 
TB was probably under-represented in this study due to the proximity of the 
(National) Chest Hospital at Welisara. However, in this 1-year study there were 17 
cases admitted to a quarter of the medical wards suggesting that there would be ~68 
cases per year admitted to the Colombo North Teaching Hospital as a whole. Most of 
the cases seen had acute presentations, which may explain why TB was not 
suspected initially. Although TB is not considered to be a major problem in Sri 
Lanka [WHO, 2008], it still represents a major socio-economic burden for 
individuals and their families in this country [Morton-Bailey, 2010]. 
 
4.2.3  Leptospirosis 
 
Although there were only 32 leptospirosis cases confirmed on gold standard 
investigations (culture or MAT serology), there were a further nine with equivocal 
serology results and another eight who were diagnosed clinically but not adequately 
investigated. Considering these diagnostic and sampling problems and also the fact 
that at least 43.0% of patients took antibiotics before admission, the true number of 
leptospirosis cases was probably significantly higher. These issues greatly impede 
the systematic study of leptospirosis in Sri Lanka, but could be partly overcome by 
using local Leptospira isolates in future MAT serology tests and an appropriate PCR 
test on admission. 
 
MAT serology is known to have low sensitivity even with paired serum samples and 
is also unreliable at predicting the infecting Leptospira serovar in cases where an 
isolate is also obtained for further identification by CAAT [Smythe et al., 2009]. 
This is often thought to be due to differences between the Leptospira serovars used 
in the MAT and those causing disease in a particular area. Therefore the use of 
region-specific or even patient-specific isolates have been recommended, but 
sometimes this seems to make little difference [Murray et al., 2011]. There are now 
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several established PCR tests for diagnosing leptospirosis [Agampodi et al., 2012] 
and although one might think that PCR testing would be difficult in developing 
countries, it can be easier to provide than leptospire culture and MAT serology 
facilities. 
 
The identification of Leptospira isolates in this study was done using CAAT and 
MLST because the panel of serovars used in the MAT serology (performed in the 
UK) was not optimised for use in diagnosing leptospirosis from Sri Lanka. Although 
13 (76.5%) of the 17 isolates were L. interrogans serovar Pyrogenes (Clonal 
Complex 12 on MLST), there were composed of four different sequence types (ST 
49, 74, 75, 76) suggesting a stable endemic situation rather than an epidemic 
situation due to a single dominant clone. The remaining four isolates included two L. 
interrogans and two L. borgpetersenii, which were all undesignated with regard to 
serovar and two of these seem to be unique to Sri Lanka according to the MLST 
database (http://leptospira.mlst.net). 
 
From the 32 confirmed cases it was possible to describe clinical and laboratory 
features (Table 3.2.6.3) for comparison with those reported previously in Sri Lanka 
(Tables 1.2.7.1 & 1.2.7.2). Earlier studies in Sri Lanka specifically recruited 
suspected leptospirosis cases based on the most characteristic features of the disease 
(eg. icterus and conjunctival suffusion) and so it is not surprising that these features 
were more common in their case series [Rajasuriya et al., 1964; Ramachandran et 
al., 1974]. The clinical and laboratory features found in my study (Table 3.2.6.3) 
suggest that the most characteristic features are less common if all febrile patients are 
recruited as this will reveal the full spectrum of disease caused by leptospirosis. Mild 
cases (possibly modified by pre-hospital antibiotic use) were often not suspected to 
be leptospirosis during this study despite the patient having significant risk factors 
for the disease. At the other end of the disease spectrum, leptospirosis was 
responsible for all ITU admissions, 35.7% of deaths with a mean age of 37.6 years 
compared to 73.8 years for deaths from other causes. 
 
Even with only 32 confirmed leptospirosis cases (and possibly 17 unidentified cases 
in the control group) it was possible to prove a significant unadjusted association 
between leptospirosis and proteinuria on admission for patients in this study (Section 
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3.2.15). However, further statistical analysis will first require improved diagnostics 
to correctly identify true leptospirosis cases as described above. Although there is an 
emphasis on using gold standard laboratory diagnostics in studies such as this, there 
is also increasing recognition that using reference tests with such high specificities 
and low sensitivities represents a sort of “fool’s gold” [Limmathurotsakul et al., 
2012]. Mathematical modelling using Bayesian latent class models enables the 
accuracy of diagnostic tests to be evaluated without the assumption that a gold 
standard reference test is perfect [Pan-Ngum et al., 2012]. The leptospirosis data 
(especially the IgM ELISA screening test and equivocal MAT serology results) in 
this study may well benefit from being re-assessed in this way. 
 
Identifying more leptospirosis cases using non-gold standard tests and mathematical 
modelling would enable more samples from this study to be used for evaluating 
diagnostic tests in the future. The latest commercial serology test for leptospirosis 
(the Panbio Leptospira IgM ELISA) is reported to have only 76.1% sensitivity and 
82.6% specificity [Desakorn et al., 2012] and this would need to be re-evaluated 
using local samples before it could be recommended for use in Sri Lanka. 
 
4.2.4  Q Fever 
 
Acute Q fever was diagnosed in 17 (2.8%) patients using serology tests at the highly-
respected WHO reference laboratory in Marseilles, France. The definition of acute Q 
fever included patients who had anti-phase II antibody titres that were ≥200 for IgG 
and ≥50 for IgM at any time. My subsequent experience of managing >60 acute Q 
fever cases from the point of seroconversion onwards [Bailey et al., 2011 & 
unpublished data] shows that nearly all acute cases are sero-negative on admission 
(but then seroconvert after ~2 weeks) and the titres used in the Marseilles definition 
are often found for up to six months after acute Q fever infection. Therefore this 
definition for acute Q fever is probably over-sensitive for clinical studies such as 
mine and this is also suggested by the findings that 50.0% of Q fever cases identified 
had co-infections and only 23 previous Q fever cases were identified compared to 18 
active cases (despite the fact that previous infections are usually identifiable years 
later). A recent publication using the same serology and definitions reported acute Q 
fever in three (1.6%) patients suspected of having rickettsial infections in southern 
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Sri Lanka, but paired serology results were only available in one case [Angelakis et 
al., 2012]. Using additional tests (eg. Q fever PCR) or alternative Q fever serology 
assays (eg. validated commercial ones) would help to clarify this matter and these 
tests could be applied retrospectively to the Ragama Fever Study samples. 
 
4.2.5  Rickettsial Infections 
 
Rickettsial infections were diagnosed in 14 (2.3%) of patients and this was also 
based on serology tests only, which are an indirect method of diagnosis and can be 
negative at presentation and positive for weeks following an acute infection. Once 
again there was a high rate of co-infections (35.7%) and a large proportion of 
“probable” (possibly previous) infections (42.9%). Although the diagnosis of a R. 
conori subspecies indica infection was robust, the diagnosis of other rickettsial 
infections was uncertain. 
 
This was most obvious for scrub typhus because eschars are usually present and do 
not occur in the typhus fevers or spotted fever due to R. conorii sub-species indica 
[La Scola et al., 2009]. The Marseille scrub typhus serology showed low sensitivity 
and specificity for suspected cases with eschars and a previous study from the same 
laboratory did not find any cases of scrub typhus in central Sri Lanka [Nagalingam et 
al., 2009] even though scrub typhus had been reported there previously [Kularatne et 
al., 2003]. The Bangkok scrub typhus serology results correlated better with the 
presence or absence of eschars and combining the positive results from each 
laboratory would have identified all cases that presented with eschars. These 
discrepancies should be discussed between the two laboratories and it may be that 
there was variation in the antigens used and that these require optimisation for use in 
Sri Lanka. A recent study in southern Sri Lanka using the Marseille scrub typhus 
serology reported that this was the most common rickettsial infection found 
[Angelakis et al., 2012] and so it may be that the problem has been resolved already. 
In future more direct methods of diagnosis (eg. biopsy and PCR of eschars) should 
be used in parallel with serology to help clarify the diagnostic accuracy of reference 
and commercial serology tests for scrub typhus [Koh et al., 2010]. 
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The exact nature of the Rickettsia species causing spotted fever in Sri Lanka has been 
elusive because the necessary range of antigens to determine this have rarely been 
used. Only one other study from Sri Lanka has used a full range of spotted fever 
antigens (also from Marseille) and no cross-adsorption western blotting results were 
reported [Angelakis et al., 2012]. Other recent studies have identified spotted fever 
cases using undefined spotted fever antigens [Liyanapathirana & Thevanesam, 
2011], R. rickettsi (Rocky Mountain spotted fever) antigen [Reller et al., 2012b] or 
generic R. conorii antigen [Premaratna et al., 2010] only. The identification of a R. 
conorii subsp. indica in this study is a significant step forwards, but direct 
identification of the Rickettsia species responsible for spotted fever in Sri Lanka (by 
culture or PCR) is still necessary to optimise diagnostic tests for this rickettsial 
infection in this country. 
 
As well as using non-optimised diagnostic tests, other studies of rickettsial infection 
in Sri Lanka have usually recruited selected patients only using various clinical 
definitions (eg. those with a rash and/or eschar and/or prolonged fever and/or prompt 
response to doxycycline or chloramphenicol), which makes it difficult to assess the 
true frequency of these infections. However, a recently published study from 
southern Sri Lanka did perform rickettsial serology tests on a large group of 
unselected febrile patients over an eight-month period [Reller et al., 2012b]. This 
found that 17.7% of cases had acute rickettsioses of whom ~69% had a spotted fever, 
~23% had a typhus fever and ~7% had scrub typhus, but these unexpected results are 
difficult to interpret since the tests used were not optimised for Sri Lanka. Overall, 
there has been a consensus developing in previous papers that spotted fever is most 
common in the central highland areas and scrub typhus is most common in more 
coastal lowland areas, but even this is not certain due to the relatively poor quality of 
the studies performed so far. 
 
Rickettsial infections remain a significant cause of febrile illness in Sri Lanka and 
are very difficult to study due to a lack of optimised diagnostic tests. More detailed 
studies are required and in the meantime local clinicians should always consider this 
diagnosis in patients with undifferentiated febrile illnesses and consider empirical 
treatment with doxycycline, azithromycin or chloramphenicol. 
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4.2.6  Dengue 
 
Dengue is endemic in Sri Lanka, as shown by official notifications of cases (Tables 
1.2.10.1 & 3.1.2.5) and occurs all year round with peaks in the rainy seasons, as 
shown by the monthly frequencies of confirmed cases during this study (Figure 
3.1.1.3). All four genotypes were identified with a predominance of DENV-3 and 
DENV-2, which has also been the pattern in previous years [Kanakaratne et al., 
2009] since the emergence of a new DENV-3 genotype III (Indian sub-continent) 
clade in 2003 [Messer et al., 2003]. This clade is thought to have originated in East 
Africa, which is also known to be the source of the chikungunya epidemic that 
spread through the Indian Ocean area in 2006-8 [Staples et al., 2009]. DHF occurred 
in only four (2.9%) of the confirmed dengue infections and two of these were RT-
PCR with both identified as DENV-3. 
 
The diagnosis of dengue was greatly helped by the availability of validated serology 
tests and an RT-PCR test, which was especially useful when only acute/admission 
serum samples were available. Without the RT-PCR tests there would have been 
only 101 dengue cases (73.7%) identified instead of 137 (Section 3.2.9). 
 
There were 10 cases of dengue and chikungunya co-infection, which is not surprising 
since both are transmitted at the same time of year by the same Aedes albopictus 
mosquitoes and co-infections have been reported previously [Chang et al., 2010]. 
 
Overall the clinical and laboratory features on admission for confirmed dengue cases 
from this study (Table 3.2.9.3) are similar to previous reports in Sri Lanka [Kularatne 
et al., 2005; Malavige et al., 2006]. Although my data adds more detail, it also 
confirms the non-specific presentation of dengue compared to other undifferentiated 
febrile illnesses (eg. chikungunya and leptospirosis) in this part of Sri Lanka. This is 
why the clinical and laboratory features were subjected to multiple logistical 
regression analysis and a clinical prediction rule was developed (Section 3.3.1), 
which is discussed later (Section 4.3). A rapid diagnostic test for dengue that was 
suitable for use in Sri Lanka would also overcome this problem and one was 
evaluated in this study (Section 3.4.1), which is also discussed later (Section 4.4). 
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4.2.7  Chikungunya 
 
An outbreak of chikungunya began in Sri Lanka in 2006 with the most cases 
occurring during the rainy season in October – December 2006, as shown by the 
epidemic curve of confirmed cases during this study (Figure 3.1.1.4). Not 
surprisingly the CHIKV strain identified was identical to that found elsewhere in the 
Indian Ocean area from 2006-8 and very similar to that found there in 2005-7 and 
also similar to the Central Africa strains from which it is thought to have originated 
(Figure 3.2.11).  
 
The diagnosis of chikungunya was also greatly helped by the availability of validated 
serology tests and an RT-PCR test, which was especially useful when only 
acute/admission serum samples were available. Without the RT-PCR tests there 
would have been only 52 chikungunya cases (50.5%) identified instead of 103 
(Section 3.2.11). The apparently long viraemia of chikungunya makes it especially 
amenable to RT-PCR diagnosis. 
 
Persistent arthralgia for >2 weeks was found in 27 (52.9%) of 51 chikungunya cases 
who attended for follow-up, but there is likely to be some positive selection bias in 
this since people with persistent arthralgia would be more likely to attend. 
 
Overall the clinical and laboratory features on admission for confirmed chikungunya 
cases from this study (Table 3.2.11.2) are similar to previous reports from the Indian 
Ocean epidemic in 2004-8 [Staples et al., 2009; Burt et al., 2012]. Although my data 
adds some detail, it also confirms the non-specific presentation of chikungunya 
compared to other undifferentiated febrile illnesses (eg. dengue and leptospirosis) in 
this part of Sri Lanka. This is why the clinical and laboratory features were subjected 
to multiple logistical regression analysis and a clinical prediction rule was developed 
(Section 3.3.1), which is discussed later (Section 4.3). A rapid diagnostic test for 
chikungunya that was suitable for use in Sri Lanka would also overcome this 
problem and one was evaluated using the data and samples from this study at a later 
date, which is also discussed later (Section 4.4). 
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4.2.8  Hantavirus Infection 
 
Although 25 (8.5%) of 295 patients with paired samples had evidence of previous 
hantavirus infection using an IgG screening ELISA, this number fell to 18 (6.1%) 
when a serology gold standard IgG/IgM IFA was used and only six (2.0%) of these 
were also IgM ELISA positive of whom only one (0.3%) showed a greater than four-
fold increase in IFA titres to confirm an acute infection. Therefore hantavirus 
infection seems to be uncommon in this part of Sri Lanka, but the discovery by RT-
PCR of a possibly novel hantavirus related to THAIV is the first direct evidence of 
human hantavirus infection in Sri Lanka and also the first direct evidence of human 
infection with a THAIV-like hantavirus. This is of considerable scientific and 
medical interest and should help in choosing and designing hantavirus diagnostic 
tests for future use in Sri Lanka. 
 
The International Committee on the Taxonomy of Viruses (www.ictvonline.org) 
requires that new hantaviruses have a ≥7% difference in amino-acid identity 
compared with previously identified complete S and M segment gene sequences, a 
≥4-fold difference in the results of 2-way cross-neutralization tests using viral 
cultures, a unique ecologic niche such as a different primary rodent/insectivore 
reservoir and no natural re-assortants with other species [Plyusnin et al., 2011]. 
These are demanding criteria and not enough data is available for the hantavirus 
identified in this study to meet them at present. However, the partial M segment 
sequence data did show only 83% genetic homology (a 17% difference) with the 
nearest known hantavirus relative (THAIV) and similar results (admittedly with 
more sequence data) have been considered evidence of novel hantavirus genotypes in 
the past [Plyusnina A et al., 2009; Cruz et al., 2012]. Therefore I suggest that the 
hantavirus identified in this study is a novel genotype most closely related to THAIV 
and propose that it be called Ragama virus (RAGV). 
 
A more recent study in the Central Province of Sri Lanka recruited 105 patients with 
suspected leptospirosis or hantavirus infection and found that 8 (7.6%) had positive 
hantavirus serology [Gamage et al., 2011]. Overall these titres were highest against 
THAIV, then SEOV and then HTNV and so these findings are consistent with my 
own. Until now THAIV and related viruses, such as Serang virus (SERV) [Plyusnina 
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et al., 2009], have only been identified in rodents and there has been only indirect 
serological evidence and limited clinical evidence of human infection [Pattamadilok 
et al., 2006; Chandy et al., 2009b; Gamage et al., 2011]. The patient (R504) from 
whom this THAIV-like hantavirus (RAGV) was identified had an illness that was 
compatible with a mild hantavirus infection and no other infectious disease was 
diagnosed from the extensive microbiological investigations used in this study. The 
patient’s previous splenectomy could have contributed to his illness (although this 
would be unusual for a viral illness) and the fact that the virus was detectable 3 days 
after the onset of symptoms. 
 
Since the reservoir hosts for THAIV and SERV are known to be the greater 
bandicoot rat (Bandicota indica) and the Asian house rat (Rattus tanezumi) 
respectively, it would be worth trying to isolate hantaviruses from similar rodent 
species in Sri Lanka to see how they compare with the hantavirus (RAGV) identified 
in this study. Bandicoot rats are known locally in Sinhalese as the “Uru-Meeya” or 
“Pig-Rat” and also include the lesser bandicoot rat (Bandicota bengalensis). 
 
4.2.9  Co-Infections 
 
Co-infections are a common finding in comprehensive studies of undifferentiated 
febrile illnesses in the tropics and sub-tropics and do raise questions regarding false 
positive results, which could arise due to cross-reactions in PCR or serology tests or 
else persistent antibody titres in serology tests. Co-infections were reported in 28 
(3%) of 876 patients in Patan, Nepal [Murdoch et al., 2004], 19 (18%) of 103 
patients in Dhulikhel, Nepal [Blacksell et al., 2007], 34 (6%) of 613 patients on the 
Thai-Burmese border [Ellis et al., 2006] and 112 (13%) of 845 patients in Thailand 
[Suttinont et al., 2006]. In this study co-infections were found in 30 (4.9%) of 617 
patients, which is similar or less than in previous studies. The most common co-
infection was dengue and chikungunya (involving 10 of 137 dengue and 103 
chikungunya patients), which is epidemically very plausible and the diagnoses were 
made by a combination PCR and well-defined serology tests. The next most common 
co-infections were Q fever with various other infections (involving 9 of 18 Q fever 
cases) and rickettsial infections with various other infections (involving 5 of 14 
rickettsial infection cases). These results are of greater concern because they are 
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unexpectedly frequent, epidemiologically less plausible and both Q fever and 
rickettsial infections were diagnosed by serology tests alone. 
 
4.2.10  Quality Assurance for Reference Laboratories 
 
One rarely questions the accuracy of diagnostic results from reference laboratories 
and this is understandable considering their expertise, internal validation systems, 
publications, prestige and generosity in supporting the work of others. Hence their 
results are rarely compared with those of other reference laboratories and this is 
especially true for the most rare infections found in this study. However, questions 
do arise because of the discrepancies in scrub typhus results between Marseille and 
Bangkok, especially regarding patients with eschars (Sections 3.2.8 & 4.2.5) and also 
due to the unexpectedly high number of co-infections involving Q fever and 
rickettsial infections (Section 4.2.9). These problems are partly due to the fact that 
these diagnoses were made using serology tests only, which can take more than two 
weeks to become positive and may then remain positive for many months. Also a 
recent comparison of Q fever serology results between three different international 
reference laboratories has shown significant differences [Healy et al., 2011]. Possible 
solutions to these problems include greater co-operation between reference 
laboratories (eg. through a quality assurance system similar to the Clinical Pathology 
Accreditation scheme in the UK) and the development of more direct diagnostic 
methods (eg. PCR and antigen detection tests) for these particular infections. 
 
4.3  Clinical Prediction Rules 
 
Previous fever studies in south and south-east Asia have usually concentrated on 
microbiology findings and paid less attention to correlating the diagnoses made with 
clinical findings (Section 1.3). Even when logistic regression has been performed the 
results have usually been unhelpful [Murdoch et al., 2004; Ellis et al., 2006] and one 
is left wondering if enough attention has been give to this issue or if useful prediction 
rules are an impossibility with such a wide range of undifferentiated febrile illnesses. 
Developing such rules for the most common infections identified was one of the 
aims of my study and the final results were disappointing because the diagnostic 
performance of the logistic regression model and clinical prediction rules were poor 
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and deteriorated significantly as they were refined using imputed data and selected 
variables (Tables 3.3.1.7 & 3.3.2.7). 
 
The clinical prediction rules for both dengue and chikungunya had poor sensitivities 
(with poor PPVs) and good specificities (with good NPVs) when using the default 
probability cut-off of 0.5. One instinctively looks for a high sensitivity (with a low 
false negative rate) in screening assessments such as these because a negative result 
will be very good at ruling out disease and a positive result will usually be further 
investigated with more specific laboratory tests. The utility of a high specificity (with 
a low false positive rate) is perhaps less obvious, but a positive result will be very 
good at ruling in disease. Therefore the high specificity of the prediction rules could 
be used to identify patients with a very high chance of either dengue or chikungunya 
for early discharge from hospital, assuming that there were no complications. 
Alternatively, the rules could be used to identify cases for further study (eg. 
surveillance of viral genotypes), assuming that cases identified by the rule were 
representative of all cases. 
 
Obviously, both good sensitivity and specificity are desirable, but the ROC curve 
analysis shows that this could not be achieved and so one must choose either a high 
sensitivity (by moving the probability cut-off) or high specificity (by using the 
default probability cut-off). The clinical prediction rules developed here can be used 
with a high sensitivity cut-off, but the resulting poor specificity (with a high false 
positive rate) would make this of limited value in defining suspected cases for further 
diagnostic testing. 
 
One reason for the poor results was the amount of missing data, which required 
imputation before analysis could be performed and this led to a loss of diagnostic 
accuracy (Tables 3.3.1.7 & 3.3.2.7). The missing data is mostly explained by the 
very large number of variables involved in the database (403 in total, of which 59 
recorded at the point of admission were used in the logistic regression model) and 
also by the use of laboratory results that were expected from all patients as part of 
their routine clinical management, but which were often not done. In future a smaller 
number of variables could be used and these should be chosen for a specific disease 
by considering the variables that were significantly associated with it in this study. 
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This smaller amount of data should then all be collected as part of that study without 
relying on data obtained from the routine management of patients. 
 
Another limitation of the clinical prediction rules developed in this study is that they 
are based on data obtained during the chikungunya outbreak in Sri Lanka from 2006-
7 and the number of cases seen each year is thought to have decreased dramatically 
since then. This is important for statistical reasons because higher prevalence leads to 
increased sensitivity and PPV, but decreased specificity and NPV. With similar 
numbers of dengue and chikungunya patients included, the rules should be good at 
distinguishing between these infections, which have very similar clinical features at 
presentation. However, they are not optimised for use when dengue is much more 
common than chikungunya, which is the normal epidemiological situation in Sri 
Lanka. In view of their similar clinical features, one could speculate that the dengue 
clinical prediction rule might have performed better if less chikungunya cases had 
been seen. Seasonal variation can also create problems for clinical prediction rules, 
which is one reason why this study was conducted over a complete year. The rules 
developed were not analysed for any seasonal variation because Sri Lanka has two 
variable rainy seasons each year (Figure 3.1.1.5) and arboviral infections occur 
throughout the whole year (Figure 3.1.1.3). Therefore it would be difficult, imprecise 
and rather artificial to create rules that worked for specific seasons only. Overall, 
variations in epidemiology pose a greater problem for the use of diagnostic rules 
compared to laboratory diagnostics. 
 
The fact that co-infections occurred in 18 (13.1%) of 137 dengue cases and 13 
(12.6%) of 103 chikungunya cases raises the question as to whether these cases 
should have been excluded during the development of clinical prediction rules. 
Ultimately, it was decided to include these cases because the majority were thought 
be genuine (including 10 cases of dengue/chikungunya co-infection) and any rules 
that were successfully developed would need to be able to reflect this fact. Also the 
omission of these cases from the analysis would probably have further compromised 
the statistical significance of the rules developed. 
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4.4  Commercial Diagnostic Tests 
 
The Panbio Dengue Duo Cassette performed poorly with both admission and follow-
up samples in comparison to the AFRIMS serology and RT-PCR tests used to define 
true dengue cases in this study. Its diagnostic performance (especially sensitivity) 
improved from admission to follow-up samples, which was expected since the onset-
to-admission time in dengue is usually short and so even IgM antibodies may not 
have risen to the detection threshold in admission samples. However, the observed 
down-grading of the IgM result for this test from admission to follow-up samples 
shows that cases would have been missed if only follow-up samples were tested. 
Therefore both admission and follow-up testing is necessary to avoid missing cases 
that would otherwise be identified. This is an important point to remember for future 
clinical and research work since there may be a temptation to use the test only on 
admission or follow-up when resources are limited. The ability of the test to 
distinguish primary from secondary dengue infections was generally good, but 
primary infections on follow-up samples were often wrongly classified because IgG 
results are more likely to become positive (and be interpreted as secondary 
infections) with increasing time after the onset of infection. 
 
Further evaluation of this Panbio Dengue Duo Cassette along with other dengue 
rapid diagnostic tests was performed using only those patients from this study who 
had paired serology samples and used only the AFRIMS serology (but not the RT-
PCR) results to define confirmed dengue infections [Blacksell et al., 2011b). In this 
select group the diagnostic indices (with 95% CIs) improved with sensitivity 70.7% 
(60.7–79.4%), specificity 80.0% (73.0–85.9%), PPV 68.6% (58.7–77.5%) and NPV 
81.5% (74.6–87.3%), which compared favourably to other commercial point-of-care 
serology tests. Further improvements in diagnostic accuracy were also achieved by 
combining serology results with antigen detection of the NS1 antigen as described in 
Section 3.4.2. Another recent study that evaluated commercial IgM and NS1 
detection ELISAs on admission samples has also reported similar results for the tests 
from Panbio (sensitivity 87.9% and specificity 84.5%) and Standard Diagnostics 
(sensitivity 87.4% and specificity of 95.6%) [Blacksell et al., 2012]. 
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It is not surprising that the diagnostic performance of these commercial assays 
improved when used on a select group of patients who had paired samples that were 
all positive on reference serology tests. Although this is a fair way to assess the 
performance of commercial assays, it does ignore the real-life occurrence of cases 
that are diagnosed without paired samples or by RT-PCR tests only, which probably 
explains why the Panbio Dengue Duo Cassette performed less well when used 
prospectively for all patients in this study. The issue of gold standard diagnostic tests 
having low sensitivity is now being investigated using Bayesian latent class models 
[Limmathurotsakul et al., 2012] and so the data obtained from this study have also 
been used recently to estimate the true accuracy of diagnostic tests for dengue 
infection using the same approach [Pan-Ngum et al., 2013]. 
 
In comparison, commercial diagnostic tests for chikungunya are much less 
developed and likely to remain so whilst there is less demand for them due to the 
epidemic (rather than endemic) nature of this disease. The earliest versions evaluated 
in this study performed poorly on acute samples, but so too did the reference 
serology test and only the RT-PCR test achieved acceptable results [Blacksell et al., 
2011a]. Similar results for serology assays have been reported since [Kosasih et al., 
2012] and there seems to be little prospect of an antigen detection test being 
developed at present. 
 
4.5  Limitations & Further Studies 
 
The main limitations of this study were the fact that it coincided with an epidemic of 
chikungunya, the 48.6% follow-up rate that compromised paired serology tests, the 
use of non-optimised diagnostic tests for use in Sri Lanka and the missing data that 
compromised the development of clinical prediction rules.  
 
There is no way that the chikungunya epidemic could have been avoided when 
conducting this study, but it does mean that the epidemiology results and clinical 
prediction rules may not be applicable in future years. However, the fact that similar 
numbers of confirmed dengue and chikungunya cases were recruited did provide an 
opportunity to develop clinical prediction rules and evaluate diagnostic tests that 
would distinguish between them. 
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Low follow-up rates are known to be a major problem when conducting fever studies 
in developing countries and are especially significant due to the use of serology tests 
that require paired samples. This problem was anticipated at the beginning of the 
study and so travel expenses were paid to all those who attended follow-up and a 
reminder card was sent those who did not. Despite reinforcing these measures 
throughout the study, the follow-up rate remained ~50% throughout and this was 
probably due to the considerable distances that many patients had to travel to reach 
hospital and also because most patients in Sri Lanka attach little importance to 
clinical follow-up if their symptoms have resolved. Another recent fever study in Sri 
Lanka visited people at home to obtain follow-up data and samples if they did not 
attend for follow-up and were able to obtain paired samples in 82.4% of cases [Reller 
et al., 2011], which seems to be a good idea for any future studies. Fortunately, the 
two most common infections found (dengue and chikungunya) were both identifiable 
by PCR tests performed in this study, but this is a circular argument since the 
availability of such tests ensured that these cases were identified. 
 
There was no way to avoid the use of non-optimised tests for use in Sri Lanka during 
this study and this was a particular problem for leptospirosis and rickettsial 
infections. Hopefully, more appropriate tests can now be identified and developed 
using the data and samples obtained in this study. For leptospirosis the use of PCR 
tests and Bayesian latent class models to evaluate existing tests (eg. the screening 
IgM ELISA used) would be appropriate. For rickettsial infections there needs to be 
some harmonisation of the scrub typhus results obtained in the Marseille and 
Bangkok laboratories and tests for Rickettsia conorii subspecies indica should be 
developed and evaluated. More directs tests (eg. culture and PCR) need to be 
performed on suspected rickettsial infection patients in Sri Lanka to identify the 
exact species and strains involved so that diagnostic tests can then be improved. 
 
Overall there was not a large amount of missing data for patients in this study, but 
there were a large number of patients with a small amount of missing data each, 
which interfered with the multiple logistic regression and clinical prediction rules. 
This occurred due to the large amount of data recorded on each patient and the use of 
“opportunistic results” that were generated by investigations used in the patients’ 
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clinical management. In future it should be possible to study individual diseases by 
collecting a smaller amount of data on each patient and ensuring that all laboratory 
tests are performed as part of the study rather than as part of patients’ expected 
clinical management. 
 
Future studies in Sri Lanka on undifferentiated febrile illnesses would be well worth 
performing since there is such a wide range of causes and renewed interest in 
researching non-malarial acute undifferentiated fevers [Naing & Kassim, 2012]. 
Using the data and samples obtained in this study, it should be possible to identify 
selection criteria or commercial diagnostic tests that would allow suspected cases of 
individual diseases to be recruited into smaller and more focussed studies. 
Confirming these diagnoses would then need even greater efforts to obtain paired 
samples (eg. by performing home visits) and improved diagnostic tests that do not 
require paired samples (eg. PCR tests) would be especially useful. I believe that 
further studies on antibiotic resistance, tuberculosis, leptospirosis, Q fever, rickettsial 
infections and hantavirus infection would be the most worthwhile because these were 
the most difficult to diagnose in this study. 
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Appendix 1 
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Data Collection for a Fever Study in Sri Lanka 
 
Last Updated 16 November 2006 
 
See Appendix 2 for the consent form 
 
Demographic details 
Name  BHT  UI 1  
Address  Age  Sex  
GN division 2  GN code 2     
Number of years of education  Number of people in household  
Household income (LKR per month)  Patient is main income provider 3 YES / NO 
Exposures within the previous 4 weeks 
Travel overseas NO / YES =  
Close contacts affected 4 
household member / visitor to house / non-visiting neighbour / work contact / other 
(give details + numbers) 
Place of work / occupation 
animal farm / paddy field / other arable farm / handling fish / river / drains / sewers 
other (give details) 
Water 5 
(please tick) Boiled Bottled Tap Well Reservoir Stream 
Drinking       
Washing 6       
Bathing 7       
Eating 
uncooked vegetables 8 never / monthly / weekly / daily 
with unwashed hands 9 never / monthly / weekly / daily 
Skin 
usual footwear 10 boots / closed shoes / open sandals / barefoot 
any skin wounds 11 YES / NO Site  
Arthropods 
visited scrub jungle 12 YES / NO Where  
definite tick bite 13 YES / NO Site  
Animals 14 
(please tick) None Present in area Present at house Direct contact 
Rodents     
Dogs     
Cats     
Pigs     
Cattle     
Sheep     
Goats     
Horses     
Birds     
Admission Data 
Name of hospital  Name of ward  
Date of arrival in hospital  Date of onset of illness 15  
Other medical problems (give details) 
Antibiotics before arrival NO / unknown medicine / unknown antibiotic / YES =  
Previous typhoid vaccine YES / NO / UNSURE Previous JE vaccine YES / NO / UNSURE 
Smoking consumption ______ cigarettes / day Alcohol consumption ______ units / week 
Blood cultures sent YES / NO Labelling + date of cultures   
Heparinised blood sent YES / NO Labelling + date of blood   
Serum samples (admission) YES / NO Labelling + date of serum   
PCR sample sent YES / NO Labelling + date of sample   
Urine sample sent YES / NO Labelling + date of urine   
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Clinical Features 
Fever (subjective) 16 YES / NO / UNSURE Fever (recorded) 17 ______ °C or ______ °F 
Fever type 18 continuous / intermittent / biphasic Fever duration(s) 19  
Other clinical features 20 Y / N / U Onset Duration Other clinical features 20 Y / N / U Onset Duration 
Chills (cold sweats) Y / N / U   Rigors Y / N / U   
Wound Y / N / U   Eschar Y / N / U   
Skin flushing Y / N / U   Skin rash  Y / N / U   
Icterus or Jaundice Y / N / U   Haemorrhage or Bruising Y / N / U   
Pruritis Y / N / U   Lymphadenopathy Y / N / U   
Conjunctival suffusion Y / N / U   Conjunctival haemorrhage Y / N / U   
Sore throat Y / N / U   Abnormal taste Y / N / U   
Headache Y / N / U   Neck stiffness Y / N / U   
Photophobia Y / N / U   Focal neurological signs Y / N / U   
Confusion Y / N / U   ↓ Glasgow Coma Scale 21      /15   
Hypotension Y / N / U   Myocarditis 22 Y / N / U   
Chest pain Y / N / U   Dyspnoea Y / N / U   
Cough Y / N / U   Sputum Y / N / U   
Haemoptysis Y / N / U   Weightloss (subjective) Y / N / U   
Anorexia Y / N / U   Constipation Y / N / U   
Abdominal pain Y / N / U   Abdominal distension Y / N / U   
Nausea Y / N / U   Vomiting Y / N / U   
Diarrhoea Y / N / U   Bloody diarrhoea Y / N / U   
Hepatomegaly Y / N / U   Splenomegaly Y / N / U   
Oliguria < 400 ml/day Y / N / U   Dysuria Y / N / U   
Myalgia Y / N / U   Arthralgia Y / N / U   
Admitted to ITU Y / N / U Antibiotics given  
Other clinical features (give details) 
Investigation results 23 First Worst Date Investigation results 23 First Worst Date 
Haematocrit    Haemoglobin    
White cell count    Neutrophils    
Lymphocytes    Platelets    
ESR    CRP    
Sodium    Potassium    
Urea    Creatinine    
Bilirubin    SGPT    
SGOT    CPK    
Tourniquet test    Urinalysis (manual)  
CXR  ECG  
Other imaging results (give details) 
Other microbiol. results 24 (give details) 
Other investigation results (give details) 
Discharge / Mortality Data 
Initial diagnosis 25 UF / VF / _____________ NA / probable / confirmed DRT aware YES / NO 
Final diagnosis 26 UF / VF / _____________ NA / probable / confirmed DRT aware YES / NO 
Outcome of case discharge / left / death Notify with final results YES / NO 
Date of discharge / death  Cause / mode of death  
Serum samples (discharge) YES / NO Labelling + date of serum   
Follow-Up Data (usually 2 weeks after discharge) 
Date of follow-up  Estimated time off work  
Features at follow-up 27 (give details) 
Knows name of disease YES / NO Understands transmission YES / NO / NA 
Serum samples (follow-up) YES / NO Labelling + date of serum   
 
UI ____________ 
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Local Microbiology Results 
Blood films for 
malaria parasites 
1st = NEG / POS / EQ / ND 2nd = NEG / POS / EQ / ND 3rd = NEG / POS / EQ / ND 
Species = NA / unidentified / P. falciparum / P. vivax / both species 
Panbio dengue serology 
(Dengue Duo Cassette) 
IgM = NEG / POS / EQ / ND IgG = NEG / POS / EQ / ND Date : 
IgM = NEG / POS / EQ / ND IgG = NEG / POS / EQ / ND Date : 
IgM = NEG / POS / EQ / ND IgG = NEG / POS / EQ / ND Date : 
MMU dengue PCR PCR = NEG / POS / EQ / ND Genotype = Date : 
Improved in-house 
blood culture 
NEG / POS / CONTAMINANT / ND Species =  
Sensitivities =  
Manual BacT/ALERT 
blood culture 
NEG / POS / CONTAMINANT / ND Species = 
Sensitivities = 
Heparinised blood 
culture for leptospires 
NEG / POS / ND Species = 
Serovar =  
Urine antibiotic screen Strep. = NEG / POS / ND E. coli = NEG / POS / ND Bacillus = NEG / POS / ND 
Other microbiology tests 
 
 
Overseas Microbiology Results 
Leptospirosis ELISA 
 (UK – LRU) 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
Leptospirosis MAT 
(UK – LRU) 
Admission date :       
Discharge date :        
Follow-up date :       
Murine typhus serology 
(Thailand – Wellcome) 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
Murine typhus serology 
(UK or France) 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
Scrub typhus serology 
(Thailand – Wellcome) 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
Scrub typhus serology 
(UK or France) 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
Dengue serology 
(UK – HPA) 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
Chikungunya serology 
(UK – HPA) 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
Jap. encephalitis serology 
(UK – HPA) 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
Hantavirus serology 
(UK – HPA) 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
Other serology 
Admission date : IgM =  IgG =  
Discharge date :  IgM =  IgG =  
Follow-up date : IgM =  IgG =  
UI ____________ 
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Definitions 
 
 1.  “Unique identifier” = eg. first patient from Ragama = R001, ninety-ninth patient from Polonnaruwa = P099 
 
 2.  “GN division” = Grama Niladhari (Sewaka) division = defined administrative area (similar to a postcode) 
 
 3.  “Main income provider” = makes biggest contribution to family income 
 
 4.  “Close contacts affected” : “neighbours” = within 100 metres, “contacts” = seen most days 
 
 5.  “Water” → tick the type of water used most often for each application 
 
 6.  “Washing” = non-immersion from washing pots, clothes or oneself 
 
 7.  “Bathing” = immersion from showering or bathing 
 
 8.  “Uncooked” = never placed in boiling water 
 
 9.  “Unwashed hands” = hands were not washed with soap & water before eating 
 
10.  “Usual footwear” → circle whichever single type is worn most often during the day 
 
11.  “Skin wounds” = any break (incision, laceration or scratch) in the skin that draws blood 
 
12.  “Visited scrub jungle” = any time spent out doors in a “scrub jungle” area 
 
13.  “Definite tick bite” = tick seen at site of bite 
 
14.  “Animals” → tick the closest contact for each animal 
 
15.  “Date of onset of illness” = when symptoms first began (illness is considered “acute” if < 2 weeks duration) 
 
16.  “Fever (subjective)” = occurring before or during the first 24 hours of admission 
 
17.  “Fever (recorded)” = maximum oral temperature in first 24 hours (by glass/mercury thermometer) 
 
18.  “Fever type” :  “continuous” = temperature never drops below 37.5 °C 
          “intermittent” = temperature drops below 37.5 °C for < 24 hours 
             “biphasic” = temperature drops below 37.5 °C for > 24 hours, but then recurs 
 
19.  “Fever duration” = from time of first temperature ≥ 38 °C until temperature < 37.5 °C for > 24 hours 
 
                 for biphasic fevers → record durations of initial fever, afebrile periods & recurrent fevers 
 
20. “Other clinical features” : “onset” = in relation to date of arrival in hospital 
                           eg. feature occurring 7 days before arrival = “-7 days” 
             eg. feature occurring 3 days after arrival = “+3 days” 
 
             the duration of features that persist at discharge should be recorded as “> x days” 
 
21.  “↓ Glasgow Coma Scale” = lowest score as measured using the standard 15 point scale 
 
22.  “Myocarditis” = clinical diagnosis by consultant physician 
 
23.  “Investigation results” → record the first result and the “worst” (most abnormal) result during admission 
        and also record the date of the “worst” result 
 
24.  “Other microbiol. results” = microbiology results not determined from blood samples 
 
25.  “Initial diagnosis” = most likely diagnosis at 24 hours after admission 
                   (UF = undifferentiated fever / VF = viral fever / DRT = dengue rapid test result) 
 
26.  “Final diagnosis” = most likely diagnosis at discharge or death 
                 (UF = undifferentiated fever / VF = viral fever / DRT = dengue rapid test result) 
 
27.  “Features at follow-up” = clinical features (symptoms + signs) that are either persistent or new at follow-up 
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Consent Form for a Fever Study in Sri Lanka 
 
Last Updated 19 November 2006 
 
 
English Version 
 
 
We are conducting a study in order to improve the diagnosis of infectious diseases in Sri 
Lanka. This work is being done in collaboration with several overseas universities, who have 
facilities that are not available in this country. 
 
The study will involve recording information on patients who are admitted with a fever and 
performing some additional blood and urine tests (free of charge). The information recorded 
for the study will be stored anonymously. We estimate that the amount of blood required for 
the study will be 4 teaspoonfuls more than is usually required on admission and 2 
teaspoonfuls more than is usually required on discharge and follow-up. Patients involved in 
the study will be treated in exactly the same way as other patients, but may benefit from the 
extra diagnostic tests being performed. 
 
This study has been approved by the Ethics Committee of the Faculty of Medicine of the 
University of Kelaniya and results will be available in due course from Dr Ranjan Premaratna 
and Dr Shaluka Jayamanne. 
 
I have read / heard and understood the information above. 
 
I agree to allow information from my case to be used in this study. 
 
I agree to have additional blood samples taken as described above. 
 
I understand that I can choose to withdraw from this study at any time. 
 
 
 
Name …………………………………………………………………………………………… 
 
Signature ………………………………………. Date ………………………………………… 
 
 
 
Sinhala and Tamil versions of this consent form are provided overleaf. 
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Ys% ,xldfõ mj;sk wdidok frda. ;;aj ms<snoj lrkq ,nk 
iuSlaIKh 
  
 
 
Ys% ,xldfõ wdidok frda. ksjerosj yoqkd.ekSu ms<snoj iuSlaIKhla 
oekg meje;afõ. fuu iuSlaIKh jsfoaYsh jsYajjsoHd, yd iïnkaO jS lrkq 
,nk w;r tu.ska wm rfÜ oekg fkdue;s mrSlaIK myiqlï ,nd 
.ekSugo wmg yelsjS we;.  
 
fï ioyd WK frda. ;;ajhla iys;j frday,a .; jk frda.Skaf.ka tu 
frda.h ms<snoj jsia;r oek .ekSug wjYH fõ. mrSlaIK ioyd wu;r 
uq;%d yd reOsr idïm, lsysmhla ,nd .ekSugo wjYH fõ. ^frday,g we;,;a 
jSfïoS reOsrh f;a ye|s 4la muK iy frday,ska msgj hdfïoS f;a ye|s 2la 
muK& fuu mrSlaIKh ioyd Tng lsisoq uqo,la jeh fkdfõ" m%;sldr l%u 
tf,iskau isoq lrk w;r Tn fuu mrSlaIKhg we;=,;a jSu ;=,ska wm 
isoqlrk wu;r jsfYaI mrSlaIK u.ska Tnf.a  frda. ;;ajh blaukska 
yoqkd .ekSfï wjia:dj ie,fikq we;ehs wms n,dfmdfrd;a;+ fjuq'   
 
wm jsiska ,nd .kakd ish,qu f;dr;=re j, ryiHNdjh iqrlsk w;r Tng 
fuu mrSlaIKfhka ´kEu fõ,djl bj;ajSugo mq:Zjk" fï ms<snoj 
wmeyeos,s lreKq iy wu;r f;dr;=re Tng iuSlaIl ffjoHjrekaf.ka 
,nd .; yel" 
 
 
 
frda.shdf.a leue;a; m%ldY lsrSu 
 
ud by; ioyka f;dr;=re lshjd f;areï .;a njg;a, fuu iuSlaIKh 
ioyd iyNd.S jSug;a udf.a leue;aa; m%ldY lrus" fï ioyd udf.a frda. 
;;ajh ms<sno f;dr;=re ,nd oSug;a, wu;r reOsr idïm, lsysmhla ,nd 
oSugo leue;a; m%ldY lrus" 
 
 
ku ( ------------------------------------------- 
 
w;aik (----------------------------------------- 
 
oskh (------------------------------------------- 
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